Hikma Pharmaceuticals
FDA Approved Drugs
Hikma Pharmaceuticals
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 1144
- Latest Approval Date Jul 28, 2026
- Data Source FDA
- First Approval Date Jan 01, 1982
Company Overview
Social Profiles
Company Snapshot
Hikma Pharmaceuticals
1 New Burlington Place, Mayfair, London, W1S 2HR
United Kingdom
www.hikma.com/home/ Sarrar@hikma.com View on MapFDA Approved Drug Records ( 1144 records )
Drug Name
ABIRATERONE ACETATE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2018-10-31
Active Ingredient
ABIRATERONE ACETATE
Application Number
208339
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2018-10-31
Regulatory Status
RX
Drug Name
ACARBOSE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2008-05-07
Active Ingredient
ACARBOSE
Application Number
78470
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2008-05-07
Regulatory Status
RX
Drug Name
ACARBOSE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2008-05-07
Active Ingredient
ACARBOSE
Application Number
78470
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2008-05-07
Regulatory Status
RX
Drug Name
ACARBOSE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2008-05-07
Active Ingredient
ACARBOSE
Application Number
78470
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2008-05-07
Regulatory Status
RX
Drug Name
ACETAMINOPHEN
Product Number
1
Dosage Form
-
Strength
1GM/100ML (10MG/ML)
Approval Date
2016-06-13
Active Ingredient
ACETAMINOPHEN
Application Number
202605
Product Number
1
Dosage Form
-
Strength
1GM/100ML (10MG/ML)
Approval Date
2016-06-13
Regulatory Status
RX
Drug Name
ACETAMINOPHEN
Product Number
1
Dosage Form
-
Strength
1GM/100ML (10MG/ML)
Approval Date
2022-06-03
Active Ingredient
ACETAMINOPHEN
Application Number
206968
Product Number
1
Dosage Form
-
Strength
1GM/100ML (10MG/ML)
Approval Date
2022-06-03
Regulatory Status
RX
Drug Name
ACETAZOLAMIDE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1995-02-28
Active Ingredient
ACETAZOLAMIDE SODIUM
Application Number
40089
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1995-02-28
Regulatory Status
RX
Drug Name
ACYCLOVIR
Product Number
1
Dosage Form
-
Strength
200MG/5ML
Approval Date
2005-06-07
Active Ingredient
ACYCLOVIR
Application Number
77026
Product Number
1
Dosage Form
-
Strength
200MG/5ML
Approval Date
2005-06-07
Regulatory Status
Discontinued
Drug Name
ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1997-12-19
Active Ingredient
ACYCLOVIR SODIUM
Application Number
74885
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1997-12-19
Regulatory Status
Discontinued
Drug Name
ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1997-12-19
Active Ingredient
ACYCLOVIR SODIUM
Application Number
74885
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1997-12-19
Regulatory Status
Discontinued
Drug Name
ACYCLOVIR SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1997-10-15
Active Ingredient
ACYCLOVIR SODIUM
Application Number
74913
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1997-10-15
Regulatory Status
Discontinued
Drug Name
ACYCLOVIR SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1997-10-15
Active Ingredient
ACYCLOVIR SODIUM
Application Number
74913
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1997-10-15
Regulatory Status
Discontinued
Drug Name
ACYCLOVIR SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2016-02-29
Active Ingredient
ACYCLOVIR SODIUM
Application Number
205771
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2016-02-29
Regulatory Status
Discontinued
Drug Name
ACYCLOVIR SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2016-02-29
Active Ingredient
ACYCLOVIR SODIUM
Application Number
205771
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2016-02-29
Regulatory Status
Discontinued
Drug Name
ADENOSINE
Product Number
1
Dosage Form
-
Strength
3MG/ML
Approval Date
2004-06-16
Active Ingredient
ADENOSINE
Application Number
76404
Product Number
1
Dosage Form
-
Strength
3MG/ML
Approval Date
2004-06-16
Regulatory Status
RX
Drug Name
ADENOSINE
Product Number
1
Dosage Form
-
Strength
3MG/ML
Approval Date
2004-06-16
Active Ingredient
ADENOSINE
Application Number
76500
Product Number
1
Dosage Form
-
Strength
3MG/ML
Approval Date
2004-06-16
Regulatory Status
RX
Drug Name
ADENOSINE
Product Number
1
Dosage Form
-
Strength
3MG/ML
Approval Date
2004-06-16
Active Ingredient
ADENOSINE
Application Number
76501
Product Number
1
Dosage Form
-
Strength
3MG/ML
Approval Date
2004-06-16
Regulatory Status
Discontinued
Drug Name
ALBUTEROL SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/5ML
Approval Date
1998-01-30
Active Ingredient
ALBUTEROL SULFATE
Application Number
74749
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/5ML
Approval Date
1998-01-30
Regulatory Status
Discontinued
Drug Name
ALENDRONATE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 70MG BASE/75ML
Approval Date
2013-02-25
Active Ingredient
ALENDRONATE SODIUM
Application Number
90520
Product Number
1
Dosage Form
-
Strength
EQ 70MG BASE/75ML
Approval Date
2013-02-25
Regulatory Status
RX
Drug Name
ALLOPURINOL SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2004-08-26
Active Ingredient
ALLOPURINOL SODIUM
Application Number
76870
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2004-08-26
Regulatory Status
RX
Drug Name
ALOSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2015-05-04
Active Ingredient
ALOSETRON HYDROCHLORIDE
Application Number
200652
Product Number
1
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2015-05-04
Regulatory Status
Discontinued
Drug Name
ALOSETRON HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2015-05-04
Active Ingredient
ALOSETRON HYDROCHLORIDE
Application Number
200652
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2015-05-04
Regulatory Status
Discontinued
Drug Name
ALPRAZOLAM
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1993-10-31
Active Ingredient
ALPRAZOLAM
Application Number
74312
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1993-10-31
Regulatory Status
RX
Drug Name
ALPROSTADIL
Product Number
1
Dosage Form
-
Strength
0.5MG/ML
Approval Date
1998-01-20
Active Ingredient
ALPROSTADIL
Application Number
74815
Product Number
1
Dosage Form
-
Strength
0.5MG/ML
Approval Date
1998-01-20
Regulatory Status
RX
Drug Name
ALVIMOPAN
Product Number
1
Dosage Form
-
Strength
12MG
Approval Date
2023-08-31
Active Ingredient
ALVIMOPAN
Application Number
217753
Product Number
1
Dosage Form
-
Strength
12MG
Approval Date
2023-08-31
Regulatory Status
RX
Drug Name
AMICAR
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Active Ingredient
AMINOCAPROIC ACID
Application Number
15197
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
AMICAR
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2004-06-24
Active Ingredient
AMINOCAPROIC ACID
Application Number
15197
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2004-06-24
Regulatory Status
RX
Drug Name
AMICAR
Product Number
2
Dosage Form
-
Strength
0.25GM/ML
Approval Date
1982-01-01
Active Ingredient
AMINOCAPROIC ACID
Application Number
15230
Product Number
2
Dosage Form
-
Strength
0.25GM/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
AMIKACIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/ML
Approval Date
1992-05-18
Active Ingredient
AMIKACIN SULFATE
Application Number
63274
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/ML
Approval Date
1992-05-18
Regulatory Status
Discontinued
Drug Name
AMIKACIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/ML
Approval Date
1992-05-18
Active Ingredient
AMIKACIN SULFATE
Application Number
63275
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/ML
Approval Date
1992-05-18
Regulatory Status
Discontinued
Drug Name
AMIKACIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/ML
Approval Date
1994-04-11
Active Ingredient
AMIKACIN SULFATE
Application Number
63313
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/ML
Approval Date
1994-04-11
Regulatory Status
RX
Drug Name
AMIKACIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/ML
Approval Date
1994-04-11
Active Ingredient
AMIKACIN SULFATE
Application Number
63315
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/ML
Approval Date
1994-04-11
Regulatory Status
RX
Drug Name
AMINOCAPROIC
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2001-05-24
Active Ingredient
AMINOCAPROIC ACID
Application Number
75602
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2001-05-24
Regulatory Status
Discontinued
Drug Name
AMINOPHYLLINE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1982-01-01
Active Ingredient
AMINOPHYLLINE
Application Number
84540
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
AMINOPHYLLINE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1982-01-01
Active Ingredient
AMINOPHYLLINE
Application Number
85003
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
AMIODARONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2008-02-25
Active Ingredient
AMIODARONE HYDROCHLORIDE
Application Number
77234
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2008-02-25
Regulatory Status
RX
Drug Name
AMLODIPINE BESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2007-07-09
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77262
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2007-07-09
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2007-07-09
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77262
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2007-07-09
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2007-07-09
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77262
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2007-07-09
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2011-04-12
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77771
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2011-04-12
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2011-04-12
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77771
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2011-04-12
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2011-04-12
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77771
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2011-04-12
Regulatory Status
Discontinued
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
875MG
Approval Date
2006-03-29
Active Ingredient
AMOXICILLIN
Application Number
65255
Product Number
1
Dosage Form
-
Strength
875MG
Approval Date
2006-03-29
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2007-02-05
Active Ingredient
AMOXICILLIN
Application Number
65291
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2007-02-05
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2007-02-05
Active Ingredient
AMOXICILLIN
Application Number
65291
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2007-02-05
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
250MG/5ML
Approval Date
2006-06-19
Active Ingredient
AMOXICILLIN
Application Number
65322
Product Number
1
Dosage Form
-
Strength
250MG/5ML
Approval Date
2006-06-19
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
2
Dosage Form
-
Strength
125MG/5ML
Approval Date
2006-06-19
Active Ingredient
AMOXICILLIN
Application Number
65322
Product Number
2
Dosage Form
-
Strength
125MG/5ML
Approval Date
2006-06-19
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
400MG/5ML
Approval Date
2006-06-19
Active Ingredient
AMOXICILLIN
Application Number
65325
Product Number
1
Dosage Form
-
Strength
400MG/5ML
Approval Date
2006-06-19
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
2
Dosage Form
-
Strength
200MG/5ML
Approval Date
2006-06-19
Active Ingredient
AMOXICILLIN
Application Number
65325
Product Number
2
Dosage Form
-
Strength
200MG/5ML
Approval Date
2006-06-19
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2020-06-25
Active Ingredient
AMOXICILLIN
Application Number
205274
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2020-06-25
Regulatory Status
Discontinued
Drug Name
AMOXICILLIN
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2020-06-25
Active Ingredient
AMOXICILLIN
Application Number
205274
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2020-06-25
Regulatory Status
Discontinued
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
1
Dosage Form
-
Strength
400MG/5ML;EQ 57MG BASE/5ML
Approval Date
2005-01-25
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65191
Product Number
1
Dosage Form
-
Strength
400MG/5ML;EQ 57MG BASE/5ML
Approval Date
2005-01-25
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
2
Dosage Form
-
Strength
200MG/5ML;EQ 28.5MG BASE/5ML
Approval Date
2005-01-25
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65191
Product Number
2
Dosage Form
-
Strength
200MG/5ML;EQ 28.5MG BASE/5ML
Approval Date
2005-01-25
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
1
Dosage Form
-
Strength
600MG/5ML;EQ 42.9MG BASE/5ML
Approval Date
2007-11-09
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65373
Product Number
1
Dosage Form
-
Strength
600MG/5ML;EQ 42.9MG BASE/5ML
Approval Date
2007-11-09
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
1
Dosage Form
-
Strength
875MG;EQ 125MG BASE
Approval Date
2016-08-23
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
203824
Product Number
1
Dosage Form
-
Strength
875MG;EQ 125MG BASE
Approval Date
2016-08-23
Regulatory Status
RX
Drug Name
AMPICILLIN AND SULBACTAM
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL
Approval Date
2002-03-19
Active Ingredient
AMPICILLIN SODIUM; SULBACTAM SODIUM
Application Number
65074
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL
Approval Date
2002-03-19
Regulatory Status
Discontinued
Drug Name
AMPICILLIN AND SULBACTAM
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL
Approval Date
2002-03-19
Active Ingredient
AMPICILLIN SODIUM; SULBACTAM SODIUM
Application Number
65074
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL
Approval Date
2002-03-19
Regulatory Status
Discontinued
Drug Name
AMPICILLIN AND SULBACTAM
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL
Approval Date
2002-03-19
Active Ingredient
AMPICILLIN SODIUM; SULBACTAM SODIUM
Application Number
65076
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL
Approval Date
2002-03-19
Regulatory Status
RX
Drug Name
AMPICILLIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 125MG BASE/VIAL
Approval Date
1986-06-24
Active Ingredient
AMPICILLIN SODIUM
Application Number
62692
Product Number
1
Dosage Form
-
Strength
EQ 125MG BASE/VIAL
Approval Date
1986-06-24
Regulatory Status
Discontinued
Drug Name
AMPICILLIN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
1986-06-24
Active Ingredient
AMPICILLIN SODIUM
Application Number
62692
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
1986-06-24
Regulatory Status
Discontinued
Drug Name
AMPICILLIN SODIUM
Product Number
3
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1986-06-24
Active Ingredient
AMPICILLIN SODIUM
Application Number
62692
Product Number
3
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1986-06-24
Regulatory Status
Discontinued
Drug Name
AMPICILLIN SODIUM
Product Number
4
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1986-06-24
Active Ingredient
AMPICILLIN SODIUM
Application Number
62692
Product Number
4
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1986-06-24
Regulatory Status
Discontinued
Drug Name
AMPICILLIN SODIUM
Product Number
5
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
1986-06-24
Active Ingredient
AMPICILLIN SODIUM
Application Number
62692
Product Number
5
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
1986-06-24
Regulatory Status
Discontinued
Drug Name
AMPICILLIN SODIUM
Product Number
6
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
1986-06-24
Active Ingredient
AMPICILLIN SODIUM
Application Number
62692
Product Number
6
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
1986-06-24
Regulatory Status
Discontinued
Drug Name
AMRINONE LACTATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-05-09
Active Ingredient
INAMRINONE LACTATE
Application Number
75513
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-05-09
Regulatory Status
RX
Drug Name
ANASTROZOLE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2010-06-28
Active Ingredient
ANASTROZOLE
Application Number
78485
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2010-06-28
Regulatory Status
Discontinued
Drug Name
ARGATROBAN
Product Number
1
Dosage Form
-
Strength
250MG/2.5ML (100MG/ML)
Approval Date
2012-01-05
Active Ingredient
ARGATROBAN
Application Number
203049
Product Number
1
Dosage Form
-
Strength
250MG/2.5ML (100MG/ML)
Approval Date
2012-01-05
Regulatory Status
RX
Drug Name
ARGATROBAN
Product Number
2
Dosage Form
-
Strength
50MG/50ML (1MG/ML)
Approval Date
2016-09-30
Active Ingredient
ARGATROBAN
Application Number
203049
Product Number
2
Dosage Form
-
Strength
50MG/50ML (1MG/ML)
Approval Date
2016-09-30
Regulatory Status
RX
Drug Name
ATIVAN
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1982-01-01
Active Ingredient
LORAZEPAM
Application Number
18140
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
ATIVAN
Product Number
2
Dosage Form
-
Strength
4MG/ML
Approval Date
1982-01-01
Active Ingredient
LORAZEPAM
Application Number
18140
Product Number
2
Dosage Form
-
Strength
4MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
ATRACURIUM BESYLATE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1997-07-18
Active Ingredient
ATRACURIUM BESYLATE
Application Number
74901
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1997-07-18
Regulatory Status
RX
Drug Name
ATRACURIUM BESYLATE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1997-07-18
Active Ingredient
ATRACURIUM BESYLATE
Application Number
74900
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1997-07-18
Regulatory Status
RX
Drug Name
ATROPINE SULFATE
Product Number
1
Dosage Form
-
Strength
8MG/20ML (0.4MG/ML)
Approval Date
2021-12-01
Active Ingredient
ATROPINE SULFATE
Application Number
213561
Product Number
1
Dosage Form
-
Strength
8MG/20ML (0.4MG/ML)
Approval Date
2021-12-01
Regulatory Status
RX
Drug Name
ATROPINE SULFATE
Product Number
1
Dosage Form
-
Strength
0.4MG/ML (0.4MG/ML)
Approval Date
2025-10-24
Active Ingredient
ATROPINE SULFATE
Application Number
217345
Product Number
1
Dosage Form
-
Strength
0.4MG/ML (0.4MG/ML)
Approval Date
2025-10-24
Regulatory Status
RX
Drug Name
ATROPINE SULFATE
Product Number
2
Dosage Form
-
Strength
1MG/ML (1MG/ML)
Approval Date
2025-10-24
Active Ingredient
ATROPINE SULFATE
Application Number
217345
Product Number
2
Dosage Form
-
Strength
1MG/ML (1MG/ML)
Approval Date
2025-10-24
Regulatory Status
RX
Drug Name
AZACITIDINE
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
2020-06-08
Active Ingredient
AZACITIDINE
Application Number
209337
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
2020-06-08
Regulatory Status
RX
Drug Name
AZATHIOPRINE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
1995-03-31
Active Ingredient
AZATHIOPRINE SODIUM
Application Number
74419
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
1995-03-31
Regulatory Status
RX
Drug Name
AZELASTINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.137MG/SPRAY
Approval Date
2014-10-24
Active Ingredient
AZELASTINE HYDROCHLORIDE
Application Number
91444
Product Number
1
Dosage Form
-
Strength
0.137MG/SPRAY
Approval Date
2014-10-24
Regulatory Status
Discontinued
Drug Name
AZELASTINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.2055MG/SPRAY
Approval Date
2017-09-22
Active Ingredient
AZELASTINE HYDROCHLORIDE
Application Number
207243
Product Number
1
Dosage Form
-
Strength
0.2055MG/SPRAY
Approval Date
2017-09-22
Regulatory Status
Discontinued
Drug Name
AZITHROMYCIN
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2007-01-18
Active Ingredient
AZITHROMYCIN
Application Number
65265
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2007-01-18
Regulatory Status
Discontinued
Drug Name
AZTREONAM
Product Number
1
Dosage Form
-
Strength
1GM/VIAL
Approval Date
2011-03-23
Active Ingredient
AZTREONAM
Application Number
65286
Product Number
1
Dosage Form
-
Strength
1GM/VIAL
Approval Date
2011-03-23
Regulatory Status
Discontinued
Drug Name
AZTREONAM
Product Number
2
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2011-03-23
Active Ingredient
AZTREONAM
Application Number
65286
Product Number
2
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2011-03-23
Regulatory Status
Discontinued
Drug Name
AZTREONAM
Product Number
1
Dosage Form
-
Strength
1GM/VIAL
Approval Date
2026-02-05
Active Ingredient
AZTREONAM
Application Number
207069
Product Number
1
Dosage Form
-
Strength
1GM/VIAL
Approval Date
2026-02-05
Regulatory Status
Discontinued
Drug Name
AZTREONAM
Product Number
2
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2026-02-05
Active Ingredient
AZTREONAM
Application Number
207069
Product Number
2
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2026-02-05
Regulatory Status
Discontinued
Drug Name
BALSALAZIDE DISODIUM
Product Number
1
Dosage Form
-
Strength
750MG
Approval Date
2007-12-28
Active Ingredient
BALSALAZIDE DISODIUM
Application Number
77806
Product Number
1
Dosage Form
-
Strength
750MG
Approval Date
2007-12-28
Regulatory Status
RX
Drug Name
BENZTROPINE MESYLATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2009-08-31
Active Ingredient
BENZTROPINE MESYLATE
Application Number
90287
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2009-08-31
Regulatory Status
RX
Drug Name
BENZTROPINE MESYLATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2021-10-14
Active Ingredient
BENZTROPINE MESYLATE
Application Number
209442
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2021-10-14
Regulatory Status
RX
Drug Name
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
Product Number
1
Dosage Form
-
Strength
3MG/ML;EQ 3MG BASE/ML
Approval Date
2023-01-17
Active Ingredient
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Application Number
77838
Product Number
1
Dosage Form
-
Strength
3MG/ML;EQ 3MG BASE/ML
Approval Date
2023-01-17
Regulatory Status
RX
Drug Name
BETAMETHASONE DIPROPIONATE
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE
Approval Date
2019-10-11
Active Ingredient
BETAMETHASONE DIPROPIONATE
Application Number
208849
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE
Approval Date
2019-10-11
Regulatory Status
Discontinued
Drug Name
BETAMETHASONE DIPROPIONATE
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE
Approval Date
2018-02-06
Active Ingredient
BETAMETHASONE DIPROPIONATE
Application Number
209896
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE
Approval Date
2018-02-06
Regulatory Status
Discontinued
Drug Name
BEXAROTENE
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2020-06-16
Active Ingredient
BEXAROTENE
Application Number
203663
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2020-06-16
Regulatory Status
RX
Drug Name
BIMATOPROST
Product Number
1
Dosage Form
-
Strength
0.03%
Approval Date
2018-10-09
Active Ingredient
BIMATOPROST
Application Number
203051
Product Number
1
Dosage Form
-
Strength
0.03%
Approval Date
2018-10-09
Regulatory Status
Discontinued
Drug Name
BIMATOPROST
Product Number
1
Dosage Form
-
Strength
0.03%
Approval Date
2018-11-08
Active Ingredient
BIMATOPROST
Application Number
203299
Product Number
1
Dosage Form
-
Strength
0.03%
Approval Date
2018-11-08
Regulatory Status
Discontinued
Drug Name
BLEOMYCIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 30 UNITS BASE/VIAL
Approval Date
2001-10-17
Active Ingredient
BLEOMYCIN SULFATE
Application Number
65042
Product Number
1
Dosage Form
-
Strength
EQ 30 UNITS BASE/VIAL
Approval Date
2001-10-17
Regulatory Status
RX
Drug Name
BLEOMYCIN SULFATE
Product Number
2
Dosage Form
-
Strength
EQ 15 UNITS BASE/VIAL
Approval Date
2001-10-17
Active Ingredient
BLEOMYCIN SULFATE
Application Number
65042
Product Number
2
Dosage Form
-
Strength
EQ 15 UNITS BASE/VIAL
Approval Date
2001-10-17
Regulatory Status
RX
Drug Name
BOSENTAN
Product Number
1
Dosage Form
-
Strength
62.5MG
Approval Date
2019-04-26
Active Ingredient
BOSENTAN
Application Number
208695
Product Number
1
Dosage Form
-
Strength
62.5MG
Approval Date
2019-04-26
Regulatory Status
Discontinued
Drug Name
BOSENTAN
Product Number
2
Dosage Form
-
Strength
125MG
Approval Date
2019-04-26
Active Ingredient
BOSENTAN
Application Number
208695
Product Number
2
Dosage Form
-
Strength
125MG
Approval Date
2019-04-26
Regulatory Status
Discontinued
Drug Name
BRETYLIUM TOSYLATE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1986-05-14
Active Ingredient
BRETYLIUM TOSYLATE
Application Number
70545
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1986-05-14
Regulatory Status
Discontinued
Drug Name
BRETYLIUM TOSYLATE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1986-05-14
Active Ingredient
BRETYLIUM TOSYLATE
Application Number
70546
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1986-05-14
Regulatory Status
Discontinued
Drug Name
BUPIVACAINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
2021-02-11
Active Ingredient
BUPIVACAINE HYDROCHLORIDE
Application Number
205141
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
BUPIVACAINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
0.5%
Approval Date
2021-02-11
Active Ingredient
BUPIVACAINE HYDROCHLORIDE
Application Number
205141
Product Number
2
Dosage Form
-
Strength
0.5%
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
2021-02-11
Active Ingredient
BUPIVACAINE HYDROCHLORIDE
Application Number
204842
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
Product Number
2
Dosage Form
-
Strength
0.5%
Approval Date
2021-02-11
Active Ingredient
BUPIVACAINE HYDROCHLORIDE
Application Number
204842
Product Number
2
Dosage Form
-
Strength
0.5%
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
Product Number
3
Dosage Form
-
Strength
0.75%
Approval Date
2021-02-11
Active Ingredient
BUPIVACAINE HYDROCHLORIDE
Application Number
204842
Product Number
3
Dosage Form
-
Strength
0.75%
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.3MG BASE/ML
Approval Date
2005-03-02
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE
Application Number
76931
Product Number
1
Dosage Form
-
Strength
EQ 0.3MG BASE/ML
Approval Date
2005-03-02
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2009-10-08
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE
Application Number
78633
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2009-10-08
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2009-10-08
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE
Application Number
78633
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2009-10-08
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE;EQ 0.5MG BASE
Approval Date
2014-06-27
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Application Number
203326
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE;EQ 0.5MG BASE
Approval Date
2014-06-27
Regulatory Status
RX
Drug Name
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE;EQ 2MG BASE
Approval Date
2014-06-27
Active Ingredient
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Application Number
203326
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE;EQ 2MG BASE
Approval Date
2014-06-27
Regulatory Status
RX
Drug Name
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Product Number
1
Dosage Form
-
Strength
500MG;50MG;40MG
Approval Date
1998-10-28
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Application Number
40261
Product Number
1
Dosage Form
-
Strength
500MG;50MG;40MG
Approval Date
1998-10-28
Regulatory Status
Discontinued
Drug Name
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Product Number
1
Dosage Form
-
Strength
500MG;50MG;40MG
Approval Date
1999-08-18
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Application Number
40336
Product Number
1
Dosage Form
-
Strength
500MG;50MG;40MG
Approval Date
1999-08-18
Regulatory Status
Discontinued
Drug Name
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Product Number
1
Dosage Form
-
Strength
325MG;50MG;40MG
Approval Date
1995-06-12
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Application Number
89718
Product Number
1
Dosage Form
-
Strength
325MG;50MG;40MG
Approval Date
1995-06-12
Regulatory Status
Discontinued
Drug Name
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Product Number
1
Dosage Form
-
Strength
300MG;50MG;40MG
Approval Date
2022-03-25
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Application Number
215135
Product Number
1
Dosage Form
-
Strength
300MG;50MG;40MG
Approval Date
2022-03-25
Regulatory Status
Discontinued
Drug Name
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Product Number
2
Dosage Form
-
Strength
325MG;50MG;40MG
Approval Date
2022-03-25
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Application Number
215135
Product Number
2
Dosage Form
-
Strength
325MG;50MG;40MG
Approval Date
2022-03-25
Regulatory Status
Discontinued
Drug Name
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Product Number
1
Dosage Form
-
Strength
325MG;50MG;40MG;30MG
Approval Date
2001-03-23
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Application Number
75618
Product Number
1
Dosage Form
-
Strength
325MG;50MG;40MG;30MG
Approval Date
2001-03-23
Regulatory Status
Discontinued
Drug Name
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Product Number
1
Dosage Form
-
Strength
325MG;50MG;40MG;30MG
Approval Date
2022-01-26
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Application Number
215138
Product Number
1
Dosage Form
-
Strength
325MG;50MG;40MG;30MG
Approval Date
2022-01-26
Regulatory Status
RX
Drug Name
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Product Number
2
Dosage Form
-
Strength
300MG;50MG;40MG;30MG
Approval Date
2022-01-26
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Application Number
215138
Product Number
2
Dosage Form
-
Strength
300MG;50MG;40MG;30MG
Approval Date
2022-01-26
Regulatory Status
RX
Drug Name
BUTALBITAL, ASPIRIN AND CAFFEINE
Product Number
2
Dosage Form
-
Strength
325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1984-02-16
Active Ingredient
ASPIRIN; BUTALBITAL; CAFFEINE
Application Number
86162
Product Number
2
Dosage Form
-
Strength
325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1984-02-16
Regulatory Status
Discontinued
Drug Name
BUTORPHANOL TARTRATE
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1998-08-12
Active Ingredient
BUTORPHANOL TARTRATE
Application Number
75046
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1998-08-12
Regulatory Status
RX
Drug Name
BUTORPHANOL TARTRATE
Product Number
1
Dosage Form
-
Strength
1MG/SPRAY
Approval Date
2002-03-12
Active Ingredient
BUTORPHANOL TARTRATE
Application Number
75824
Product Number
1
Dosage Form
-
Strength
1MG/SPRAY
Approval Date
2002-03-12
Regulatory Status
RX
Drug Name
BUTORPHANOL TARTRATE
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2009-04-29
Active Ingredient
BUTORPHANOL TARTRATE
Application Number
78247
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2009-04-29
Regulatory Status
Discontinued
Drug Name
BUTORPHANOL TARTRATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2009-05-01
Active Ingredient
BUTORPHANOL TARTRATE
Application Number
78400
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2009-05-01
Regulatory Status
RX
Drug Name
BUTORPHANOL TARTRATE
Product Number
2
Dosage Form
-
Strength
2MG/ML
Approval Date
2009-05-01
Active Ingredient
BUTORPHANOL TARTRATE
Application Number
78400
Product Number
2
Dosage Form
-
Strength
2MG/ML
Approval Date
2009-05-01
Regulatory Status
RX
Drug Name
BUTORPHANOL TARTRATE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1998-08-12
Active Ingredient
BUTORPHANOL TARTRATE
Application Number
75045
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1998-08-12
Regulatory Status
RX
Drug Name
BUTORPHANOL TARTRATE PRESERVATIVE FREE
Product Number
2
Dosage Form
-
Strength
2MG/ML
Approval Date
1998-08-12
Active Ingredient
BUTORPHANOL TARTRATE
Application Number
75045
Product Number
2
Dosage Form
-
Strength
2MG/ML
Approval Date
1998-08-12
Regulatory Status
RX
Drug Name
CAFCIT
Product Number
1
Dosage Form
-
Strength
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Approval Date
1999-09-21
Active Ingredient
CAFFEINE CITRATE
Application Number
20793
Product Number
1
Dosage Form
-
Strength
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Approval Date
1999-09-21
Regulatory Status
RX
Drug Name
CAFCIT
Product Number
2
Dosage Form
-
Strength
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2000-04-12
Active Ingredient
CAFFEINE CITRATE
Application Number
20793
Product Number
2
Dosage Form
-
Strength
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2000-04-12
Regulatory Status
Discontinued
Drug Name
CALCIPOTRIENE
Product Number
1
Dosage Form
-
Strength
0.005%
Approval Date
2009-11-19
Active Ingredient
CALCIPOTRIENE
Application Number
77579
Product Number
1
Dosage Form
-
Strength
0.005%
Approval Date
2009-11-19
Regulatory Status
Discontinued
Drug Name
CALCITRIOL
Product Number
1
Dosage Form
-
Strength
1MCG/ML
Approval Date
2003-07-18
Active Ingredient
CALCITRIOL
Application Number
76242
Product Number
1
Dosage Form
-
Strength
1MCG/ML
Approval Date
2003-07-18
Regulatory Status
RX
Drug Name
CALCITRIOL
Product Number
1
Dosage Form
-
Strength
0.25MCG
Approval Date
2006-03-27
Active Ingredient
CALCITRIOL
Application Number
76917
Product Number
1
Dosage Form
-
Strength
0.25MCG
Approval Date
2006-03-27
Regulatory Status
RX
Drug Name
CALCIUM ACETATE
Product Number
1
Dosage Form
-
Strength
667MG
Approval Date
2008-01-30
Active Ingredient
CALCIUM ACETATE
Application Number
77693
Product Number
1
Dosage Form
-
Strength
667MG
Approval Date
2008-01-30
Regulatory Status
Discontinued
Drug Name
CALCIUM ACETATE
Product Number
1
Dosage Form
-
Strength
667MG
Approval Date
2008-02-26
Active Ingredient
CALCIUM ACETATE
Application Number
77728
Product Number
1
Dosage Form
-
Strength
667MG
Approval Date
2008-02-26
Regulatory Status
RX
Drug Name
CAPECITABINE
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2016-07-14
Active Ingredient
CAPECITABINE
Application Number
200483
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2016-07-14
Regulatory Status
Discontinued
Drug Name
CAPECITABINE
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2016-07-14
Active Ingredient
CAPECITABINE
Application Number
200483
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2016-07-14
Regulatory Status
Discontinued
Drug Name
CAPTOPRIL
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
1996-02-13
Active Ingredient
CAPTOPRIL
Application Number
74505
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
1996-02-13
Regulatory Status
RX
Drug Name
CAPTOPRIL
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
1996-02-13
Active Ingredient
CAPTOPRIL
Application Number
74505
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
1996-02-13
Regulatory Status
RX
Drug Name
CAPTOPRIL
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
1996-02-13
Active Ingredient
CAPTOPRIL
Application Number
74505
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
1996-02-13
Regulatory Status
RX
Drug Name
CAPTOPRIL
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
1996-02-13
Active Ingredient
CAPTOPRIL
Application Number
74505
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
1996-02-13
Regulatory Status
RX
Drug Name
CARBOPLATIN
Product Number
1
Dosage Form
-
Strength
50MG/VIAL
Approval Date
2004-10-14
Active Ingredient
CARBOPLATIN
Application Number
76099
Product Number
1
Dosage Form
-
Strength
50MG/VIAL
Approval Date
2004-10-14
Regulatory Status
Discontinued
Drug Name
CARBOPLATIN
Product Number
2
Dosage Form
-
Strength
150MG/VIAL
Approval Date
2004-10-14
Active Ingredient
CARBOPLATIN
Application Number
76099
Product Number
2
Dosage Form
-
Strength
150MG/VIAL
Approval Date
2004-10-14
Regulatory Status
Discontinued
Drug Name
CARBOPLATIN
Product Number
3
Dosage Form
-
Strength
450MG/VIAL
Approval Date
2004-10-14
Active Ingredient
CARBOPLATIN
Application Number
76099
Product Number
3
Dosage Form
-
Strength
450MG/VIAL
Approval Date
2004-10-14
Regulatory Status
Discontinued
Drug Name
CARBOPLATIN
Product Number
1
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2004-10-15
Active Ingredient
CARBOPLATIN
Application Number
77244
Product Number
1
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2004-10-15
Regulatory Status
RX
Drug Name
CARBOPLATIN
Product Number
2
Dosage Form
-
Strength
150MG/15ML (10MG/ML)
Approval Date
2004-10-15
Active Ingredient
CARBOPLATIN
Application Number
77244
Product Number
2
Dosage Form
-
Strength
150MG/15ML (10MG/ML)
Approval Date
2004-10-15
Regulatory Status
RX
Drug Name
CARBOPLATIN
Product Number
3
Dosage Form
-
Strength
450MG/45ML (10MG/ML)
Approval Date
2004-10-15
Active Ingredient
CARBOPLATIN
Application Number
77244
Product Number
3
Dosage Form
-
Strength
450MG/45ML (10MG/ML)
Approval Date
2004-10-15
Regulatory Status
RX
Drug Name
CARBOPLATIN
Product Number
4
Dosage Form
-
Strength
600MG/60ML (10MG/ML)
Approval Date
2006-01-20
Active Ingredient
CARBOPLATIN
Application Number
77244
Product Number
4
Dosage Form
-
Strength
600MG/60ML (10MG/ML)
Approval Date
2006-01-20
Regulatory Status
RX
Drug Name
CARISOPRODOL
Product Number
1
Dosage Form
-
Strength
350MG
Approval Date
1996-01-24
Active Ingredient
CARISOPRODOL
Application Number
40124
Product Number
1
Dosage Form
-
Strength
350MG
Approval Date
1996-01-24
Regulatory Status
Discontinued
Drug Name
CARVEDILOL
Product Number
1
Dosage Form
-
Strength
3.125MG
Approval Date
2007-09-07
Active Ingredient
CARVEDILOL
Application Number
77887
Product Number
1
Dosage Form
-
Strength
3.125MG
Approval Date
2007-09-07
Regulatory Status
Discontinued
Drug Name
CARVEDILOL
Product Number
2
Dosage Form
-
Strength
6.25MG
Approval Date
2007-09-07
Active Ingredient
CARVEDILOL
Application Number
77887
Product Number
2
Dosage Form
-
Strength
6.25MG
Approval Date
2007-09-07
Regulatory Status
Discontinued
Drug Name
CARVEDILOL
Product Number
3
Dosage Form
-
Strength
12.5MG
Approval Date
2007-09-07
Active Ingredient
CARVEDILOL
Application Number
77887
Product Number
3
Dosage Form
-
Strength
12.5MG
Approval Date
2007-09-07
Regulatory Status
Discontinued
Drug Name
CARVEDILOL
Product Number
4
Dosage Form
-
Strength
25MG
Approval Date
2007-09-07
Active Ingredient
CARVEDILOL
Application Number
77887
Product Number
4
Dosage Form
-
Strength
25MG
Approval Date
2007-09-07
Regulatory Status
Discontinued
Drug Name
CEFACLOR
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2007-04-03
Active Ingredient
CEFACLOR
Application Number
65350
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2007-04-03
Regulatory Status
Discontinued
Drug Name
CEFACLOR
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2007-04-03
Active Ingredient
CEFACLOR
Application Number
65350
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2007-04-03
Regulatory Status
Discontinued
Drug Name
CEFADROXIL
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
2006-03-30
Active Ingredient
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Application Number
65260
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
2006-03-30
Regulatory Status
Discontinued
Drug Name
CEFADROXIL
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2006-02-07
Active Ingredient
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Application Number
65311
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2006-02-07
Regulatory Status
Discontinued
Drug Name
CEFADROXIL
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/5ML
Approval Date
2012-11-28
Active Ingredient
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Application Number
91036
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/5ML
Approval Date
2012-11-28
Regulatory Status
Discontinued
Drug Name
CEFADROXIL
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/5ML
Approval Date
2012-11-28
Active Ingredient
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Application Number
91036
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/5ML
Approval Date
2012-11-28
Regulatory Status
Discontinued
Drug Name
CEFAZOLIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
1988-01-12
Active Ingredient
CEFAZOLIN SODIUM
Application Number
62807
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
1988-01-12
Regulatory Status
Discontinued
Drug Name
CEFAZOLIN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1988-01-12
Active Ingredient
CEFAZOLIN SODIUM
Application Number
62807
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1988-01-12
Regulatory Status
Discontinued
Drug Name
CEFAZOLIN SODIUM
Product Number
3
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1988-01-12
Active Ingredient
CEFAZOLIN SODIUM
Application Number
62807
Product Number
3
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1988-01-12
Regulatory Status
Discontinued
Drug Name
CEFAZOLIN SODIUM
Product Number
4
Dosage Form
-
Strength
EQ 5GM BASE/VIAL
Approval Date
1988-01-12
Active Ingredient
CEFAZOLIN SODIUM
Application Number
62807
Product Number
4
Dosage Form
-
Strength
EQ 5GM BASE/VIAL
Approval Date
1988-01-12
Regulatory Status
Discontinued
Drug Name
CEFAZOLIN SODIUM
Product Number
5
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
1988-01-12
Active Ingredient
CEFAZOLIN SODIUM
Application Number
62807
Product Number
5
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
1988-01-12
Regulatory Status
Discontinued
Drug Name
CEFAZOLIN SODIUM
Product Number
6
Dosage Form
-
Strength
EQ 20GM BASE/VIAL
Approval Date
1988-01-12
Active Ingredient
CEFAZOLIN SODIUM
Application Number
62807
Product Number
6
Dosage Form
-
Strength
EQ 20GM BASE/VIAL
Approval Date
1988-01-12
Regulatory Status
Discontinued
Drug Name
CEFAZOLIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2001-09-18
Active Ingredient
CEFAZOLIN SODIUM
Application Number
65047
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2001-09-18
Regulatory Status
RX
Drug Name
CEFAZOLIN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2001-09-18
Active Ingredient
CEFAZOLIN SODIUM
Application Number
65047
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2001-09-18
Regulatory Status
RX
Drug Name
CEFAZOLIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2004-10-18
Active Ingredient
CEFAZOLIN SODIUM
Application Number
65143
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2004-10-18
Regulatory Status
RX
Drug Name
CEFAZOLIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2022-10-07
Active Ingredient
CEFAZOLIN SODIUM
Application Number
216109
Product Number
1
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2022-10-07
Regulatory Status
RX
Drug Name
CEFAZOLIN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 3GM BASE/VIAL
Approval Date
2022-10-07
Active Ingredient
CEFAZOLIN SODIUM
Application Number
216109
Product Number
2
Dosage Form
-
Strength
EQ 3GM BASE/VIAL
Approval Date
2022-10-07
Regulatory Status
RX
Drug Name
CEFEPIME HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2024-05-22
Active Ingredient
CEFEPIME HYDROCHLORIDE
Application Number
214402
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2024-05-22
Regulatory Status
RX
Drug Name
CEFEPIME HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2024-05-22
Active Ingredient
CEFEPIME HYDROCHLORIDE
Application Number
214402
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2024-05-22
Regulatory Status
RX
Drug Name
CEFOTAXIME
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2002-11-20
Active Ingredient
CEFOTAXIME SODIUM
Application Number
65071
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2002-11-20
Regulatory Status
Discontinued
Drug Name
CEFOTAXIME
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2002-11-20
Active Ingredient
CEFOTAXIME SODIUM
Application Number
65072
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2002-11-20
Regulatory Status
Discontinued
Drug Name
CEFOTAXIME
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2002-11-20
Active Ingredient
CEFOTAXIME SODIUM
Application Number
65072
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2002-11-20
Regulatory Status
Discontinued
Drug Name
CEFOTAXIME
Product Number
3
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2002-11-20
Active Ingredient
CEFOTAXIME SODIUM
Application Number
65072
Product Number
3
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2002-11-20
Regulatory Status
Discontinued
Drug Name
CEFOTETAN
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2011-10-26
Active Ingredient
CEFOTETAN DISODIUM
Application Number
91031
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2011-10-26
Regulatory Status
Discontinued
Drug Name
CEFOTETAN
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2011-10-26
Active Ingredient
CEFOTETAN DISODIUM
Application Number
91031
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2011-10-26
Regulatory Status
Discontinued
Drug Name
CEFOXITIN
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2000-09-11
Active Ingredient
CEFOXITIN SODIUM
Application Number
65050
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2000-09-11
Regulatory Status
RX
Drug Name
CEFOXITIN
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2000-09-11
Active Ingredient
CEFOXITIN SODIUM
Application Number
65051
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2000-09-11
Regulatory Status
RX
Drug Name
CEFOXITIN
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2000-09-11
Active Ingredient
CEFOXITIN SODIUM
Application Number
65051
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2000-09-11
Regulatory Status
RX
Drug Name
CEFOXITIN
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2010-03-12
Active Ingredient
CEFOXITIN SODIUM
Application Number
65238
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2010-03-12
Regulatory Status
RX
Drug Name
CEFOXITIN
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2010-03-12
Active Ingredient
CEFOXITIN SODIUM
Application Number
65238
Product Number
2
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2010-03-12
Regulatory Status
RX
Drug Name
CEFOXITIN
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2010-03-02
Active Ingredient
CEFOXITIN SODIUM
Application Number
65239
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2010-03-02
Regulatory Status
RX
Drug Name
CEFTRIAXONE
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
2008-01-10
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
65342
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
2008-01-10
Regulatory Status
RX
Drug Name
CEFTRIAXONE
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2008-01-10
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
65342
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2008-01-10
Regulatory Status
RX
Drug Name
CEFTRIAXONE
Product Number
3
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2008-01-10
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
65342
Product Number
3
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2008-01-10
Regulatory Status
RX
Drug Name
CEFTRIAXONE
Product Number
4
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2008-01-10
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
65342
Product Number
4
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2008-01-10
Regulatory Status
RX
Drug Name
CEFTRIAXONE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2017-10-04
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
90701
Product Number
1
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2017-10-04
Regulatory Status
RX
Drug Name
CEFUROXIME
Product Number
3
Dosage Form
-
Strength
1.5G/20ML
Approval Date
-
Active Ingredient
CEFUROXIME
Application Number
65048
Product Number
3
Dosage Form
-
Strength
1.5G/20ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CEFUROXIME
Product Number
4
Dosage Form
-
Strength
1.5G/100ML
Approval Date
-
Active Ingredient
CEFUROXIME
Application Number
65048
Product Number
4
Dosage Form
-
Strength
1.5G/100ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CEFUROXIME SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 7.5GM BASE/VIAL
Approval Date
2004-01-09
Active Ingredient
CEFUROXIME SODIUM
Application Number
65046
Product Number
1
Dosage Form
-
Strength
EQ 7.5GM BASE/VIAL
Approval Date
2004-01-09
Regulatory Status
Discontinued
Drug Name
CEFUROXIME SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 750MG BASE/VIAL
Approval Date
2004-01-09
Active Ingredient
CEFUROXIME SODIUM
Application Number
65048
Product Number
1
Dosage Form
-
Strength
EQ 750MG BASE/VIAL
Approval Date
2004-01-09
Regulatory Status
RX
Drug Name
CEFUROXIME SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 1.5GM BASE/VIAL
Approval Date
2004-01-09
Active Ingredient
CEFUROXIME SODIUM
Application Number
65048
Product Number
2
Dosage Form
-
Strength
EQ 1.5GM BASE/VIAL
Approval Date
2004-01-09
Regulatory Status
RX
Drug Name
CEPHALEXIN
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2006-01-24
Active Ingredient
CEPHALEXIN
Application Number
65215
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2006-01-24
Regulatory Status
Discontinued
Drug Name
CEPHALEXIN
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2006-01-24
Active Ingredient
CEPHALEXIN
Application Number
65215
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2006-01-24
Regulatory Status
Discontinued
Drug Name
CEPHALEXIN
Product Number
1
Dosage Form
-
Strength
EQ 125MG BASE/5ML
Approval Date
2009-08-28
Active Ingredient
CEPHALEXIN
Application Number
65444
Product Number
1
Dosage Form
-
Strength
EQ 125MG BASE/5ML
Approval Date
2009-08-28
Regulatory Status
Discontinued
Drug Name
CEPHALEXIN
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE/5ML
Approval Date
2009-08-28
Active Ingredient
CEPHALEXIN
Application Number
65444
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE/5ML
Approval Date
2009-08-28
Regulatory Status
Discontinued
Drug Name
CEPHAPIRIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1987-07-02
Active Ingredient
CEPHAPIRIN SODIUM
Application Number
62720
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1987-07-02
Regulatory Status
Discontinued
Drug Name
CEPHAPIRIN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1987-07-02
Active Ingredient
CEPHAPIRIN SODIUM
Application Number
62720
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1987-07-02
Regulatory Status
Discontinued
Drug Name
CEPHAPIRIN SODIUM
Product Number
3
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
1987-07-02
Active Ingredient
CEPHAPIRIN SODIUM
Application Number
62720
Product Number
3
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
1987-07-02
Regulatory Status
Discontinued
Drug Name
CEPHAPIRIN SODIUM
Product Number
4
Dosage Form
-
Strength
EQ 20GM BASE/VIAL
Approval Date
1987-07-02
Active Ingredient
CEPHAPIRIN SODIUM
Application Number
62720
Product Number
4
Dosage Form
-
Strength
EQ 20GM BASE/VIAL
Approval Date
1987-07-02
Regulatory Status
Discontinued
Drug Name
CERUBIDINE
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/VIAL
Approval Date
1995-02-03
Active Ingredient
DAUNORUBICIN HYDROCHLORIDE
Application Number
64103
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/VIAL
Approval Date
1995-02-03
Regulatory Status
RX
Drug Name
CEVIMELINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
2013-07-08
Active Ingredient
CEVIMELINE HYDROCHLORIDE
Application Number
91591
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
2013-07-08
Regulatory Status
RX
Drug Name
CHLOROPROCAINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1998-09-09
Active Ingredient
CHLOROPROCAINE HYDROCHLORIDE
Application Number
40273
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1998-09-09
Regulatory Status
RX
Drug Name
CHLOROPROCAINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
3%
Approval Date
1998-09-09
Active Ingredient
CHLOROPROCAINE HYDROCHLORIDE
Application Number
40273
Product Number
2
Dosage Form
-
Strength
3%
Approval Date
1998-09-09
Regulatory Status
RX
Drug Name
CHLOROQUINE PHOSPHATE
Product Number
1
Dosage Form
-
Strength
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
CHLOROQUINE PHOSPHATE
Application Number
83082
Product Number
1
Dosage Form
-
Strength
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
CHLOROQUINE PHOSPHATE
Product Number
2
Dosage Form
-
Strength
500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-09-17
Active Ingredient
CHLOROQUINE PHOSPHATE
Application Number
83082
Product Number
2
Dosage Form
-
Strength
500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-09-17
Regulatory Status
Discontinued
Drug Name
CHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1982-07-14
Active Ingredient
CHLOROTHIAZIDE
Application Number
86028
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1982-07-14
Regulatory Status
Discontinued
Drug Name
CHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-07-14
Active Ingredient
CHLOROTHIAZIDE
Application Number
87736
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-07-14
Regulatory Status
Discontinued
Drug Name
CHLOROTHIAZIDE AND RESERPINE
Product Number
1
Dosage Form
-
Strength
500MG;0.125MG
Approval Date
1983-12-22
Active Ingredient
CHLOROTHIAZIDE; RESERPINE
Application Number
88365
Product Number
1
Dosage Form
-
Strength
500MG;0.125MG
Approval Date
1983-12-22
Regulatory Status
Discontinued
Drug Name
CHLOROTHIAZIDE AND RESERPINE
Product Number
2
Dosage Form
-
Strength
250MG;0.125MG
Approval Date
1983-12-22
Active Ingredient
CHLOROTHIAZIDE; RESERPINE
Application Number
88365
Product Number
2
Dosage Form
-
Strength
250MG;0.125MG
Approval Date
1983-12-22
Regulatory Status
Discontinued
Drug Name
CHLOROTHIAZIDE AND RESERPINE
Product Number
1
Dosage Form
-
Strength
250MG;0.125MG
Approval Date
-
Active Ingredient
CHLOROTHIAZIDE; RESERPINE
Application Number
88557
Product Number
1
Dosage Form
-
Strength
250MG;0.125MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CHLORPROMAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Active Ingredient
CHLORPROMAZINE HYDROCHLORIDE
Application Number
83329
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
CHLORPROMAZINE HYDROCHLORIDE INTENSOL
Product Number
1
Dosage Form
-
Strength
30MG/ML
Approval Date
1983-04-27
Active Ingredient
CHLORPROMAZINE HYDROCHLORIDE
Application Number
88157
Product Number
1
Dosage Form
-
Strength
30MG/ML
Approval Date
1983-04-27
Regulatory Status
Discontinued
Drug Name
CHLORPROMAZINE HYDROCHLORIDE INTENSOL
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1983-04-27
Active Ingredient
CHLORPROMAZINE HYDROCHLORIDE
Application Number
88158
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1983-04-27
Regulatory Status
Discontinued
Drug Name
CICLOPIROX
Product Number
1
Dosage Form
-
Strength
8%
Approval Date
2007-09-18
Active Ingredient
CICLOPIROX
Application Number
78270
Product Number
1
Dosage Form
-
Strength
8%
Approval Date
2007-09-18
Regulatory Status
Discontinued
Drug Name
CILOSTAZOL
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2005-05-17
Active Ingredient
CILOSTAZOL
Application Number
77024
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2005-05-17
Regulatory Status
Discontinued
Drug Name
CILOSTAZOL
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2005-05-17
Active Ingredient
CILOSTAZOL
Application Number
77024
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2005-05-17
Regulatory Status
Discontinued
Drug Name
CIMETIDINE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1998-12-18
Active Ingredient
CIMETIDINE
Application Number
74890
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1998-12-18
Regulatory Status
Discontinued
Drug Name
CIMETIDINE
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
1998-12-18
Active Ingredient
CIMETIDINE
Application Number
74890
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
1998-12-18
Regulatory Status
Discontinued
Drug Name
CIMETIDINE
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
1998-12-18
Active Ingredient
CIMETIDINE
Application Number
74890
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
1998-12-18
Regulatory Status
Discontinued
Drug Name
CIMETIDINE
Product Number
4
Dosage Form
-
Strength
800MG
Approval Date
1998-12-18
Active Ingredient
CIMETIDINE
Application Number
74890
Product Number
4
Dosage Form
-
Strength
800MG
Approval Date
1998-12-18
Regulatory Status
Discontinued
Drug Name
CIPROFLOXACIN
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
-
Active Ingredient
CIPROFLOXACIN
Application Number
76558
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CIPROFLOXACIN
Product Number
1
Dosage Form
-
Strength
200MG/20ML (10MG/ML)
Approval Date
2009-12-22
Active Ingredient
CIPROFLOXACIN
Application Number
76717
Product Number
1
Dosage Form
-
Strength
200MG/20ML (10MG/ML)
Approval Date
2009-12-22
Regulatory Status
RX
Drug Name
CIPROFLOXACIN
Product Number
2
Dosage Form
-
Strength
400MG/40ML (10MG/ML)
Approval Date
2009-12-22
Active Ingredient
CIPROFLOXACIN
Application Number
76717
Product Number
2
Dosage Form
-
Strength
400MG/40ML (10MG/ML)
Approval Date
2009-12-22
Regulatory Status
RX
Drug Name
CIPROFLOXACIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2004-06-09
Active Ingredient
CIPROFLOXACIN HYDROCHLORIDE
Application Number
76558
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2004-06-09
Regulatory Status
Discontinued
Drug Name
CIPROFLOXACIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2004-06-09
Active Ingredient
CIPROFLOXACIN HYDROCHLORIDE
Application Number
76558
Product Number
3
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2004-06-09
Regulatory Status
Discontinued
Drug Name
CIPROFLOXACIN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 750MG BASE
Approval Date
2004-06-09
Active Ingredient
CIPROFLOXACIN HYDROCHLORIDE
Application Number
76558
Product Number
4
Dosage Form
-
Strength
EQ 750MG BASE
Approval Date
2004-06-09
Regulatory Status
Discontinued
Drug Name
CIPROFLOXACIN IN DEXTROSE 5%
Product Number
1
Dosage Form
-
Strength
200MG/100ML
Approval Date
2008-04-21
Active Ingredient
CIPROFLOXACIN
Application Number
76757
Product Number
1
Dosage Form
-
Strength
200MG/100ML
Approval Date
2008-04-21
Regulatory Status
Discontinued
Drug Name
CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
400MG/200ML
Approval Date
2009-11-18
Active Ingredient
CIPROFLOXACIN
Application Number
78431
Product Number
1
Dosage Form
-
Strength
400MG/200ML
Approval Date
2009-11-18
Regulatory Status
RX
Drug Name
CISATRACURIUM BESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2022-06-28
Active Ingredient
CISATRACURIUM BESYLATE
Application Number
203078
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2022-06-28
Regulatory Status
RX
Drug Name
CISATRACURIUM BESYLATE
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2023-12-18
Active Ingredient
CISATRACURIUM BESYLATE
Application Number
203078
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2023-12-18
Regulatory Status
RX
Drug Name
CISATRACURIUM BESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2023-04-19
Active Ingredient
CISATRACURIUM BESYLATE
Application Number
203079
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2023-04-19
Regulatory Status
RX
Drug Name
CISPLATIN
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2000-11-07
Active Ingredient
CISPLATIN
Application Number
75036
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2000-11-07
Regulatory Status
RX
Drug Name
CITALOPRAM HYDROBROMIDE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/5ML
Approval Date
2004-12-13
Active Ingredient
CITALOPRAM HYDROBROMIDE
Application Number
77043
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/5ML
Approval Date
2004-12-13
Regulatory Status
RX
Drug Name
CLADRIBINE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2000-02-28
Active Ingredient
CLADRIBINE
Application Number
75405
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2000-02-28
Regulatory Status
RX
Drug Name
CLARITHROMYCIN
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2004-05-25
Active Ingredient
CLARITHROMYCIN
Application Number
65178
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2004-05-25
Regulatory Status
Discontinued
Drug Name
CLARITHROMYCIN
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2004-05-25
Active Ingredient
CLARITHROMYCIN
Application Number
65178
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2004-05-25
Regulatory Status
Discontinued
Drug Name
CLINDAMYCIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
1987-10-15
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
62806
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
1987-10-15
Regulatory Status
Discontinued
Drug Name
CLINDAMYCIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
1988-04-25
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
62889
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
1988-04-25
Regulatory Status
RX
Drug Name
CLINDAMYCIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
1988-04-21
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
62953
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
1988-04-21
Regulatory Status
Discontinued
Drug Name
CLINDAMYCIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
1989-08-28
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
63068
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
1989-08-28
Regulatory Status
Discontinued
Drug Name
CLINDAMYCIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
2004-09-24
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
65206
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/ML
Approval Date
2004-09-24
Regulatory Status
RX
Drug Name
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/ML
Approval Date
2023-04-05
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
214401
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/ML
Approval Date
2023-04-05
Regulatory Status
RX
Drug Name
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Product Number
2
Dosage Form
-
Strength
EQ 12MG BASE/ML
Approval Date
2023-04-05
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
214401
Product Number
2
Dosage Form
-
Strength
EQ 12MG BASE/ML
Approval Date
2023-04-05
Regulatory Status
RX
Drug Name
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Product Number
3
Dosage Form
-
Strength
EQ 18MG BASE/ML
Approval Date
2023-04-05
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
214401
Product Number
3
Dosage Form
-
Strength
EQ 18MG BASE/ML
Approval Date
2023-04-05
Regulatory Status
RX
Drug Name
CLOBAZAM
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2018-10-22
Active Ingredient
CLOBAZAM
Application Number
208785
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2018-10-22
Regulatory Status
Discontinued
Drug Name
CLOBAZAM
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2018-10-22
Active Ingredient
CLOBAZAM
Application Number
208785
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2018-10-22
Regulatory Status
Discontinued
Drug Name
CLOBAZAM
Product Number
1
Dosage Form
-
Strength
2.5MG/ML
Approval Date
2018-10-22
Active Ingredient
CLOBAZAM
Application Number
209715
Product Number
1
Dosage Form
-
Strength
2.5MG/ML
Approval Date
2018-10-22
Regulatory Status
Discontinued
Drug Name
CLOBETASOL PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2017-10-27
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
209871
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2017-10-27
Regulatory Status
Discontinued
Drug Name
CLONIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2011-01-26
Active Ingredient
CLONIDINE HYDROCHLORIDE
Application Number
200300
Product Number
1
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2011-01-26
Regulatory Status
RX
Drug Name
CLONIDINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
5MG/10ML (0.5MG/ML)
Approval Date
2011-01-26
Active Ingredient
CLONIDINE HYDROCHLORIDE
Application Number
200300
Product Number
2
Dosage Form
-
Strength
5MG/10ML (0.5MG/ML)
Approval Date
2011-01-26
Regulatory Status
RX
Drug Name
CLOTRIMAZOLE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2004-07-29
Active Ingredient
CLOTRIMAZOLE
Application Number
76387
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2004-07-29
Regulatory Status
RX
Drug Name
CODEINE SULFATE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2009-07-16
Active Ingredient
CODEINE SULFATE
Application Number
22402
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2009-07-16
Regulatory Status
RX
Drug Name
CODEINE SULFATE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2009-07-16
Active Ingredient
CODEINE SULFATE
Application Number
22402
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2009-07-16
Regulatory Status
RX
Drug Name
CODEINE SULFATE
Product Number
3
Dosage Form
-
Strength
60MG
Approval Date
2009-07-16
Active Ingredient
CODEINE SULFATE
Application Number
22402
Product Number
3
Dosage Form
-
Strength
60MG
Approval Date
2009-07-16
Regulatory Status
RX
Drug Name
CODEINE SULFATE
Product Number
1
Dosage Form
-
Strength
30MG/5ML
Approval Date
2011-06-30
Active Ingredient
CODEINE SULFATE
Application Number
202245
Product Number
1
Dosage Form
-
Strength
30MG/5ML
Approval Date
2011-06-30
Regulatory Status
Discontinued
Drug Name
COMBOGESIC IV
Product Number
1
Dosage Form
-
Strength
1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML)
Approval Date
2023-10-17
Active Ingredient
ACETAMINOPHEN; IBUPROFEN SODIUM
Application Number
215320
Product Number
1
Dosage Form
-
Strength
1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML)
Approval Date
2023-10-17
Regulatory Status
RX
Drug Name
CORMAX
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1997-05-16
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
74220
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1997-05-16
Regulatory Status
Discontinued
Drug Name
CORTISONE ACETATE
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
1982-01-01
Active Ingredient
CORTISONE ACETATE
Application Number
80776
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
CROMOLYN SODIUM
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-04-30
Active Ingredient
CROMOLYN SODIUM
Application Number
75333
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-04-30
Regulatory Status
Discontinued
Drug Name
CYCLOPHOSPHAMIDE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2013-09-16
Active Ingredient
CYCLOPHOSPHAMIDE
Application Number
203856
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2013-09-16
Regulatory Status
RX
Drug Name
CYCLOPHOSPHAMIDE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2013-09-16
Active Ingredient
CYCLOPHOSPHAMIDE
Application Number
203856
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2013-09-16
Regulatory Status
RX
Drug Name
CYCLOPHOSPHAMIDE
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2023-12-18
Active Ingredient
CYCLOPHOSPHAMIDE
Application Number
216958
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2023-12-18
Regulatory Status
RX
Drug Name
CYCLOPHOSPHAMIDE
Product Number
2
Dosage Form
-
Strength
1GM/VIAL
Approval Date
2023-12-18
Active Ingredient
CYCLOPHOSPHAMIDE
Application Number
216958
Product Number
2
Dosage Form
-
Strength
1GM/VIAL
Approval Date
2023-12-18
Regulatory Status
RX
Drug Name
CYCLOPHOSPHAMIDE
Product Number
3
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2023-12-18
Active Ingredient
CYCLOPHOSPHAMIDE
Application Number
216958
Product Number
3
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2023-12-18
Regulatory Status
RX
Drug Name
CYCLOSPORINE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1999-10-29
Active Ingredient
CYCLOSPORINE
Application Number
65004
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1999-10-29
Regulatory Status
RX
Drug Name
CYTARABINE
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
1989-08-02
Active Ingredient
CYTARABINE
Application Number
71471
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
1989-08-02
Regulatory Status
RX
Drug Name
CYTARABINE
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
1989-08-02
Active Ingredient
CYTARABINE
Application Number
71472
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
1989-08-02
Regulatory Status
RX
Drug Name
DACARBAZINE
Product Number
1
Dosage Form
-
Strength
200MG/VIAL
Approval Date
2001-06-15
Active Ingredient
DACARBAZINE
Application Number
75812
Product Number
1
Dosage Form
-
Strength
200MG/VIAL
Approval Date
2001-06-15
Regulatory Status
RX
Drug Name
DACARBAZINE
Product Number
2
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2002-10-31
Active Ingredient
DACARBAZINE
Application Number
75812
Product Number
2
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2002-10-31
Regulatory Status
RX
Drug Name
DACTINOMYCIN
Product Number
1
Dosage Form
-
Strength
0.5MG/VIAL
Approval Date
2010-03-16
Active Ingredient
DACTINOMYCIN
Application Number
90304
Product Number
1
Dosage Form
-
Strength
0.5MG/VIAL
Approval Date
2010-03-16
Regulatory Status
Discontinued
Drug Name
DALFAMPRIDINE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2018-10-24
Active Ingredient
DALFAMPRIDINE
Application Number
206646
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2018-10-24
Regulatory Status
Discontinued
Drug Name
DANTROLENE SODIUM
Product Number
1
Dosage Form
-
Strength
20MG/VIAL
Approval Date
2017-06-19
Active Ingredient
DANTROLENE SODIUM
Application Number
204762
Product Number
1
Dosage Form
-
Strength
20MG/VIAL
Approval Date
2017-06-19
Regulatory Status
RX
Drug Name
DAPTOMYCIN
Product Number
1
Dosage Form
-
Strength
350MG/VIAL
Approval Date
2017-10-20
Active Ingredient
DAPTOMYCIN
Application Number
209949
Product Number
1
Dosage Form
-
Strength
350MG/VIAL
Approval Date
2017-10-20
Regulatory Status
RX
Drug Name
DAPTOMYCIN
Product Number
1
Dosage Form
-
Strength
350MG/VIAL
Approval Date
2023-01-30
Active Ingredient
DAPTOMYCIN
Application Number
217415
Product Number
1
Dosage Form
-
Strength
350MG/VIAL
Approval Date
2023-01-30
Regulatory Status
RX
Drug Name
DAPTOMYCIN
Product Number
2
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2023-01-30
Active Ingredient
DAPTOMYCIN
Application Number
217415
Product Number
2
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2023-01-30
Regulatory Status
RX
Drug Name
DAUNORUBICIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1998-01-30
Active Ingredient
DAUNORUBICIN HYDROCHLORIDE
Application Number
50731
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1998-01-30
Regulatory Status
RX
Drug Name
DEFERIPRONE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2021-03-29
Active Ingredient
DEFERIPRONE
Application Number
213239
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2021-03-29
Regulatory Status
RX
Drug Name
DEFERIPRONE
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2022-02-08
Active Ingredient
DEFERIPRONE
Application Number
213239
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2022-02-08
Regulatory Status
RX
Drug Name
DEFEROXAMINE MESYLATE
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2007-05-30
Active Ingredient
DEFEROXAMINE MESYLATE
Application Number
78086
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2007-05-30
Regulatory Status
Discontinued
Drug Name
DEFEROXAMINE MESYLATE
Product Number
2
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2007-05-30
Active Ingredient
DEFEROXAMINE MESYLATE
Application Number
78086
Product Number
2
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2007-05-30
Regulatory Status
Discontinued
Drug Name
DESONIDE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2017-03-27
Active Ingredient
DESONIDE
Application Number
208836
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2017-03-27
Regulatory Status
Discontinued
Drug Name
DESVENLAFAXINE SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2016-02-16
Active Ingredient
DESVENLAFAXINE SUCCINATE
Application Number
204083
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2016-02-16
Regulatory Status
RX
Drug Name
DESVENLAFAXINE SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2016-02-16
Active Ingredient
DESVENLAFAXINE SUCCINATE
Application Number
204083
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2016-02-16
Regulatory Status
RX
Drug Name
DESVENLAFAXINE SUCCINATE
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2016-02-16
Active Ingredient
DESVENLAFAXINE SUCCINATE
Application Number
204083
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2016-02-16
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
1
Dosage Form
-
Strength
4MG
Approval Date
1982-01-01
Active Ingredient
DEXAMETHASONE
Application Number
84612
Product Number
1
Dosage Form
-
Strength
4MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
2
Dosage Form
-
Strength
0.5MG
Approval Date
1982-01-01
Active Ingredient
DEXAMETHASONE
Application Number
84612
Product Number
2
Dosage Form
-
Strength
0.5MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
3
Dosage Form
-
Strength
0.75MG
Approval Date
1982-01-01
Active Ingredient
DEXAMETHASONE
Application Number
84612
Product Number
3
Dosage Form
-
Strength
0.75MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
4
Dosage Form
-
Strength
1MG
Approval Date
1983-09-15
Active Ingredient
DEXAMETHASONE
Application Number
84612
Product Number
4
Dosage Form
-
Strength
1MG
Approval Date
1983-09-15
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
5
Dosage Form
-
Strength
1.5MG
Approval Date
1982-01-01
Active Ingredient
DEXAMETHASONE
Application Number
84612
Product Number
5
Dosage Form
-
Strength
1.5MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
6
Dosage Form
-
Strength
2MG
Approval Date
1982-01-01
Active Ingredient
DEXAMETHASONE
Application Number
84612
Product Number
6
Dosage Form
-
Strength
2MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
7
Dosage Form
-
Strength
6MG
Approval Date
1983-09-15
Active Ingredient
DEXAMETHASONE
Application Number
84612
Product Number
7
Dosage Form
-
Strength
6MG
Approval Date
1983-09-15
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
1
Dosage Form
-
Strength
0.5MG/5ML
Approval Date
1983-09-01
Active Ingredient
DEXAMETHASONE
Application Number
88248
Product Number
1
Dosage Form
-
Strength
0.5MG/5ML
Approval Date
1983-09-01
Regulatory Status
RX
Drug Name
DEXAMETHASONE
Product Number
1
Dosage Form
-
Strength
6MG
Approval Date
-
Active Ingredient
DEXAMETHASONE
Application Number
88316
Product Number
1
Dosage Form
-
Strength
6MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DEXAMETHASONE INTENSOL
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1983-09-01
Active Ingredient
DEXAMETHASONE
Application Number
88252
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1983-09-01
Regulatory Status
RX
Drug Name
DEXAMETHASONE SODIUM PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 4MG PHOSPHATE/ML
Approval Date
1982-01-01
Active Ingredient
DEXAMETHASONE SODIUM PHOSPHATE
Application Number
84282
Product Number
1
Dosage Form
-
Strength
EQ 4MG PHOSPHATE/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
DEXAMETHASONE SODIUM PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 10MG PHOSPHATE/ML
Approval Date
1982-09-07
Active Ingredient
DEXAMETHASONE SODIUM PHOSPHATE
Application Number
87702
Product Number
1
Dosage Form
-
Strength
EQ 10MG PHOSPHATE/ML
Approval Date
1982-09-07
Regulatory Status
RX
Drug Name
DEXAMETHASONE SODIUM PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 4MG PHOSPHATE/ML
Approval Date
2023-08-01
Active Ingredient
DEXAMETHASONE SODIUM PHOSPHATE
Application Number
211451
Product Number
1
Dosage Form
-
Strength
EQ 4MG PHOSPHATE/ML
Approval Date
2023-08-01
Regulatory Status
Discontinued
Drug Name
DEXMEDETOMIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)
Approval Date
2017-04-26
Active Ingredient
DEXMEDETOMIDINE HYDROCHLORIDE
Application Number
205046
Product Number
1
Dosage Form
-
Strength
EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)
Approval Date
2017-04-26
Regulatory Status
RX
Drug Name
DEXMEDETOMIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)
Approval Date
2020-01-30
Active Ingredient
DEXMEDETOMIDINE HYDROCHLORIDE
Application Number
206407
Product Number
1
Dosage Form
-
Strength
EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)
Approval Date
2020-01-30
Regulatory Status
RX
Drug Name
DEXMEDETOMIDINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)
Approval Date
2020-01-30
Active Ingredient
DEXMEDETOMIDINE HYDROCHLORIDE
Application Number
206407
Product Number
2
Dosage Form
-
Strength
EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)
Approval Date
2020-01-30
Regulatory Status
RX
Drug Name
DEXMEDETOMIDINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 1MG BASE/250ML (EQ 4MCG BASE/ML)
Approval Date
2025-05-30
Active Ingredient
DEXMEDETOMIDINE HYDROCHLORIDE
Application Number
206407
Product Number
3
Dosage Form
-
Strength
EQ 1MG BASE/250ML (EQ 4MCG BASE/ML)
Approval Date
2025-05-30
Regulatory Status
RX
Drug Name
DEXRAZOXANE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
2004-09-28
Active Ingredient
DEXRAZOXANE HYDROCHLORIDE
Application Number
76068
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
2004-09-28
Regulatory Status
RX
Drug Name
DEXRAZOXANE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2004-09-28
Active Ingredient
DEXRAZOXANE HYDROCHLORIDE
Application Number
76068
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2004-09-28
Regulatory Status
RX
Drug Name
DIAZEPAM
Product Number
1
Dosage Form
-
Strength
50MG/10ML (5MG/ML)
Approval Date
1985-12-16
Active Ingredient
DIAZEPAM
Application Number
70311
Product Number
1
Dosage Form
-
Strength
50MG/10ML (5MG/ML)
Approval Date
1985-12-16
Regulatory Status
RX
Drug Name
DIAZEPAM
Product Number
2
Dosage Form
-
Strength
5MG/ML (5MG/ML)
Approval Date
1985-12-16
Active Ingredient
DIAZEPAM
Application Number
70311
Product Number
2
Dosage Form
-
Strength
5MG/ML (5MG/ML)
Approval Date
1985-12-16
Regulatory Status
Discontinued
Drug Name
DIAZEPAM
Product Number
3
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
1985-12-16
Active Ingredient
DIAZEPAM
Application Number
70311
Product Number
3
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
1985-12-16
Regulatory Status
Discontinued
Drug Name
DIAZEPAM
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1985-12-16
Active Ingredient
DIAZEPAM
Application Number
70312
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1985-12-16
Regulatory Status
Discontinued
Drug Name
DIAZEPAM
Product Number
1
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
1985-12-16
Active Ingredient
DIAZEPAM
Application Number
70313
Product Number
1
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
1985-12-16
Regulatory Status
RX
Drug Name
DIAZEPAM
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
1987-04-03
Active Ingredient
DIAZEPAM
Application Number
70928
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
1987-04-03
Regulatory Status
RX
Drug Name
DIAZEPAM
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1987-07-17
Active Ingredient
DIAZEPAM
Application Number
71308
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1987-07-17
Regulatory Status
Discontinued
Drug Name
DIAZEPAM
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1987-07-17
Active Ingredient
DIAZEPAM
Application Number
71309
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1987-07-17
Regulatory Status
Discontinued
Drug Name
DIAZEPAM
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1987-07-17
Active Ingredient
DIAZEPAM
Application Number
71310
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1987-07-17
Regulatory Status
Discontinued
Drug Name
DIAZEPAM INTENSOL
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1987-04-03
Active Ingredient
DIAZEPAM
Application Number
71415
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1987-04-03
Regulatory Status
RX
Drug Name
DICLOFENAC SODIUM
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2018-11-21
Active Ingredient
DICLOFENAC SODIUM
Application Number
209484
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2018-11-21
Regulatory Status
Discontinued
Drug Name
DICYCLOMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1996-10-01
Active Ingredient
DICYCLOMINE HYDROCHLORIDE
Application Number
40161
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1996-10-01
Regulatory Status
RX
Drug Name
DICYCLOMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2019-02-11
Active Ingredient
DICYCLOMINE HYDROCHLORIDE
Application Number
210788
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2019-02-11
Regulatory Status
Discontinued
Drug Name
DICYCLOMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/5ML
Approval Date
2020-05-22
Active Ingredient
DICYCLOMINE HYDROCHLORIDE
Application Number
212286
Product Number
1
Dosage Form
-
Strength
10MG/5ML
Approval Date
2020-05-22
Regulatory Status
RX
Drug Name
DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2003-06-30
Active Ingredient
DICYCLOMINE HYDROCHLORIDE
Application Number
40465
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2003-06-30
Regulatory Status
RX
Drug Name
DIGOXIN
Product Number
1
Dosage Form
-
Strength
0.05MG/ML
Approval Date
2004-08-26
Active Ingredient
DIGOXIN
Application Number
21648
Product Number
1
Dosage Form
-
Strength
0.05MG/ML
Approval Date
2004-08-26
Regulatory Status
RX
Drug Name
DIGOXIN
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
2007-10-30
Active Ingredient
DIGOXIN
Application Number
77002
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
2007-10-30
Regulatory Status
RX
Drug Name
DIGOXIN
Product Number
2
Dosage Form
-
Strength
0.125MG
Approval Date
2007-10-30
Active Ingredient
DIGOXIN
Application Number
77002
Product Number
2
Dosage Form
-
Strength
0.125MG
Approval Date
2007-10-30
Regulatory Status
RX
Drug Name
DIGOXIN
Product Number
1
Dosage Form
-
Strength
0.25MG/ML
Approval Date
1982-01-01
Active Ingredient
DIGOXIN
Application Number
83391
Product Number
1
Dosage Form
-
Strength
0.25MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
DIHYDROERGOTAMINE MESYLATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2003-06-09
Active Ingredient
DIHYDROERGOTAMINE MESYLATE
Application Number
40453
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2003-06-09
Regulatory Status
RX
Drug Name
DIHYDROERGOTAMINE MESYLATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2017-09-15
Active Ingredient
DIHYDROERGOTAMINE MESYLATE
Application Number
206621
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2017-09-15
Regulatory Status
RX
Drug Name
DIHYDROERGOTAMINE MESYLATE
Product Number
1
Dosage Form
-
Strength
0.5MG/SPRAY
Approval Date
2020-02-28
Active Ingredient
DIHYDROERGOTAMINE MESYLATE
Application Number
211393
Product Number
1
Dosage Form
-
Strength
0.5MG/SPRAY
Approval Date
2020-02-28
Regulatory Status
RX
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
2008-12-17
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
78538
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
2008-12-17
Regulatory Status
RX
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
2012-08-09
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
202651
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
2012-08-09
Regulatory Status
Discontinued
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
50MG/10ML
Approval Date
-
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
202651
Product Number
2
Dosage Form
-
Strength
50MG/10ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DILTIAZEM HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
125MG/25ML
Approval Date
-
Active Ingredient
DILTIAZEM HYDROCHLORIDE
Application Number
202651
Product Number
3
Dosage Form
-
Strength
125MG/25ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DIPHENHYDRAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Active Ingredient
DIPHENHYDRAMINE HYDROCHLORIDE
Application Number
83183
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
DIPHENHYDRAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Active Ingredient
DIPHENHYDRAMINE HYDROCHLORIDE
Application Number
83567
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
Product Number
1
Dosage Form
-
Strength
0.025MG/5ML;2.5MG/5ML
Approval Date
1982-05-03
Active Ingredient
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
Application Number
87708
Product Number
1
Dosage Form
-
Strength
0.025MG/5ML;2.5MG/5ML
Approval Date
1982-05-03
Regulatory Status
RX
Drug Name
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
Product Number
1
Dosage Form
-
Strength
0.025MG;2.5MG
Approval Date
1982-03-15
Active Ingredient
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
Application Number
87765
Product Number
1
Dosage Form
-
Strength
0.025MG;2.5MG
Approval Date
1982-03-15
Regulatory Status
Discontinued
Drug Name
DIPYRIDAMOLE
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1996-10-18
Active Ingredient
DIPYRIDAMOLE
Application Number
74521
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1996-10-18
Regulatory Status
RX
Drug Name
DISULFIRAM
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2014-02-05
Active Ingredient
DISULFIRAM
Application Number
202652
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2014-02-05
Regulatory Status
Discontinued
Drug Name
DISULFIRAM
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2014-02-05
Active Ingredient
DISULFIRAM
Application Number
202652
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2014-02-05
Regulatory Status
Discontinued
Drug Name
DOBUTAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG BASE/ML
Approval Date
1994-10-31
Active Ingredient
DOBUTAMINE HYDROCHLORIDE
Application Number
74277
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG BASE/ML
Approval Date
1994-10-31
Regulatory Status
RX
Drug Name
DOCETAXEL
Product Number
1
Dosage Form
-
Strength
20MG/ML (20MG/ML)
Approval Date
2021-01-14
Active Ingredient
DOCETAXEL
Application Number
204490
Product Number
1
Dosage Form
-
Strength
20MG/ML (20MG/ML)
Approval Date
2021-01-14
Regulatory Status
RX
Drug Name
DOCETAXEL
Product Number
2
Dosage Form
-
Strength
80MG/4ML (20MG/ML)
Approval Date
2021-01-14
Active Ingredient
DOCETAXEL
Application Number
204490
Product Number
2
Dosage Form
-
Strength
80MG/4ML (20MG/ML)
Approval Date
2021-01-14
Regulatory Status
RX
Drug Name
DOLOPHINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
6134
Product Number
2
Dosage Form
-
Strength
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
DOLOPHINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
10MG/30ML
Approval Date
1982-01-01
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
6134
Product Number
4
Dosage Form
-
Strength
10MG/30ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
DOLOPHINE HYDROCHLORIDE
Product Number
10
Dosage Form
-
Strength
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
6134
Product Number
10
Dosage Form
-
Strength
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
DONEPEZIL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2011-05-31
Active Ingredient
DONEPEZIL HYDROCHLORIDE
Application Number
90247
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2011-05-31
Regulatory Status
Discontinued
Drug Name
DONEPEZIL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2011-05-31
Active Ingredient
DONEPEZIL HYDROCHLORIDE
Application Number
90247
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2011-05-31
Regulatory Status
Discontinued
Drug Name
DOPAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2018-04-11
Active Ingredient
DOPAMINE HYDROCHLORIDE
Application Number
207707
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2018-04-11
Regulatory Status
RX
Drug Name
DOPAMINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
80MG/ML
Approval Date
2018-04-11
Active Ingredient
DOPAMINE HYDROCHLORIDE
Application Number
207707
Product Number
2
Dosage Form
-
Strength
80MG/ML
Approval Date
2018-04-11
Regulatory Status
RX
Drug Name
DOPRAM
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
1982-01-01
Active Ingredient
DOXAPRAM HYDROCHLORIDE
Application Number
14879
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
DORZOLAMIDE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2% BASE
Approval Date
2008-10-28
Active Ingredient
DORZOLAMIDE HYDROCHLORIDE
Application Number
77846
Product Number
1
Dosage Form
-
Strength
EQ 2% BASE
Approval Date
2008-10-28
Regulatory Status
Discontinued
Drug Name
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Product Number
1
Dosage Form
-
Strength
EQ 2% BASE;EQ 0.5% BASE
Approval Date
2008-10-28
Active Ingredient
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
Application Number
77847
Product Number
1
Dosage Form
-
Strength
EQ 2% BASE;EQ 0.5% BASE
Approval Date
2008-10-28
Regulatory Status
Discontinued
Drug Name
DOXERCALCIFEROL
Product Number
1
Dosage Form
-
Strength
4MCG/2ML (2MCG/ML)
Approval Date
2013-08-30
Active Ingredient
DOXERCALCIFEROL
Application Number
91101
Product Number
1
Dosage Form
-
Strength
4MCG/2ML (2MCG/ML)
Approval Date
2013-08-30
Regulatory Status
Discontinued
Drug Name
DOXERCALCIFEROL
Product Number
1
Dosage Form
-
Strength
0.5MCG
Approval Date
2011-09-23
Active Ingredient
DOXERCALCIFEROL
Application Number
91433
Product Number
1
Dosage Form
-
Strength
0.5MCG
Approval Date
2011-09-23
Regulatory Status
Discontinued
Drug Name
DOXERCALCIFEROL
Product Number
2
Dosage Form
-
Strength
1MCG
Approval Date
2014-01-14
Active Ingredient
DOXERCALCIFEROL
Application Number
91433
Product Number
2
Dosage Form
-
Strength
1MCG
Approval Date
2014-01-14
Regulatory Status
Discontinued
Drug Name
DOXERCALCIFEROL
Product Number
3
Dosage Form
-
Strength
2.5MCG
Approval Date
2014-01-14
Active Ingredient
DOXERCALCIFEROL
Application Number
91433
Product Number
3
Dosage Form
-
Strength
2.5MCG
Approval Date
2014-01-14
Regulatory Status
Discontinued
Drug Name
DOXORUBICIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
1989-03-17
Active Ingredient
DOXORUBICIN HYDROCHLORIDE
Application Number
62921
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
1989-03-17
Regulatory Status
RX
Drug Name
DOXORUBICIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
1989-03-17
Active Ingredient
DOXORUBICIN HYDROCHLORIDE
Application Number
62921
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
1989-03-17
Regulatory Status
RX
Drug Name
DOXORUBICIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
50MG/VIAL
Approval Date
1989-03-17
Active Ingredient
DOXORUBICIN HYDROCHLORIDE
Application Number
62921
Product Number
3
Dosage Form
-
Strength
50MG/VIAL
Approval Date
1989-03-17
Regulatory Status
RX
Drug Name
DOXORUBICIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1989-03-17
Active Ingredient
DOXORUBICIN HYDROCHLORIDE
Application Number
62975
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1989-03-17
Regulatory Status
RX
Drug Name
DOXORUBICIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
200MG/100ML
Approval Date
1994-09-13
Active Ingredient
DOXORUBICIN HYDROCHLORIDE
Application Number
64097
Product Number
1
Dosage Form
-
Strength
200MG/100ML
Approval Date
1994-09-13
Regulatory Status
RX
Drug Name
DOXYCYCLINE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
1983-10-27
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
62450
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
1983-10-27
Regulatory Status
Discontinued
Drug Name
DOXYCYCLINE
Product Number
2
Dosage Form
-
Strength
EQ 200MG BASE/VIAL
Approval Date
1983-10-27
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
62450
Product Number
2
Dosage Form
-
Strength
EQ 200MG BASE/VIAL
Approval Date
1983-10-27
Regulatory Status
Discontinued
Drug Name
DOXYCYCLINE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
1988-03-09
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
62569
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
1988-03-09
Regulatory Status
Discontinued
Drug Name
DOXYCYCLINE
Product Number
2
Dosage Form
-
Strength
EQ 200MG BASE/VIAL
Approval Date
1988-03-09
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
62569
Product Number
2
Dosage Form
-
Strength
EQ 200MG BASE/VIAL
Approval Date
1988-03-09
Regulatory Status
Discontinued
Drug Name
DOXYCYCLINE HYCLATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
1984-05-07
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
62396
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
1984-05-07
Regulatory Status
RX
Drug Name
DOXYCYCLINE HYCLATE
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
1984-11-07
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
62396
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
1984-11-07
Regulatory Status
RX
Drug Name
DOXYCYCLINE HYCLATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2003-07-02
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
65095
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2003-07-02
Regulatory Status
RX
Drug Name
DOXYCYCLINE HYCLATE
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2005-05-13
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
65103
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2005-05-13
Regulatory Status
Discontinued
Drug Name
DRONABINOL
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2014-06-20
Active Ingredient
DRONABINOL
Application Number
79217
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2014-06-20
Regulatory Status
Discontinued
Drug Name
DRONABINOL
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2014-06-20
Active Ingredient
DRONABINOL
Application Number
79217
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2014-06-20
Regulatory Status
Discontinued
Drug Name
DRONABINOL
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2014-06-20
Active Ingredient
DRONABINOL
Application Number
79217
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2014-06-20
Regulatory Status
Discontinued
Drug Name
DROPERIDOL
Product Number
1
Dosage Form
-
Strength
2.5MG/ML
Approval Date
2017-12-14
Active Ingredient
DROPERIDOL
Application Number
208197
Product Number
1
Dosage Form
-
Strength
2.5MG/ML
Approval Date
2017-12-14
Regulatory Status
RX
Drug Name
DROXIDOPA
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2021-02-18
Active Ingredient
DROXIDOPA
Application Number
212835
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2021-02-18
Regulatory Status
Discontinued
Drug Name
DROXIDOPA
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2021-02-18
Active Ingredient
DROXIDOPA
Application Number
212835
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2021-02-18
Regulatory Status
Discontinued
Drug Name
DROXIDOPA
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2021-02-18
Active Ingredient
DROXIDOPA
Application Number
212835
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2021-02-18
Regulatory Status
Discontinued
Drug Name
DURAMORPH PF
Product Number
1
Dosage Form
-
Strength
0.5MG/ML
Approval Date
1984-09-18
Active Ingredient
MORPHINE SULFATE
Application Number
18565
Product Number
1
Dosage Form
-
Strength
0.5MG/ML
Approval Date
1984-09-18
Regulatory Status
RX
Drug Name
DURAMORPH PF
Product Number
2
Dosage Form
-
Strength
1MG/ML
Approval Date
1984-09-18
Active Ingredient
MORPHINE SULFATE
Application Number
18565
Product Number
2
Dosage Form
-
Strength
1MG/ML
Approval Date
1984-09-18
Regulatory Status
RX
Drug Name
DUTASTERIDE
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
2015-11-23
Active Ingredient
DUTASTERIDE
Application Number
202204
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
2015-11-23
Regulatory Status
Discontinued
Drug Name
EDARAVONE
Product Number
1
Dosage Form
-
Strength
30MG/100ML (0.3MG/ML)
Approval Date
2024-05-06
Active Ingredient
EDARAVONE
Application Number
215508
Product Number
1
Dosage Form
-
Strength
30MG/100ML (0.3MG/ML)
Approval Date
2024-05-06
Regulatory Status
RX
Drug Name
EDARAVONE
Product Number
2
Dosage Form
-
Strength
60mg/100mL
Approval Date
-
Active Ingredient
EDARAVONE
Application Number
215508
Product Number
2
Dosage Form
-
Strength
60mg/100mL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ELTROMBOPAG OLAMINE
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG ACID
Approval Date
2026-04-08
Active Ingredient
ELTROMBOPAG OLAMINE
Application Number
220033
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG ACID
Approval Date
2026-04-08
Regulatory Status
RX
Drug Name
ELTROMBOPAG OLAMINE
Product Number
2
Dosage Form
-
Strength
EQ 25MG ACID
Approval Date
2026-04-08
Active Ingredient
ELTROMBOPAG OLAMINE
Application Number
220033
Product Number
2
Dosage Form
-
Strength
EQ 25MG ACID
Approval Date
2026-04-08
Regulatory Status
RX
Drug Name
ELTROMBOPAG OLAMINE
Product Number
3
Dosage Form
-
Strength
EQ 50MG ACID
Approval Date
2026-04-08
Active Ingredient
ELTROMBOPAG OLAMINE
Application Number
220033
Product Number
3
Dosage Form
-
Strength
EQ 50MG ACID
Approval Date
2026-04-08
Regulatory Status
RX
Drug Name
ELTROMBOPAG OLAMINE
Product Number
4
Dosage Form
-
Strength
EQ 75MG ACID
Approval Date
2026-04-08
Active Ingredient
ELTROMBOPAG OLAMINE
Application Number
220033
Product Number
4
Dosage Form
-
Strength
EQ 75MG ACID
Approval Date
2026-04-08
Regulatory Status
RX
Drug Name
EMBELINE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1995-03-31
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
74221
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1995-03-31
Regulatory Status
Discontinued
Drug Name
EMBELINE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1995-12-06
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
74222
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1995-12-06
Regulatory Status
Discontinued
Drug Name
EMBELINE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2002-04-12
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
76141
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2002-04-12
Regulatory Status
Discontinued
Drug Name
EMBELINE E
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1998-12-24
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
75325
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1998-12-24
Regulatory Status
Discontinued
Drug Name
ENALAPRILAT
Product Number
1
Dosage Form
-
Strength
1.25MG/ML
Approval Date
2008-12-23
Active Ingredient
ENALAPRILAT
Application Number
78687
Product Number
1
Dosage Form
-
Strength
1.25MG/ML
Approval Date
2008-12-23
Regulatory Status
RX
Drug Name
ENOBY
Product Number
1
Dosage Form
-
Strength
60MG/ML
Approval Date
-
Active Ingredient
DENOSUMAB-QBDE
Application Number
761439
Product Number
1
Dosage Form
-
Strength
60MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ENZALUTAMIDE
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
-
Active Ingredient
ENZALUTAMIDE
Application Number
218731
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ENZALUTAMIDE
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
-
Active Ingredient
ENZALUTAMIDE
Application Number
218731
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EPHEDRINE SULFATE
Product Number
1
Dosage Form
-
Strength
50MG/ML (50MG/ML)
Approval Date
2020-12-15
Active Ingredient
EPHEDRINE SULFATE
Application Number
214334
Product Number
1
Dosage Form
-
Strength
50MG/ML (50MG/ML)
Approval Date
2020-12-15
Regulatory Status
RX
Drug Name
EPHEDRINE SULFATE
Product Number
1
Dosage Form
-
Strength
25MG/5ML (5MG/ML)
Approval Date
2024-10-11
Active Ingredient
EPHEDRINE SULFATE
Application Number
217721
Product Number
1
Dosage Form
-
Strength
25MG/5ML (5MG/ML)
Approval Date
2024-10-11
Regulatory Status
RX
Drug Name
EPINEPHRINE
Product Number
1
Dosage Form
-
Strength
1MG/ML (1MG/ML)
Approval Date
2026-05-29
Active Ingredient
EPINEPHRINE
Application Number
220562
Product Number
1
Dosage Form
-
Strength
1MG/ML (1MG/ML)
Approval Date
2026-05-29
Regulatory Status
RX
Drug Name
EPIRUBICIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG/25ML (2MG/ML)
Approval Date
2007-06-27
Active Ingredient
EPIRUBICIN HYDROCHLORIDE
Application Number
65289
Product Number
1
Dosage Form
-
Strength
50MG/25ML (2MG/ML)
Approval Date
2007-06-27
Regulatory Status
RX
Drug Name
EPIRUBICIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2007-06-27
Active Ingredient
EPIRUBICIN HYDROCHLORIDE
Application Number
65289
Product Number
2
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2007-06-27
Regulatory Status
RX
Drug Name
ERGOTAMINE TARTRATE AND CAFFEINE
Product Number
1
Dosage Form
-
Strength
100MG;1MG
Approval Date
2004-09-17
Active Ingredient
CAFFEINE; ERGOTAMINE TARTRATE
Application Number
40510
Product Number
1
Dosage Form
-
Strength
100MG;1MG
Approval Date
2004-09-17
Regulatory Status
Discontinued
Drug Name
ERTUGLIFLOZIN
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2025-01-21
Active Ingredient
ERTUGLIFLOZIN
Application Number
216842
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2025-01-21
Regulatory Status
Discontinued
Drug Name
ERTUGLIFLOZIN
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2025-01-21
Active Ingredient
ERTUGLIFLOZIN
Application Number
216842
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2025-01-21
Regulatory Status
Discontinued
Drug Name
ESCITALOPRAM OXALATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-09-11
Active Ingredient
ESCITALOPRAM OXALATE
Application Number
78766
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-09-11
Regulatory Status
Discontinued
Drug Name
ESCITALOPRAM OXALATE
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-09-11
Active Ingredient
ESCITALOPRAM OXALATE
Application Number
78766
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-09-11
Regulatory Status
Discontinued
Drug Name
ESCITALOPRAM OXALATE
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-09-11
Active Ingredient
ESCITALOPRAM OXALATE
Application Number
78766
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-09-11
Regulatory Status
Discontinued
Drug Name
ESMOLOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2004-08-10
Active Ingredient
ESMOLOL HYDROCHLORIDE
Application Number
76323
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2004-08-10
Regulatory Status
RX
Drug Name
ESTRADIOL VALERATE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2020-04-21
Active Ingredient
ESTRADIOL VALERATE
Application Number
203723
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2020-04-21
Regulatory Status
RX
Drug Name
ESTRADIOL VALERATE
Product Number
2
Dosage Form
-
Strength
20MG/ML
Approval Date
2020-04-21
Active Ingredient
ESTRADIOL VALERATE
Application Number
203723
Product Number
2
Dosage Form
-
Strength
20MG/ML
Approval Date
2020-04-21
Regulatory Status
RX
Drug Name
ESTRADIOL VALERATE
Product Number
3
Dosage Form
-
Strength
40MG/ML
Approval Date
2020-04-21
Active Ingredient
ESTRADIOL VALERATE
Application Number
203723
Product Number
3
Dosage Form
-
Strength
40MG/ML
Approval Date
2020-04-21
Regulatory Status
RX
Drug Name
ESZOPICLONE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2014-04-15
Active Ingredient
ESZOPICLONE
Application Number
91153
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2014-04-15
Regulatory Status
Discontinued
Drug Name
ESZOPICLONE
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2014-04-15
Active Ingredient
ESZOPICLONE
Application Number
91153
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2014-04-15
Regulatory Status
Discontinued
Drug Name
ESZOPICLONE
Product Number
3
Dosage Form
-
Strength
3MG
Approval Date
2014-04-15
Active Ingredient
ESZOPICLONE
Application Number
91153
Product Number
3
Dosage Form
-
Strength
3MG
Approval Date
2014-04-15
Regulatory Status
Discontinued
Drug Name
ETHACRYNIC ACID
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2017-02-23
Active Ingredient
ETHACRYNIC ACID
Application Number
207262
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2017-02-23
Regulatory Status
Discontinued
Drug Name
ETOMIDATE
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1996-11-04
Active Ingredient
ETOMIDATE
Application Number
74593
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1996-11-04
Regulatory Status
RX
Drug Name
ETOMIDATE
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2016-02-25
Active Ingredient
ETOMIDATE
Application Number
202354
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2016-02-25
Regulatory Status
RX
Drug Name
ETOPOSIDE
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
1995-07-17
Active Ingredient
ETOPOSIDE
Application Number
74290
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
1995-07-17
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
2018-04-12
Active Ingredient
EVEROLIMUS
Application Number
206133
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
2018-04-12
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
2
Dosage Form
-
Strength
0.5MG
Approval Date
2018-04-12
Active Ingredient
EVEROLIMUS
Application Number
206133
Product Number
2
Dosage Form
-
Strength
0.5MG
Approval Date
2018-04-12
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
3
Dosage Form
-
Strength
0.75MG
Approval Date
2018-04-12
Active Ingredient
EVEROLIMUS
Application Number
206133
Product Number
3
Dosage Form
-
Strength
0.75MG
Approval Date
2018-04-12
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
4
Dosage Form
-
Strength
1MG
Approval Date
2021-11-18
Active Ingredient
EVEROLIMUS
Application Number
206133
Product Number
4
Dosage Form
-
Strength
1MG
Approval Date
2021-11-18
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2020-06-08
Active Ingredient
EVEROLIMUS
Application Number
207486
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2020-06-08
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2020-06-08
Active Ingredient
EVEROLIMUS
Application Number
207486
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2020-06-08
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2020-06-08
Active Ingredient
EVEROLIMUS
Application Number
207486
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2020-06-08
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2021-11-23
Active Ingredient
EVEROLIMUS
Application Number
207486
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2021-11-23
Regulatory Status
RX
Drug Name
EXEMESTANE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2011-04-01
Active Ingredient
EXEMESTANE
Application Number
77431
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2011-04-01
Regulatory Status
Discontinued
Drug Name
FACTREL
Product Number
1
Dosage Form
-
Strength
EQ 0.1MG BASE/VIAL
Approval Date
1982-09-30
Active Ingredient
GONADORELIN HYDROCHLORIDE
Application Number
18123
Product Number
1
Dosage Form
-
Strength
EQ 0.1MG BASE/VIAL
Approval Date
1982-09-30
Regulatory Status
Discontinued
Drug Name
FACTREL
Product Number
2
Dosage Form
-
Strength
EQ 0.2MG BASE/VIAL
Approval Date
1982-09-30
Active Ingredient
GONADORELIN HYDROCHLORIDE
Application Number
18123
Product Number
2
Dosage Form
-
Strength
EQ 0.2MG BASE/VIAL
Approval Date
1982-09-30
Regulatory Status
Discontinued
Drug Name
FACTREL
Product Number
3
Dosage Form
-
Strength
EQ 0.5MG BASE/VIAL
Approval Date
1982-09-30
Active Ingredient
GONADORELIN HYDROCHLORIDE
Application Number
18123
Product Number
3
Dosage Form
-
Strength
EQ 0.5MG BASE/VIAL
Approval Date
1982-09-30
Regulatory Status
Discontinued
Drug Name
FAMCICLOVIR
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2011-03-21
Active Ingredient
FAMCICLOVIR
Application Number
90128
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2011-03-21
Regulatory Status
Discontinued
Drug Name
FAMCICLOVIR
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2011-03-21
Active Ingredient
FAMCICLOVIR
Application Number
90128
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2011-03-21
Regulatory Status
Discontinued
Drug Name
FAMCICLOVIR
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
2011-03-21
Active Ingredient
FAMCICLOVIR
Application Number
90128
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
2011-03-21
Regulatory Status
Discontinued
Drug Name
FAMOTIDINE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2001-04-16
Active Ingredient
FAMOTIDINE
Application Number
75488
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2001-04-16
Regulatory Status
RX
Drug Name
FAMOTIDINE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-04-30
Active Ingredient
FAMOTIDINE
Application Number
75799
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-04-30
Regulatory Status
Discontinued
Drug Name
FAMOTIDINE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2001-04-16
Active Ingredient
FAMOTIDINE
Application Number
75486
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2001-04-16
Regulatory Status
RX
Drug Name
FAMOTIDINE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-04-30
Active Ingredient
FAMOTIDINE
Application Number
75789
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-04-30
Regulatory Status
Discontinued
Drug Name
FEBUXOSTAT
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2019-10-15
Active Ingredient
FEBUXOSTAT
Application Number
205414
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2019-10-15
Regulatory Status
RX
Drug Name
FEBUXOSTAT
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
2019-10-15
Active Ingredient
FEBUXOSTAT
Application Number
205414
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
2019-10-15
Regulatory Status
RX
Drug Name
FENOLDOPAM MESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2004-10-12
Active Ingredient
FENOLDOPAM MESYLATE
Application Number
76582
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2004-10-12
Regulatory Status
Discontinued
Drug Name
FENTANYL CITRATE
Product Number
1
Dosage Form
-
Strength
EQ 0.05MG BASE/ML
Approval Date
1984-07-11
Active Ingredient
FENTANYL CITRATE
Application Number
19101
Product Number
1
Dosage Form
-
Strength
EQ 0.05MG BASE/ML
Approval Date
1984-07-11
Regulatory Status
RX
Drug Name
FENTANYL CITRATE
Product Number
2
Dosage Form
-
Strength
EQ 0.025MG BASE/0.5ML
Approval Date
2023-01-20
Active Ingredient
FENTANYL CITRATE
Application Number
19101
Product Number
2
Dosage Form
-
Strength
EQ 0.025MG BASE/0.5ML
Approval Date
2023-01-20
Regulatory Status
RX
Drug Name
FLECAINIDE ACETATE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2003-01-14
Active Ingredient
FLECAINIDE ACETATE
Application Number
76278
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2003-01-14
Regulatory Status
RX
Drug Name
FLECAINIDE ACETATE
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2003-01-14
Active Ingredient
FLECAINIDE ACETATE
Application Number
76278
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2003-01-14
Regulatory Status
RX
Drug Name
FLECAINIDE ACETATE
Product Number
3
Dosage Form
-
Strength
150MG
Approval Date
2003-01-14
Active Ingredient
FLECAINIDE ACETATE
Application Number
76278
Product Number
3
Dosage Form
-
Strength
150MG
Approval Date
2003-01-14
Regulatory Status
RX
Drug Name
FLOXURIDINE
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2000-04-16
Active Ingredient
FLOXURIDINE
Application Number
75387
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2000-04-16
Regulatory Status
RX
Drug Name
FLUCONAZOLE
Product Number
1
Dosage Form
-
Strength
50MG/5ML
Approval Date
2004-07-29
Active Ingredient
FLUCONAZOLE
Application Number
76246
Product Number
1
Dosage Form
-
Strength
50MG/5ML
Approval Date
2004-07-29
Regulatory Status
Discontinued
Drug Name
FLUCONAZOLE
Product Number
2
Dosage Form
-
Strength
200MG/5ML
Approval Date
2004-07-29
Active Ingredient
FLUCONAZOLE
Application Number
76246
Product Number
2
Dosage Form
-
Strength
200MG/5ML
Approval Date
2004-07-29
Regulatory Status
Discontinued
Drug Name
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2012-01-30
Active Ingredient
FLUCONAZOLE
Application Number
78764
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2012-01-30
Regulatory Status
Discontinued
Drug Name
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
2
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2012-01-30
Active Ingredient
FLUCONAZOLE
Application Number
78764
Product Number
2
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2012-01-30
Regulatory Status
Discontinued
Drug Name
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2004-07-29
Active Ingredient
FLUCONAZOLE
Application Number
76087
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2004-07-29
Regulatory Status
RX
Drug Name
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
Product Number
2
Dosage Form
-
Strength
100MG/50ML (2MG/ML)
Approval Date
2008-09-26
Active Ingredient
FLUCONAZOLE
Application Number
76087
Product Number
2
Dosage Form
-
Strength
100MG/50ML (2MG/ML)
Approval Date
2008-09-26
Regulatory Status
RX
Drug Name
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
Product Number
3
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2004-07-29
Active Ingredient
FLUCONAZOLE
Application Number
76087
Product Number
3
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2004-07-29
Regulatory Status
RX
Drug Name
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2005-08-23
Active Ingredient
FLUCONAZOLE
Application Number
76736
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2005-08-23
Regulatory Status
RX
Drug Name
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2008-07-30
Active Ingredient
FLUCONAZOLE
Application Number
78107
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2008-07-30
Regulatory Status
RX
Drug Name
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Product Number
2
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2008-07-30
Active Ingredient
FLUCONAZOLE
Application Number
78107
Product Number
2
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2008-07-30
Regulatory Status
RX
Drug Name
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2012-01-30
Active Ingredient
FLUCONAZOLE
Application Number
78698
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2012-01-30
Regulatory Status
RX
Drug Name
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Product Number
2
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2012-01-30
Active Ingredient
FLUCONAZOLE
Application Number
78698
Product Number
2
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2012-01-30
Regulatory Status
RX
Drug Name
FLUCYTOSINE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2017-10-17
Active Ingredient
FLUCYTOSINE
Application Number
206550
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2017-10-17
Regulatory Status
Discontinued
Drug Name
FLUCYTOSINE
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2017-10-17
Active Ingredient
FLUCYTOSINE
Application Number
206550
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2017-10-17
Regulatory Status
Discontinued
Drug Name
FLUDARABINE PHOSPHATE
Product Number
1
Dosage Form
-
Strength
50MG/VIAL
Approval Date
2003-08-28
Active Ingredient
FLUDARABINE PHOSPHATE
Application Number
76349
Product Number
1
Dosage Form
-
Strength
50MG/VIAL
Approval Date
2003-08-28
Regulatory Status
RX
Drug Name
FLUDROCORTISONE ACETATE
Product Number
1
Dosage Form
-
Strength
0.1MG
Approval Date
2011-07-22
Active Ingredient
FLUDROCORTISONE ACETATE
Application Number
91302
Product Number
1
Dosage Form
-
Strength
0.1MG
Approval Date
2011-07-22
Regulatory Status
Discontinued
Drug Name
FLUMAZENIL
Product Number
1
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2004-10-12
Active Ingredient
FLUMAZENIL
Application Number
76256
Product Number
1
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2004-10-12
Regulatory Status
RX
Drug Name
FLUMAZENIL
Product Number
2
Dosage Form
-
Strength
0.5MG/5ML (0.1MG/ML)
Approval Date
2004-10-12
Active Ingredient
FLUMAZENIL
Application Number
76256
Product Number
2
Dosage Form
-
Strength
0.5MG/5ML (0.1MG/ML)
Approval Date
2004-10-12
Regulatory Status
RX
Drug Name
FLUMAZENIL
Product Number
1
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2004-10-12
Active Ingredient
FLUMAZENIL
Application Number
76787
Product Number
1
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2004-10-12
Regulatory Status
Discontinued
Drug Name
FLUMAZENIL
Product Number
2
Dosage Form
-
Strength
0.5MG/5ML (0.1MG/ML)
Approval Date
2004-10-12
Active Ingredient
FLUMAZENIL
Application Number
76787
Product Number
2
Dosage Form
-
Strength
0.5MG/5ML (0.1MG/ML)
Approval Date
2004-10-12
Regulatory Status
Discontinued
Drug Name
FLUMAZENIL
Product Number
1
Dosage Form
-
Strength
0.5MG/5ML (0.1MG/ML)
Approval Date
2009-03-23
Active Ingredient
FLUMAZENIL
Application Number
78527
Product Number
1
Dosage Form
-
Strength
0.5MG/5ML (0.1MG/ML)
Approval Date
2009-03-23
Regulatory Status
RX
Drug Name
FLUMAZENIL
Product Number
2
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2009-03-23
Active Ingredient
FLUMAZENIL
Application Number
78527
Product Number
2
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2009-03-23
Regulatory Status
RX
Drug Name
FLUPHENAZINE DECANOATE
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1996-08-30
Active Ingredient
FLUPHENAZINE DECANOATE
Application Number
74531
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1996-08-30
Regulatory Status
RX
Drug Name
FLURAZEPAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
-
Active Ingredient
FLURAZEPAM HYDROCHLORIDE
Application Number
71107
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
FLURAZEPAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
1986-12-08
Active Ingredient
FLURAZEPAM HYDROCHLORIDE
Application Number
71108
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
1986-12-08
Regulatory Status
Discontinued
Drug Name
FLURAZEPAM HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
1986-12-08
Active Ingredient
FLURAZEPAM HYDROCHLORIDE
Application Number
71108
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
1986-12-08
Regulatory Status
Discontinued
Drug Name
FLUTICASONE PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05MG/SPRAY
Approval Date
2006-02-22
Active Ingredient
FLUTICASONE PROPIONATE
Application Number
76504
Product Number
1
Dosage Form
-
Strength
0.05MG/SPRAY
Approval Date
2006-02-22
Regulatory Status
RX
Drug Name
FLUTICASONE PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05MG/SPRAY
Approval Date
2008-01-16
Active Ingredient
FLUTICASONE PROPIONATE
Application Number
77570
Product Number
1
Dosage Form
-
Strength
0.05MG/SPRAY
Approval Date
2008-01-16
Regulatory Status
Discontinued
Drug Name
FLUTICASONE PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05MG/SPRAY
Approval Date
2016-05-26
Active Ingredient
FLUTICASONE PROPIONATE
Application Number
207957
Product Number
1
Dosage Form
-
Strength
0.05MG/SPRAY
Approval Date
2016-05-26
Regulatory Status
OTC
Drug Name
FLUTICASONE PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05MG/SPRAY
Approval Date
2019-04-17
Active Ingredient
FLUTICASONE PROPIONATE
Application Number
208024
Product Number
1
Dosage Form
-
Strength
0.05MG/SPRAY
Approval Date
2019-04-17
Regulatory Status
Discontinued
Drug Name
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
Product Number
1
Dosage Form
-
Strength
0.1MG/INH;EQ 0.05MG BASE/INH
Approval Date
2020-12-17
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
203433
Product Number
1
Dosage Form
-
Strength
0.1MG/INH;EQ 0.05MG BASE/INH
Approval Date
2020-12-17
Regulatory Status
RX
Drug Name
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
Product Number
2
Dosage Form
-
Strength
0.25MG/INH;EQ 0.05MG BASE/INH
Approval Date
2020-12-17
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
203433
Product Number
2
Dosage Form
-
Strength
0.25MG/INH;EQ 0.05MG BASE/INH
Approval Date
2020-12-17
Regulatory Status
RX
Drug Name
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
Product Number
3
Dosage Form
-
Strength
0.5MG/INH;EQ 0.05MG BASE/INH
Approval Date
2023-12-19
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
203433
Product Number
3
Dosage Form
-
Strength
0.5MG/INH;EQ 0.05MG BASE/INH
Approval Date
2023-12-19
Regulatory Status
RX
Drug Name
FOLIC ACID
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
1982-01-01
Active Ingredient
FOLIC ACID
Application Number
80600
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
FOSPHENYTOIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 50MG PHENYTOIN NA/ML
Approval Date
2007-08-06
Active Ingredient
FOSPHENYTOIN SODIUM
Application Number
77481
Product Number
1
Dosage Form
-
Strength
EQ 50MG PHENYTOIN NA/ML
Approval Date
2007-08-06
Regulatory Status
RX
Drug Name
FOSPHENYTOIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 50MG PHENYTOIN NA/ML
Approval Date
2007-08-06
Active Ingredient
FOSPHENYTOIN SODIUM
Application Number
77989
Product Number
1
Dosage Form
-
Strength
EQ 50MG PHENYTOIN NA/ML
Approval Date
2007-08-06
Regulatory Status
RX
Drug Name
FOSPHENYTOIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 50MG PHENYTOIN NA/ML
Approval Date
2009-12-02
Active Ingredient
FOSPHENYTOIN SODIUM
Application Number
78765
Product Number
1
Dosage Form
-
Strength
EQ 50MG PHENYTOIN NA/ML
Approval Date
2009-12-02
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1982-01-01
Active Ingredient
FUROSEMIDE
Application Number
18267
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1983-11-10
Active Ingredient
FUROSEMIDE
Application Number
18823
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1983-11-10
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
1983-11-10
Active Ingredient
FUROSEMIDE
Application Number
18823
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
1983-11-10
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
1
Dosage Form
-
Strength
80MG
Approval Date
1986-01-24
Active Ingredient
FUROSEMIDE
Application Number
70086
Product Number
1
Dosage Form
-
Strength
80MG
Approval Date
1986-01-24
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
1
Dosage Form
-
Strength
40MG/5ML
Approval Date
1987-04-22
Active Ingredient
FUROSEMIDE
Application Number
70433
Product Number
1
Dosage Form
-
Strength
40MG/5ML
Approval Date
1987-04-22
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1987-04-22
Active Ingredient
FUROSEMIDE
Application Number
70434
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1987-04-22
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1990-09-14
Active Ingredient
FUROSEMIDE
Application Number
71439
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1990-09-14
Regulatory Status
Discontinued
Drug Name
GABAPENTIN
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2007-09-25
Active Ingredient
GABAPENTIN
Application Number
78150
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2007-09-25
Regulatory Status
Discontinued
Drug Name
GABAPENTIN
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2007-09-25
Active Ingredient
GABAPENTIN
Application Number
78150
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2007-09-25
Regulatory Status
Discontinued
Drug Name
GABAPENTIN
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
2007-09-25
Active Ingredient
GABAPENTIN
Application Number
78150
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
2007-09-25
Regulatory Status
Discontinued
Drug Name
GABAPENTIN
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2011-07-21
Active Ingredient
GABAPENTIN
Application Number
78782
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2011-07-21
Regulatory Status
Discontinued
Drug Name
GABAPENTIN
Product Number
2
Dosage Form
-
Strength
800MG
Approval Date
2011-07-21
Active Ingredient
GABAPENTIN
Application Number
78782
Product Number
2
Dosage Form
-
Strength
800MG
Approval Date
2011-07-21
Regulatory Status
Discontinued
Drug Name
GALANTAMINE HYDROBROMIDE
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2009-02-11
Active Ingredient
GALANTAMINE HYDROBROMIDE
Application Number
77608
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2009-02-11
Regulatory Status
Discontinued
Drug Name
GALANTAMINE HYDROBROMIDE
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2009-02-11
Active Ingredient
GALANTAMINE HYDROBROMIDE
Application Number
77608
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2009-02-11
Regulatory Status
Discontinued
Drug Name
GALANTAMINE HYDROBROMIDE
Product Number
3
Dosage Form
-
Strength
EQ 12MG BASE
Approval Date
2009-02-11
Active Ingredient
GALANTAMINE HYDROBROMIDE
Application Number
77608
Product Number
3
Dosage Form
-
Strength
EQ 12MG BASE
Approval Date
2009-02-11
Regulatory Status
Discontinued
Drug Name
GALANTAMINE HYDROBROMIDE
Product Number
1
Dosage Form
-
Strength
4MG/ML
Approval Date
2009-01-30
Active Ingredient
GALANTAMINE HYDROBROMIDE
Application Number
78185
Product Number
1
Dosage Form
-
Strength
4MG/ML
Approval Date
2009-01-30
Regulatory Status
RX
Drug Name
GANCICLOVIR SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2003-07-16
Active Ingredient
GANCICLOVIR SODIUM
Application Number
76222
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2003-07-16
Regulatory Status
RX
Drug Name
GATIFLOXACIN
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
2014-09-03
Active Ingredient
GATIFLOXACIN
Application Number
203189
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
2014-09-03
Regulatory Status
Discontinued
Drug Name
GEMCITABINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/VIAL
Approval Date
2021-06-25
Active Ingredient
GEMCITABINE HYDROCHLORIDE
Application Number
206617
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/VIAL
Approval Date
2021-06-25
Regulatory Status
Discontinued
Drug Name
GEMCITABINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2021-06-25
Active Ingredient
GEMCITABINE HYDROCHLORIDE
Application Number
206617
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2021-06-25
Regulatory Status
Discontinued
Drug Name
GEMCITABINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
200MG/5.26ML (38MG/ML)
Approval Date
2023-03-07
Active Ingredient
GEMCITABINE HYDROCHLORIDE
Application Number
213175
Product Number
1
Dosage Form
-
Strength
200MG/5.26ML (38MG/ML)
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
GEMCITABINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
1GM/26.3ML (38MG/ML)
Approval Date
2023-03-07
Active Ingredient
GEMCITABINE HYDROCHLORIDE
Application Number
213175
Product Number
2
Dosage Form
-
Strength
1GM/26.3ML (38MG/ML)
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
GEMCITABINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
2GM/52.6ML (38MG/ML)
Approval Date
2023-03-07
Active Ingredient
GEMCITABINE HYDROCHLORIDE
Application Number
213175
Product Number
3
Dosage Form
-
Strength
2GM/52.6ML (38MG/ML)
Approval Date
2023-03-07
Regulatory Status
RX
Drug Name
GEMFIBROZIL
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2010-08-16
Active Ingredient
GEMFIBROZIL
Application Number
78599
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2010-08-16
Regulatory Status
Discontinued
Drug Name
GENTAMICIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
1982-01-01
Active Ingredient
GENTAMICIN SULFATE
Application Number
62251
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
GENTAMICIN SULFATE
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
1982-01-01
Active Ingredient
GENTAMICIN SULFATE
Application Number
62251
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
GLIMEPIRIDE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2013-08-01
Active Ingredient
GLIMEPIRIDE
Application Number
78952
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2013-08-01
Regulatory Status
Discontinued
Drug Name
GLIMEPIRIDE
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2013-08-01
Active Ingredient
GLIMEPIRIDE
Application Number
78952
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2013-08-01
Regulatory Status
Discontinued
Drug Name
GLIMEPIRIDE
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2013-08-01
Active Ingredient
GLIMEPIRIDE
Application Number
78952
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2013-08-01
Regulatory Status
Discontinued
Drug Name
GLYBURIDE (MICRONIZED)
Product Number
1
Dosage Form
-
Strength
1.5MG
Approval Date
2003-07-31
Active Ingredient
GLYBURIDE
Application Number
75890
Product Number
1
Dosage Form
-
Strength
1.5MG
Approval Date
2003-07-31
Regulatory Status
Discontinued
Drug Name
GLYBURIDE (MICRONIZED)
Product Number
2
Dosage Form
-
Strength
3MG
Approval Date
2003-07-31
Active Ingredient
GLYBURIDE
Application Number
75890
Product Number
2
Dosage Form
-
Strength
3MG
Approval Date
2003-07-31
Regulatory Status
Discontinued
Drug Name
GLYBURIDE (MICRONIZED)
Product Number
3
Dosage Form
-
Strength
6MG
Approval Date
2003-07-31
Active Ingredient
GLYBURIDE
Application Number
75890
Product Number
3
Dosage Form
-
Strength
6MG
Approval Date
2003-07-31
Regulatory Status
Discontinued
Drug Name
GLYCOPYRROLATE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2009-03-05
Active Ingredient
GLYCOPYRROLATE
Application Number
40836
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2009-03-05
Regulatory Status
Discontinued
Drug Name
GLYCOPYRROLATE
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2009-03-05
Active Ingredient
GLYCOPYRROLATE
Application Number
40836
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2009-03-05
Regulatory Status
Discontinued
Drug Name
GLYCOPYRROLATE
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
2011-09-21
Active Ingredient
GLYCOPYRROLATE
Application Number
90963
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
2011-09-21
Regulatory Status
RX
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
Approval Date
2007-12-31
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
77177
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
Approval Date
2007-12-31
Regulatory Status
RX
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
Approval Date
2008-06-30
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
77186
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
Approval Date
2008-06-30
Regulatory Status
RX
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML (EQ 1MG BASE/ML)
Approval Date
2008-06-30
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
77187
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML (EQ 1MG BASE/ML)
Approval Date
2008-06-30
Regulatory Status
RX
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2007-12-31
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
77842
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2007-12-31
Regulatory Status
Discontinued
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
Approval Date
2008-06-26
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
77913
Product Number
1
Dosage Form
-
Strength
EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
Approval Date
2008-06-26
Regulatory Status
RX
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML (EQ 1MG BASE/ML)
Approval Date
2009-12-23
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
78629
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML (EQ 1MG BASE/ML)
Approval Date
2009-12-23
Regulatory Status
RX
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
Approval Date
2009-12-23
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
78629
Product Number
2
Dosage Form
-
Strength
EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
Approval Date
2009-12-23
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2001-06-18
Active Ingredient
HALOPERIDOL LACTATE
Application Number
75858
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2001-06-18
Regulatory Status
RX
Drug Name
HALOPERIDOL DECANOATE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/ML
Approval Date
1998-01-30
Active Ingredient
HALOPERIDOL DECANOATE
Application Number
74811
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/ML
Approval Date
1998-01-30
Regulatory Status
Discontinued
Drug Name
HALOPERIDOL DECANOATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/ML
Approval Date
1998-09-28
Active Ingredient
HALOPERIDOL DECANOATE
Application Number
75305
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/ML
Approval Date
1998-09-28
Regulatory Status
RX
Drug Name
HALOPERIDOL INTENSOL
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
1988-04-12
Active Ingredient
HALOPERIDOL LACTATE
Application Number
72045
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
1988-04-12
Regulatory Status
Discontinued
Drug Name
HEPARIN LOCK FLUSH
Product Number
8
Dosage Form
-
Strength
10 UNITS/ML
Approval Date
-
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
8
Dosage Form
-
Strength
10 UNITS/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
HEPARIN LOCK FLUSH
Product Number
9
Dosage Form
-
Strength
100 UNITS/ML
Approval Date
-
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
9
Dosage Form
-
Strength
100 UNITS/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
HEPARIN SODIUM
Product Number
1
Dosage Form
-
Strength
1,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
1
Dosage Form
-
Strength
1,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
2
Dosage Form
-
Strength
5,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
2
Dosage Form
-
Strength
5,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
3
Dosage Form
-
Strength
7,500 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
3
Dosage Form
-
Strength
7,500 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
4
Dosage Form
-
Strength
10,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
4
Dosage Form
-
Strength
10,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
5
Dosage Form
-
Strength
15,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
5
Dosage Form
-
Strength
15,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
6
Dosage Form
-
Strength
20,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
6
Dosage Form
-
Strength
20,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
7
Dosage Form
-
Strength
2,500 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
7
Dosage Form
-
Strength
2,500 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
10
Dosage Form
-
Strength
5,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17007
Product Number
10
Dosage Form
-
Strength
5,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
1
Dosage Form
-
Strength
1,000 UNITS/ML
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17037
Product Number
1
Dosage Form
-
Strength
1,000 UNITS/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
HEPARIN SODIUM
Product Number
2
Dosage Form
-
Strength
5,000 UNITS/ML
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17037
Product Number
2
Dosage Form
-
Strength
5,000 UNITS/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
HEPARIN SODIUM
Product Number
3
Dosage Form
-
Strength
10,000 UNITS/ML
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17037
Product Number
3
Dosage Form
-
Strength
10,000 UNITS/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
HEPARIN SODIUM
Product Number
13
Dosage Form
-
Strength
5,000 UNITS/0.5ML
Approval Date
1986-04-07
Active Ingredient
HEPARIN SODIUM
Application Number
17037
Product Number
13
Dosage Form
-
Strength
5,000 UNITS/0.5ML
Approval Date
1986-04-07
Regulatory Status
RX
Drug Name
HYDRALAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2020-12-18
Active Ingredient
HYDRALAZINE HYDROCHLORIDE
Application Number
213667
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2020-12-18
Regulatory Status
RX
Drug Name
HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
2007-11-26
Active Ingredient
HYDROCHLOROTHIAZIDE
Application Number
77885
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
2007-11-26
Regulatory Status
Discontinued
Drug Name
HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Active Ingredient
HYDROCHLOROTHIAZIDE
Application Number
84878
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2006-07-12
Active Ingredient
HYDROCHLOROTHIAZIDE
Application Number
84878
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2006-07-12
Regulatory Status
Discontinued
Drug Name
HYDROCORTISONE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1982-01-01
Active Ingredient
HYDROCORTISONE
Application Number
83365
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HYDROCORTISONE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2015-02-23
Active Ingredient
HYDROCORTISONE
Application Number
83365
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2015-02-23
Regulatory Status
Discontinued
Drug Name
HYDROCORTISONE
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2015-02-23
Active Ingredient
HYDROCORTISONE
Application Number
83365
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2015-02-23
Regulatory Status
Discontinued
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
8MG
Approval Date
1998-07-29
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
74597
Product Number
1
Dosage Form
-
Strength
8MG
Approval Date
1998-07-29
Regulatory Status
Discontinued
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2009-05-29
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
74597
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2009-05-29
Regulatory Status
Discontinued
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
1998-07-29
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
74653
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
1998-07-29
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2018-04-27
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
202159
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2018-04-27
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
2024-02-09
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
216899
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
2024-02-09
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
0.5MG/0.5ML
Approval Date
2024-02-09
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
216899
Product Number
2
Dosage Form
-
Strength
0.5MG/0.5ML
Approval Date
2024-02-09
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
1MG/ML
Approval Date
2024-02-09
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
216899
Product Number
3
Dosage Form
-
Strength
1MG/ML
Approval Date
2024-02-09
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
2MG/ML
Approval Date
2024-02-09
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
216899
Product Number
4
Dosage Form
-
Strength
2MG/ML
Approval Date
2024-02-09
Regulatory Status
RX
Drug Name
HYDROMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG/20ML (2MG/ML)
Approval Date
2023-12-14
Active Ingredient
HYDROMORPHONE HYDROCHLORIDE
Application Number
217812
Product Number
1
Dosage Form
-
Strength
40MG/20ML (2MG/ML)
Approval Date
2023-12-14
Regulatory Status
RX
Drug Name
HYDROXYCHLOROQUINE SULFATE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2007-08-15
Active Ingredient
HYDROXYCHLOROQUINE SULFATE
Application Number
40760
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2007-08-15
Regulatory Status
Discontinued
Drug Name
HYDROXYZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/5ML
Approval Date
1994-10-28
Active Ingredient
HYDROXYZINE HYDROCHLORIDE
Application Number
40010
Product Number
1
Dosage Form
-
Strength
10MG/5ML
Approval Date
1994-10-28
Regulatory Status
Discontinued
Drug Name
ICOSAPENT ETHYL
Product Number
1
Dosage Form
-
Strength
1GM
Approval Date
2020-05-21
Active Ingredient
ICOSAPENT ETHYL
Application Number
209457
Product Number
1
Dosage Form
-
Strength
1GM
Approval Date
2020-05-21
Regulatory Status
RX
Drug Name
ICOSAPENT ETHYL
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2023-03-08
Active Ingredient
ICOSAPENT ETHYL
Application Number
209457
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2023-03-08
Regulatory Status
RX
Drug Name
IDARUBICIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML (1MG/ML)
Approval Date
2006-12-14
Active Ingredient
IDARUBICIN HYDROCHLORIDE
Application Number
65275
Product Number
1
Dosage Form
-
Strength
5MG/5ML (1MG/ML)
Approval Date
2006-12-14
Regulatory Status
RX
Drug Name
IDARUBICIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG/10ML (1MG/ML)
Approval Date
2006-12-14
Active Ingredient
IDARUBICIN HYDROCHLORIDE
Application Number
65275
Product Number
2
Dosage Form
-
Strength
10MG/10ML (1MG/ML)
Approval Date
2006-12-14
Regulatory Status
RX
Drug Name
IDARUBICIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
20MG/20ML (1MG/ML)
Approval Date
2006-12-14
Active Ingredient
IDARUBICIN HYDROCHLORIDE
Application Number
65275
Product Number
3
Dosage Form
-
Strength
20MG/20ML (1MG/ML)
Approval Date
2006-12-14
Regulatory Status
RX
Drug Name
IDARUBICIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML (1MG/ML)
Approval Date
2007-05-15
Active Ingredient
IDARUBICIN HYDROCHLORIDE
Application Number
65288
Product Number
1
Dosage Form
-
Strength
5MG/5ML (1MG/ML)
Approval Date
2007-05-15
Regulatory Status
RX
Drug Name
IDARUBICIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG/10ML (1MG/ML)
Approval Date
2007-05-15
Active Ingredient
IDARUBICIN HYDROCHLORIDE
Application Number
65288
Product Number
2
Dosage Form
-
Strength
10MG/10ML (1MG/ML)
Approval Date
2007-05-15
Regulatory Status
RX
Drug Name
IDARUBICIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
20MG/20ML (1MG/ML)
Approval Date
2007-05-15
Active Ingredient
IDARUBICIN HYDROCHLORIDE
Application Number
65288
Product Number
3
Dosage Form
-
Strength
20MG/20ML (1MG/ML)
Approval Date
2007-05-15
Regulatory Status
RX
Drug Name
IFOSFAMIDE
Product Number
1
Dosage Form
-
Strength
1GM/20ML (50MG/ML)
Approval Date
2011-06-29
Active Ingredient
IFOSFAMIDE
Application Number
76619
Product Number
1
Dosage Form
-
Strength
1GM/20ML (50MG/ML)
Approval Date
2011-06-29
Regulatory Status
RX
Drug Name
IFOSFAMIDE
Product Number
2
Dosage Form
-
Strength
3GM/60ML (50MG/ML)
Approval Date
2011-06-29
Active Ingredient
IFOSFAMIDE
Application Number
76619
Product Number
2
Dosage Form
-
Strength
3GM/60ML (50MG/ML)
Approval Date
2011-06-29
Regulatory Status
RX
Drug Name
IMATINIB MESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2018-07-13
Active Ingredient
IMATINIB MESYLATE
Application Number
207586
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2018-07-13
Regulatory Status
Discontinued
Drug Name
IMATINIB MESYLATE
Product Number
2
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2018-07-13
Active Ingredient
IMATINIB MESYLATE
Application Number
207586
Product Number
2
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2018-07-13
Regulatory Status
Discontinued
Drug Name
IMIPRAMINE PAMOATE
Product Number
1
Dosage Form
-
Strength
EQ 75MG HYDROCHLORIDE
Approval Date
2010-04-16
Active Ingredient
IMIPRAMINE PAMOATE
Application Number
91099
Product Number
1
Dosage Form
-
Strength
EQ 75MG HYDROCHLORIDE
Approval Date
2010-04-16
Regulatory Status
RX
Drug Name
IMIPRAMINE PAMOATE
Product Number
2
Dosage Form
-
Strength
EQ 100MG HYDROCHLORIDE
Approval Date
2010-04-16
Active Ingredient
IMIPRAMINE PAMOATE
Application Number
91099
Product Number
2
Dosage Form
-
Strength
EQ 100MG HYDROCHLORIDE
Approval Date
2010-04-16
Regulatory Status
RX
Drug Name
IMIPRAMINE PAMOATE
Product Number
3
Dosage Form
-
Strength
EQ 125MG HYDROCHLORIDE
Approval Date
2010-04-16
Active Ingredient
IMIPRAMINE PAMOATE
Application Number
91099
Product Number
3
Dosage Form
-
Strength
EQ 125MG HYDROCHLORIDE
Approval Date
2010-04-16
Regulatory Status
RX
Drug Name
IMIPRAMINE PAMOATE
Product Number
4
Dosage Form
-
Strength
EQ 150MG HYDROCHLORIDE
Approval Date
2010-04-16
Active Ingredient
IMIPRAMINE PAMOATE
Application Number
91099
Product Number
4
Dosage Form
-
Strength
EQ 150MG HYDROCHLORIDE
Approval Date
2010-04-16
Regulatory Status
RX
Drug Name
IMMPHENTIV
Product Number
4
Dosage Form
-
Strength
0.5MG/5ML (0.1MG/ML)
Approval Date
2023-03-09
Active Ingredient
PHENYLEPHRINE HYDROCHLORIDE
Application Number
203826
Product Number
4
Dosage Form
-
Strength
0.5MG/5ML (0.1MG/ML)
Approval Date
2023-03-09
Regulatory Status
RX
Drug Name
IMMPHENTIV
Product Number
5
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2023-03-09
Active Ingredient
PHENYLEPHRINE HYDROCHLORIDE
Application Number
203826
Product Number
5
Dosage Form
-
Strength
1MG/10ML (0.1MG/ML)
Approval Date
2023-03-09
Regulatory Status
RX
Drug Name
INDOMETHACIN
Product Number
1
Dosage Form
-
Strength
25MG/5ML
Approval Date
1987-03-18
Active Ingredient
INDOMETHACIN
Application Number
71412
Product Number
1
Dosage Form
-
Strength
25MG/5ML
Approval Date
1987-03-18
Regulatory Status
Discontinued
Drug Name
INDOMETHACIN
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2024-11-19
Active Ingredient
INDOMETHACIN
Application Number
215899
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2024-11-19
Regulatory Status
RX
Drug Name
INDOMETHACIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/VIAL
Approval Date
2008-07-16
Active Ingredient
INDOMETHACIN SODIUM
Application Number
78713
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/VIAL
Approval Date
2008-07-16
Regulatory Status
Discontinued
Drug Name
INFUMORPH
Product Number
3
Dosage Form
-
Strength
10MG/ML
Approval Date
1991-07-19
Active Ingredient
MORPHINE SULFATE
Application Number
18565
Product Number
3
Dosage Form
-
Strength
10MG/ML
Approval Date
1991-07-19
Regulatory Status
RX
Drug Name
INFUMORPH
Product Number
4
Dosage Form
-
Strength
25MG/ML
Approval Date
1991-07-19
Active Ingredient
MORPHINE SULFATE
Application Number
18565
Product Number
4
Dosage Form
-
Strength
25MG/ML
Approval Date
1991-07-19
Regulatory Status
RX
Drug Name
IPRATROPIUM BROMIDE
Product Number
1
Dosage Form
-
Strength
0.042MG/SPRAY
Approval Date
2003-11-05
Active Ingredient
IPRATROPIUM BROMIDE
Application Number
76598
Product Number
1
Dosage Form
-
Strength
0.042MG/SPRAY
Approval Date
2003-11-05
Regulatory Status
RX
Drug Name
IPRATROPIUM BROMIDE
Product Number
1
Dosage Form
-
Strength
0.021MG/SPRAY
Approval Date
2003-11-05
Active Ingredient
IPRATROPIUM BROMIDE
Application Number
76664
Product Number
1
Dosage Form
-
Strength
0.021MG/SPRAY
Approval Date
2003-11-05
Regulatory Status
RX
Drug Name
IRBESARTAN
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2012-10-15
Active Ingredient
IRBESARTAN
Application Number
90201
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2012-10-15
Regulatory Status
Discontinued
Drug Name
IRBESARTAN
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2012-10-15
Active Ingredient
IRBESARTAN
Application Number
90201
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2012-10-15
Regulatory Status
Discontinued
Drug Name
IRBESARTAN
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2012-10-15
Active Ingredient
IRBESARTAN
Application Number
90201
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2012-10-15
Regulatory Status
Discontinued
Drug Name
IRBESARTAN AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;150MG
Approval Date
2012-10-15
Active Ingredient
HYDROCHLOROTHIAZIDE; IRBESARTAN
Application Number
90351
Product Number
1
Dosage Form
-
Strength
12.5MG;150MG
Approval Date
2012-10-15
Regulatory Status
Discontinued
Drug Name
IRBESARTAN AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;300MG
Approval Date
2012-10-15
Active Ingredient
HYDROCHLOROTHIAZIDE; IRBESARTAN
Application Number
90351
Product Number
2
Dosage Form
-
Strength
12.5MG;300MG
Approval Date
2012-10-15
Regulatory Status
Discontinued
Drug Name
IRBESARTAN AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
25MG;300MG
Approval Date
2017-06-08
Active Ingredient
HYDROCHLOROTHIAZIDE; IRBESARTAN
Application Number
90351
Product Number
3
Dosage Form
-
Strength
25MG;300MG
Approval Date
2017-06-08
Regulatory Status
Discontinued
Drug Name
IRINOTECAN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG/2ML (20MG/ML)
Approval Date
2008-12-24
Active Ingredient
IRINOTECAN HYDROCHLORIDE
Application Number
78753
Product Number
1
Dosage Form
-
Strength
40MG/2ML (20MG/ML)
Approval Date
2008-12-24
Regulatory Status
RX
Drug Name
IRINOTECAN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG/5ML (20MG/ML)
Approval Date
2008-12-24
Active Ingredient
IRINOTECAN HYDROCHLORIDE
Application Number
78753
Product Number
2
Dosage Form
-
Strength
100MG/5ML (20MG/ML)
Approval Date
2008-12-24
Regulatory Status
RX
Drug Name
IRINOTECAN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG/2ML (20MG/ML)
Approval Date
2010-12-20
Active Ingredient
IRINOTECAN HYDROCHLORIDE
Application Number
91032
Product Number
1
Dosage Form
-
Strength
40MG/2ML (20MG/ML)
Approval Date
2010-12-20
Regulatory Status
RX
Drug Name
IRINOTECAN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG/5ML (20MG/ML)
Approval Date
2010-12-20
Active Ingredient
IRINOTECAN HYDROCHLORIDE
Application Number
91032
Product Number
2
Dosage Form
-
Strength
100MG/5ML (20MG/ML)
Approval Date
2010-12-20
Regulatory Status
RX
Drug Name
ISONIAZID
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1982-01-01
Active Ingredient
ISONIAZID
Application Number
80212
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
ISONIAZID
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
1982-01-01
Active Ingredient
ISONIAZID
Application Number
80212
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
ISONIAZID
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
-
Active Ingredient
ISONIAZID
Application Number
87425
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ISOPROTERENOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
2023-04-26
Active Ingredient
ISOPROTERENOL HYDROCHLORIDE
Application Number
211703
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
2023-04-26
Regulatory Status
RX
Drug Name
ISOSORBIDE DINITRATE
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
2007-01-10
Active Ingredient
ISOSORBIDE DINITRATE
Application Number
40591
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
2007-01-10
Regulatory Status
Discontinued
Drug Name
ISOSORBIDE DINITRATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1987-11-02
Active Ingredient
ISOSORBIDE DINITRATE
Application Number
86055
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1987-11-02
Regulatory Status
Discontinued
Drug Name
ISOSORBIDE DINITRATE
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
1987-10-29
Active Ingredient
ISOSORBIDE DINITRATE
Application Number
86055
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
1987-10-29
Regulatory Status
Discontinued
Drug Name
ISOSORBIDE DINITRATE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1987-11-02
Active Ingredient
ISOSORBIDE DINITRATE
Application Number
88088
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1987-11-02
Regulatory Status
RX
Drug Name
ISOSORBIDE DINITRATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
1987-10-29
Active Ingredient
ISOSORBIDE DINITRATE
Application Number
88088
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
1987-10-29
Regulatory Status
RX
Drug Name
ISOSORBIDE DINITRATE
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
1987-10-29
Active Ingredient
ISOSORBIDE DINITRATE
Application Number
88088
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
1987-10-29
Regulatory Status
RX
Drug Name
ISOSORBIDE MONONITRATE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2000-10-05
Active Ingredient
ISOSORBIDE MONONITRATE
Application Number
75361
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2000-10-05
Regulatory Status
Discontinued
Drug Name
ISOSORBIDE MONONITRATE
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2005-01-07
Active Ingredient
ISOSORBIDE MONONITRATE
Application Number
76813
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2005-01-07
Regulatory Status
Discontinued
Drug Name
ISOSORBIDE MONONITRATE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2006-03-30
Active Ingredient
ISOSORBIDE MONONITRATE
Application Number
76813
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2006-03-30
Regulatory Status
Discontinued
Drug Name
KANAMYCIN
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE/2ML
Approval Date
1982-01-01
Active Ingredient
KANAMYCIN SULFATE
Application Number
62324
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE/2ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
KANAMYCIN
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/2ML
Approval Date
1982-01-01
Active Ingredient
KANAMYCIN SULFATE
Application Number
62324
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/2ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
KANAMYCIN
Product Number
3
Dosage Form
-
Strength
EQ 1GM BASE/3ML
Approval Date
1982-01-01
Active Ingredient
KANAMYCIN SULFATE
Application Number
62324
Product Number
3
Dosage Form
-
Strength
EQ 1GM BASE/3ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
KETAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/ML
Approval Date
1996-03-22
Active Ingredient
KETAMINE HYDROCHLORIDE
Application Number
74524
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/ML
Approval Date
1996-03-22
Regulatory Status
RX
Drug Name
KETAMINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE/ML
Approval Date
1996-03-22
Active Ingredient
KETAMINE HYDROCHLORIDE
Application Number
74524
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE/ML
Approval Date
1996-03-22
Regulatory Status
RX
Drug Name
KETOROLAC TROMETHAMINE
Product Number
1
Dosage Form
-
Strength
15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-04-26
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
75222
Product Number
1
Dosage Form
-
Strength
15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-04-26
Regulatory Status
Discontinued
Drug Name
KETOROLAC TROMETHAMINE
Product Number
2
Dosage Form
-
Strength
30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-04-26
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
75222
Product Number
2
Dosage Form
-
Strength
30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-04-26
Regulatory Status
Discontinued
Drug Name
KETOROLAC TROMETHAMINE
Product Number
1
Dosage Form
-
Strength
30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-04-26
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
75228
Product Number
1
Dosage Form
-
Strength
30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-04-26
Regulatory Status
Discontinued
Drug Name
KETOROLAC TROMETHAMINE
Product Number
1
Dosage Form
-
Strength
15MG/ML
Approval Date
1999-11-03
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
75299
Product Number
1
Dosage Form
-
Strength
15MG/ML
Approval Date
1999-11-03
Regulatory Status
Discontinued
Drug Name
KETOROLAC TROMETHAMINE
Product Number
2
Dosage Form
-
Strength
30MG/ML
Approval Date
1999-11-03
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
75299
Product Number
2
Dosage Form
-
Strength
30MG/ML
Approval Date
1999-11-03
Regulatory Status
Discontinued
Drug Name
KETOROLAC TROMETHAMINE
Product Number
1
Dosage Form
-
Strength
15MG/ML
Approval Date
2004-07-21
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
75772
Product Number
1
Dosage Form
-
Strength
15MG/ML
Approval Date
2004-07-21
Regulatory Status
RX
Drug Name
KETOROLAC TROMETHAMINE
Product Number
2
Dosage Form
-
Strength
30MG/ML
Approval Date
2004-07-21
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
75772
Product Number
2
Dosage Form
-
Strength
30MG/ML
Approval Date
2004-07-21
Regulatory Status
RX
Drug Name
KETOROLAC TROMETHAMINE
Product Number
3
Dosage Form
-
Strength
60MG/2ML
Approval Date
-
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
75772
Product Number
3
Dosage Form
-
Strength
60MG/2ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
KLOXXADO
Product Number
1
Dosage Form
-
Strength
8MG/SPRAY
Approval Date
2021-04-29
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
212045
Product Number
1
Dosage Form
-
Strength
8MG/SPRAY
Approval Date
2021-04-29
Regulatory Status
RX
Drug Name
KLOXXADO
Product Number
2
Dosage Form
-
Strength
4MG/SPRAY
Approval Date
2025-08-25
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
212045
Product Number
2
Dosage Form
-
Strength
4MG/SPRAY
Approval Date
2025-08-25
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1999-05-28
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
75303
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1999-05-28
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
2022-03-18
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
213330
Product Number
5
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
2022-03-18
Regulatory Status
Discontinued
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
20MG/4ML (5MG/ML)
Approval Date
2024-08-19
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
213330
Product Number
6
Dosage Form
-
Strength
20MG/4ML (5MG/ML)
Approval Date
2024-08-19
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE IN DEXTROSE
Product Number
1
Dosage Form
-
Strength
200MG/200ML (1MG/ML)
Approval Date
2020-11-09
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
213330
Product Number
1
Dosage Form
-
Strength
200MG/200ML (1MG/ML)
Approval Date
2020-11-09
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG/100ML (1MG/ML)
Approval Date
2020-11-09
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
213330
Product Number
2
Dosage Form
-
Strength
100MG/100ML (1MG/ML)
Approval Date
2020-11-09
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE
Product Number
3
Dosage Form
-
Strength
200MG/200ML (1MG/ML)
Approval Date
2020-11-09
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
213330
Product Number
3
Dosage Form
-
Strength
200MG/200ML (1MG/ML)
Approval Date
2020-11-09
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE
Product Number
4
Dosage Form
-
Strength
300MG/300ML (1MG/ML)
Approval Date
2020-11-09
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
213330
Product Number
4
Dosage Form
-
Strength
300MG/300ML (1MG/ML)
Approval Date
2020-11-09
Regulatory Status
RX
Drug Name
LACOSAMIDE
Product Number
1
Dosage Form
-
Strength
200MG/20ML (10MG/ML)
Approval Date
2024-04-05
Active Ingredient
LACOSAMIDE
Application Number
216806
Product Number
1
Dosage Form
-
Strength
200MG/20ML (10MG/ML)
Approval Date
2024-04-05
Regulatory Status
RX
Drug Name
LACTULOSE
Product Number
1
Dosage Form
-
Strength
10GM/15ML
Approval Date
1992-05-29
Active Ingredient
LACTULOSE
Application Number
73591
Product Number
1
Dosage Form
-
Strength
10GM/15ML
Approval Date
1992-05-29
Regulatory Status
Discontinued
Drug Name
LACTULOSE
Product Number
1
Dosage Form
-
Strength
10GM/15ML
Approval Date
1995-07-03
Active Ingredient
LACTULOSE
Application Number
74076
Product Number
1
Dosage Form
-
Strength
10GM/15ML
Approval Date
1995-07-03
Regulatory Status
Discontinued
Drug Name
LAMOTRIGINE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2011-04-19
Active Ingredient
LAMOTRIGINE
Application Number
78134
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2011-04-19
Regulatory Status
Discontinued
Drug Name
LAMOTRIGINE
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2011-04-19
Active Ingredient
LAMOTRIGINE
Application Number
78134
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2011-04-19
Regulatory Status
Discontinued
Drug Name
LAMOTRIGINE
Product Number
3
Dosage Form
-
Strength
150MG
Approval Date
2011-04-19
Active Ingredient
LAMOTRIGINE
Application Number
78134
Product Number
3
Dosage Form
-
Strength
150MG
Approval Date
2011-04-19
Regulatory Status
Discontinued
Drug Name
LAMOTRIGINE
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2011-04-19
Active Ingredient
LAMOTRIGINE
Application Number
78134
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2011-04-19
Regulatory Status
Discontinued
Drug Name
LARGON
Product Number
2
Dosage Form
-
Strength
20MG/ML
Approval Date
1982-01-01
Active Ingredient
PROPIOMAZINE HYDROCHLORIDE
Application Number
12382
Product Number
2
Dosage Form
-
Strength
20MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
LETROZOLE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2011-06-03
Active Ingredient
LETROZOLE
Application Number
90838
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2011-06-03
Regulatory Status
Discontinued
Drug Name
LETROZOLE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2016-06-03
Active Ingredient
LETROZOLE
Application Number
203796
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2016-06-03
Regulatory Status
Discontinued
Drug Name
LEUCOVORIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
1993-02-22
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
72733
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
1993-02-22
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
1993-02-22
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
72734
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
1993-02-22
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 15MG BASE
Approval Date
1993-02-22
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
72735
Product Number
1
Dosage Form
-
Strength
EQ 15MG BASE
Approval Date
1993-02-22
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
1993-02-22
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
72736
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
1993-02-22
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/VIAL
Approval Date
1987-09-14
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
89384
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/VIAL
Approval Date
1987-09-14
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
1988-03-28
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
89717
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
1988-03-28
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/VIAL
Approval Date
1995-05-23
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
40056
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/VIAL
Approval Date
1995-05-23
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 350MG BASE/VIAL
Approval Date
2000-04-20
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
40335
Product Number
1
Dosage Form
-
Strength
EQ 350MG BASE/VIAL
Approval Date
2000-04-20
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 300MG BASE/30ML (EQ 10MG BASE/ML)
Approval Date
2000-04-25
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
40347
Product Number
1
Dosage Form
-
Strength
EQ 300MG BASE/30ML (EQ 10MG BASE/ML)
Approval Date
2000-04-25
Regulatory Status
Discontinued
Drug Name
LEUCOVORIN CALCIUM PRESERVATIVE FREE
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/50ML (EQ 10MG BASE/ML)
Approval Date
2000-04-25
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
40347
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/50ML (EQ 10MG BASE/ML)
Approval Date
2000-04-25
Regulatory Status
Discontinued
Drug Name
LEVETIRACETAM
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2012-02-28
Active Ingredient
LEVETIRACETAM
Application Number
90601
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2012-02-28
Regulatory Status
Discontinued
Drug Name
LEVETIRACETAM
Product Number
1
Dosage Form
-
Strength
500MG/5ML (100MG/ML)
Approval Date
2011-10-13
Active Ingredient
LEVETIRACETAM
Application Number
90981
Product Number
1
Dosage Form
-
Strength
500MG/5ML (100MG/ML)
Approval Date
2011-10-13
Regulatory Status
RX
Drug Name
LEVETIRACETAM IN SODIUM CHLORIDE
Product Number
1
Dosage Form
-
Strength
500MG/100ML (5MG/ML)
Approval Date
2024-02-12
Active Ingredient
LEVETIRACETAM
Application Number
211356
Product Number
1
Dosage Form
-
Strength
500MG/100ML (5MG/ML)
Approval Date
2024-02-12
Regulatory Status
RX
Drug Name
LEVETIRACETAM IN SODIUM CHLORIDE
Product Number
2
Dosage Form
-
Strength
1GM/100ML (10MG/ML)
Approval Date
2024-02-12
Active Ingredient
LEVETIRACETAM
Application Number
211356
Product Number
2
Dosage Form
-
Strength
1GM/100ML (10MG/ML)
Approval Date
2024-02-12
Regulatory Status
RX
Drug Name
LEVETIRACETAM IN SODIUM CHLORIDE
Product Number
3
Dosage Form
-
Strength
1.5GM/100ML (15MG/ML)
Approval Date
2024-02-12
Active Ingredient
LEVETIRACETAM
Application Number
211356
Product Number
3
Dosage Form
-
Strength
1.5GM/100ML (15MG/ML)
Approval Date
2024-02-12
Regulatory Status
RX
Drug Name
LEVOCARNITINE
Product Number
1
Dosage Form
-
Strength
200MG/ML
Approval Date
2001-03-29
Active Ingredient
LEVOCARNITINE
Application Number
75567
Product Number
1
Dosage Form
-
Strength
200MG/ML
Approval Date
2001-03-29
Regulatory Status
RX
Drug Name
LEVOCARNITINE
Product Number
1
Dosage Form
-
Strength
1GM/10ML
Approval Date
2007-10-25
Active Ingredient
LEVOCARNITINE
Application Number
77399
Product Number
1
Dosage Form
-
Strength
1GM/10ML
Approval Date
2007-10-25
Regulatory Status
Discontinued
Drug Name
LEVOFLOXACIN
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
-
Active Ingredient
LEVOFLOXACIN
Application Number
78767
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LEVOFLOXACIN
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
-
Active Ingredient
LEVOFLOXACIN
Application Number
78767
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LEVOFLOXACIN
Product Number
3
Dosage Form
-
Strength
750MG
Approval Date
-
Active Ingredient
LEVOFLOXACIN
Application Number
78767
Product Number
3
Dosage Form
-
Strength
750MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
EQ 250MG/50ML (EQ 5MG/ML)
Approval Date
2011-09-16
Active Ingredient
LEVOFLOXACIN
Application Number
91375
Product Number
1
Dosage Form
-
Strength
EQ 250MG/50ML (EQ 5MG/ML)
Approval Date
2011-09-16
Regulatory Status
RX
Drug Name
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
2
Dosage Form
-
Strength
EQ 500MG/100ML (EQ 5MG/ML)
Approval Date
2011-09-16
Active Ingredient
LEVOFLOXACIN
Application Number
91375
Product Number
2
Dosage Form
-
Strength
EQ 500MG/100ML (EQ 5MG/ML)
Approval Date
2011-09-16
Regulatory Status
RX
Drug Name
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
3
Dosage Form
-
Strength
EQ 750MG/150ML (EQ 5MG/ML)
Approval Date
2011-09-16
Active Ingredient
LEVOFLOXACIN
Application Number
91375
Product Number
3
Dosage Form
-
Strength
EQ 750MG/150ML (EQ 5MG/ML)
Approval Date
2011-09-16
Regulatory Status
RX
Drug Name
LEVOLEUCOVORIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/VIAL
Approval Date
2016-06-16
Active Ingredient
LEVOLEUCOVORIN CALCIUM
Application Number
206263
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/VIAL
Approval Date
2016-06-16
Regulatory Status
Discontinued
Drug Name
LEVOMILNACIPRAN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2020-11-05
Active Ingredient
LEVOMILNACIPRAN HYDROCHLORIDE
Application Number
210732
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2020-11-05
Regulatory Status
Discontinued
Drug Name
LEVOMILNACIPRAN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2020-11-05
Active Ingredient
LEVOMILNACIPRAN HYDROCHLORIDE
Application Number
210732
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2020-11-05
Regulatory Status
Discontinued
Drug Name
LEVOMILNACIPRAN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2020-11-05
Active Ingredient
LEVOMILNACIPRAN HYDROCHLORIDE
Application Number
210732
Product Number
3
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2020-11-05
Regulatory Status
Discontinued
Drug Name
LEVOMILNACIPRAN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 120MG BASE
Approval Date
2020-11-05
Active Ingredient
LEVOMILNACIPRAN HYDROCHLORIDE
Application Number
210732
Product Number
4
Dosage Form
-
Strength
EQ 120MG BASE
Approval Date
2020-11-05
Regulatory Status
Discontinued
Drug Name
LEVORPHANOL TARTRATE
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2000-03-31
Active Ingredient
LEVORPHANOL TARTRATE
Application Number
74278
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2000-03-31
Regulatory Status
RX
Drug Name
LEVORPHANOL TARTRATE
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
2018-06-18
Active Ingredient
LEVORPHANOL TARTRATE
Application Number
74278
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
2018-06-18
Regulatory Status
Discontinued
Drug Name
LEVORPHANOL TARTRATE
Product Number
3
Dosage Form
-
Strength
3MG
Approval Date
2018-06-18
Active Ingredient
LEVORPHANOL TARTRATE
Application Number
74278
Product Number
3
Dosage Form
-
Strength
3MG
Approval Date
2018-06-18
Regulatory Status
Discontinued
Drug Name
LEVOTHYROXINE SODIUM
Product Number
1
Dosage Form
-
Strength
100MCG/ML
Approval Date
2021-05-17
Active Ingredient
LEVOTHYROXINE SODIUM
Application Number
214253
Product Number
1
Dosage Form
-
Strength
100MCG/ML
Approval Date
2021-05-17
Regulatory Status
RX
Drug Name
LIDOCAINE AND PRILOCAINE
Product Number
1
Dosage Form
-
Strength
2.5%;2.5%
Approval Date
2003-09-25
Active Ingredient
LIDOCAINE; PRILOCAINE
Application Number
76290
Product Number
1
Dosage Form
-
Strength
2.5%;2.5%
Approval Date
2003-09-25
Regulatory Status
Discontinued
Drug Name
LIDOCAINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1995-07-10
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
40014
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1995-07-10
Regulatory Status
Discontinued
Drug Name
LIDOCAINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
4%
Approval Date
1985-04-03
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
88803
Product Number
1
Dosage Form
-
Strength
4%
Approval Date
1985-04-03
Regulatory Status
RX
Drug Name
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1982-01-01
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
84625
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
Product Number
2
Dosage Form
-
Strength
2%
Approval Date
1982-01-01
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
84625
Product Number
2
Dosage Form
-
Strength
2%
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
LIDOCAINE VISCOUS
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1985-04-26
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
88802
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1985-04-26
Regulatory Status
RX
Drug Name
LINEZOLID
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2015-06-03
Active Ingredient
LINEZOLID
Application Number
200068
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2015-06-03
Regulatory Status
RX
Drug Name
LINEZOLID
Product Number
1
Dosage Form
-
Strength
600MG/300ML (2MG/ML)
Approval Date
2022-08-22
Active Ingredient
LINEZOLID
Application Number
206454
Product Number
1
Dosage Form
-
Strength
600MG/300ML (2MG/ML)
Approval Date
2022-08-22
Regulatory Status
RX
Drug Name
LIRAGLUTIDE
Product Number
1
Dosage Form
-
Strength
18MG/3ML (6MG/ML)
Approval Date
2024-12-23
Active Ingredient
LIRAGLUTIDE
Application Number
215503
Product Number
1
Dosage Form
-
Strength
18MG/3ML (6MG/ML)
Approval Date
2024-12-23
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
202827
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
202827
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
202827
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
4
Dosage Form
-
Strength
50MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
202827
Product Number
4
Dosage Form
-
Strength
50MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
5
Dosage Form
-
Strength
60MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
202827
Product Number
5
Dosage Form
-
Strength
60MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
6
Dosage Form
-
Strength
70MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
202827
Product Number
6
Dosage Form
-
Strength
70MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
7
Dosage Form
-
Strength
10MG
Approval Date
2024-01-17
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
202827
Product Number
7
Dosage Form
-
Strength
10MG
Approval Date
2024-01-17
Regulatory Status
RX
Drug Name
LISINOPRIL
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2002-07-01
Active Ingredient
LISINOPRIL
Application Number
76063
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2002-07-01
Regulatory Status
Discontinued
Drug Name
LISINOPRIL
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2002-07-01
Active Ingredient
LISINOPRIL
Application Number
76063
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2002-07-01
Regulatory Status
Discontinued
Drug Name
LISINOPRIL
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2002-07-01
Active Ingredient
LISINOPRIL
Application Number
76063
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2002-07-01
Regulatory Status
Discontinued
Drug Name
LISINOPRIL
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2002-07-01
Active Ingredient
LISINOPRIL
Application Number
76063
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2002-07-01
Regulatory Status
Discontinued
Drug Name
LISINOPRIL
Product Number
5
Dosage Form
-
Strength
40MG
Approval Date
2002-07-01
Active Ingredient
LISINOPRIL
Application Number
76063
Product Number
5
Dosage Form
-
Strength
40MG
Approval Date
2002-07-01
Regulatory Status
Discontinued
Drug Name
LISINOPRIL
Product Number
6
Dosage Form
-
Strength
30MG
Approval Date
2003-06-27
Active Ingredient
LISINOPRIL
Application Number
76063
Product Number
6
Dosage Form
-
Strength
30MG
Approval Date
2003-06-27
Regulatory Status
Discontinued
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;10MG
Approval Date
2002-07-08
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
76265
Product Number
1
Dosage Form
-
Strength
12.5MG;10MG
Approval Date
2002-07-08
Regulatory Status
Discontinued
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;20MG
Approval Date
2002-07-08
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
76265
Product Number
2
Dosage Form
-
Strength
12.5MG;20MG
Approval Date
2002-07-08
Regulatory Status
Discontinued
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
25MG;20MG
Approval Date
2002-07-08
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
76265
Product Number
3
Dosage Form
-
Strength
25MG;20MG
Approval Date
2002-07-08
Regulatory Status
Discontinued
Drug Name
LITHIUM CARBONATE
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
1982-01-01
Active Ingredient
LITHIUM CARBONATE
Application Number
17812
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
LITHIUM CARBONATE
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
1987-01-28
Active Ingredient
LITHIUM CARBONATE
Application Number
17812
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
1987-01-28
Regulatory Status
RX
Drug Name
LITHIUM CARBONATE
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
1987-01-28
Active Ingredient
LITHIUM CARBONATE
Application Number
17812
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
1987-01-28
Regulatory Status
RX
Drug Name
LITHIUM CARBONATE
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
1982-01-29
Active Ingredient
LITHIUM CARBONATE
Application Number
18558
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
1982-01-29
Regulatory Status
RX
Drug Name
LITHIUM CARBONATE
Product Number
1
Dosage Form
-
Strength
450MG
Approval Date
2003-06-17
Active Ingredient
LITHIUM CARBONATE
Application Number
76490
Product Number
1
Dosage Form
-
Strength
450MG
Approval Date
2003-06-17
Regulatory Status
Discontinued
Drug Name
LITHIUM CARBONATE
Product Number
1
Dosage Form
-
Strength
450MG
Approval Date
2004-01-05
Active Ingredient
LITHIUM CARBONATE
Application Number
76691
Product Number
1
Dosage Form
-
Strength
450MG
Approval Date
2004-01-05
Regulatory Status
RX
Drug Name
LITHIUM CARBONATE
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2004-10-28
Active Ingredient
LITHIUM CARBONATE
Application Number
76832
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2004-10-28
Regulatory Status
RX
Drug Name
LITHIUM CARBONATE
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2010-12-28
Active Ingredient
LITHIUM CARBONATE
Application Number
78715
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2010-12-28
Regulatory Status
Discontinued
Drug Name
LITHIUM CITRATE
Product Number
1
Dosage Form
-
Strength
EQ 300MG CARBONATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
LITHIUM CITRATE
Application Number
18421
Product Number
1
Dosage Form
-
Strength
EQ 300MG CARBONATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
LORAZEPAM
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1998-09-28
Active Ingredient
LORAZEPAM
Application Number
74496
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1998-09-28
Regulatory Status
Discontinued
Drug Name
LORAZEPAM
Product Number
2
Dosage Form
-
Strength
4MG/ML
Approval Date
1998-09-28
Active Ingredient
LORAZEPAM
Application Number
74496
Product Number
2
Dosage Form
-
Strength
4MG/ML
Approval Date
1998-09-28
Regulatory Status
Discontinued
Drug Name
LORAZEPAM
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2012-01-30
Active Ingredient
LORAZEPAM
Application Number
200169
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2012-01-30
Regulatory Status
Discontinued
Drug Name
LORAZEPAM INTENSOL
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1991-06-28
Active Ingredient
LORAZEPAM
Application Number
72755
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1991-06-28
Regulatory Status
RX
Drug Name
LOSARTAN POTASSIUM
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2010-10-06
Active Ingredient
LOSARTAN POTASSIUM
Application Number
77459
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2010-10-06
Regulatory Status
Discontinued
Drug Name
LOSARTAN POTASSIUM
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2010-10-06
Active Ingredient
LOSARTAN POTASSIUM
Application Number
77459
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2010-10-06
Regulatory Status
Discontinued
Drug Name
LOSARTAN POTASSIUM
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2010-10-06
Active Ingredient
LOSARTAN POTASSIUM
Application Number
77459
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2010-10-06
Regulatory Status
Discontinued
Drug Name
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;100MG
Approval Date
2010-04-06
Active Ingredient
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Application Number
77732
Product Number
1
Dosage Form
-
Strength
12.5MG;100MG
Approval Date
2010-04-06
Regulatory Status
Discontinued
Drug Name
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;50MG
Approval Date
2010-10-06
Active Ingredient
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Application Number
77732
Product Number
2
Dosage Form
-
Strength
12.5MG;50MG
Approval Date
2010-10-06
Regulatory Status
Discontinued
Drug Name
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
25MG;100MG
Approval Date
2010-10-06
Active Ingredient
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Application Number
77732
Product Number
3
Dosage Form
-
Strength
25MG;100MG
Approval Date
2010-10-06
Regulatory Status
Discontinued
Drug Name
LOTEPREDNOL ETABONATE
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
2023-11-29
Active Ingredient
LOTEPREDNOL ETABONATE
Application Number
213956
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
2023-11-29
Regulatory Status
Discontinued
Drug Name
MEDROXYPROGESTERONE ACETATE
Product Number
1
Dosage Form
-
Strength
150MG/ML
Approval Date
2023-01-05
Active Ingredient
MEDROXYPROGESTERONE ACETATE
Application Number
214309
Product Number
1
Dosage Form
-
Strength
150MG/ML
Approval Date
2023-01-05
Regulatory Status
Discontinued
Drug Name
MEFLOQUINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2004-10-01
Active Ingredient
MEFLOQUINE HYDROCHLORIDE
Application Number
76523
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2004-10-01
Regulatory Status
Discontinued
Drug Name
MEFLOQUINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2010-04-21
Active Ingredient
MEFLOQUINE HYDROCHLORIDE
Application Number
77699
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2010-04-21
Regulatory Status
Discontinued
Drug Name
MEGESTROL ACETATE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1995-09-29
Active Ingredient
MEGESTROL ACETATE
Application Number
74458
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1995-09-29
Regulatory Status
Discontinued
Drug Name
MEGESTROL ACETATE
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
1995-09-29
Active Ingredient
MEGESTROL ACETATE
Application Number
74458
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
1995-09-29
Regulatory Status
Discontinued
Drug Name
MEGESTROL ACETATE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2002-02-15
Active Ingredient
MEGESTROL ACETATE
Application Number
75997
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2002-02-15
Regulatory Status
Discontinued
Drug Name
MEGESTROL ACETATE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2017-06-09
Active Ingredient
MEGESTROL ACETATE
Application Number
203960
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2017-06-09
Regulatory Status
Discontinued
Drug Name
MELPHALAN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/VIAL
Approval Date
2010-10-28
Active Ingredient
MELPHALAN HYDROCHLORIDE
Application Number
90303
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/VIAL
Approval Date
2010-10-28
Regulatory Status
RX
Drug Name
MEMANTINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2020-02-28
Active Ingredient
MEMANTINE HYDROCHLORIDE
Application Number
208173
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2020-02-28
Regulatory Status
Discontinued
Drug Name
MEMANTINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2020-02-28
Active Ingredient
MEMANTINE HYDROCHLORIDE
Application Number
208173
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2020-02-28
Regulatory Status
Discontinued
Drug Name
MEPERGAN
Product Number
1
Dosage Form
-
Strength
25MG/ML;25MG/ML
Approval Date
1982-01-01
Active Ingredient
MEPERIDINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
Application Number
11730
Product Number
1
Dosage Form
-
Strength
25MG/ML;25MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
MEPERIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1997-03-12
Active Ingredient
MEPERIDINE HYDROCHLORIDE
Application Number
40110
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1997-03-12
Regulatory Status
Discontinued
Drug Name
MEPERIDINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
1997-03-12
Active Ingredient
MEPERIDINE HYDROCHLORIDE
Application Number
40110
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
1997-03-12
Regulatory Status
Discontinued
Drug Name
MEPERIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG/5ML
Approval Date
1985-01-30
Active Ingredient
MEPERIDINE HYDROCHLORIDE
Application Number
88744
Product Number
1
Dosage Form
-
Strength
50MG/5ML
Approval Date
1985-01-30
Regulatory Status
RX
Drug Name
MERCAPTOPURINE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2004-02-13
Active Ingredient
MERCAPTOPURINE
Application Number
40528
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2004-02-13
Regulatory Status
RX
Drug Name
MERCAPTOPURINE
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2025-02-26
Active Ingredient
MERCAPTOPURINE
Application Number
216418
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2025-02-26
Regulatory Status
RX
Drug Name
MESNA
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2004-01-09
Active Ingredient
MESNA
Application Number
75739
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2004-01-09
Regulatory Status
RX
Drug Name
MESNA
Product Number
2
Dosage Form
-
Strength
1G/10ML
Approval Date
-
Active Ingredient
MESNA
Application Number
75739
Product Number
2
Dosage Form
-
Strength
1G/10ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
1982-01-01
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
17058
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1998-04-30
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
40180
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1998-04-30
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
1982-01-01
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
87393
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/5ML
Approval Date
1982-08-30
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
87997
Product Number
1
Dosage Form
-
Strength
10MG/5ML
Approval Date
1982-08-30
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
1983-03-08
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
88109
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
1983-03-08
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
1983-03-08
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
88109
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
1983-03-08
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2025-05-05
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
218609
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2025-05-05
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE INTENSOL
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1988-09-06
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
89897
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
1988-09-06
Regulatory Status
RX
Drug Name
METHAMPHETAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-11-17
Active Ingredient
METHAMPHETAMINE HYDROCHLORIDE
Application Number
203846
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-11-17
Regulatory Status
RX
Drug Name
METHOCARBAMOL
Product Number
1
Dosage Form
-
Strength
750MG
Approval Date
1982-01-01
Active Ingredient
METHOCARBAMOL
Application Number
85123
Product Number
1
Dosage Form
-
Strength
750MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
METHOCARBAMOL
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Active Ingredient
METHOCARBAMOL
Application Number
85123
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
METHOCARBAMOL
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
-
Active Ingredient
METHOCARBAMOL
Application Number
85159
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
METHOTREXATE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
1994-08-01
Active Ingredient
METHOTREXATE SODIUM
Application Number
40054
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
1994-08-01
Regulatory Status
RX
Drug Name
METHOTREXATE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/4ML (EQ 25MG BASE/ML)
Approval Date
1986-09-16
Active Ingredient
METHOTREXATE SODIUM
Application Number
89341
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/4ML (EQ 25MG BASE/ML)
Approval Date
1986-09-16
Regulatory Status
RX
Drug Name
METHOTREXATE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/8ML (EQ 25MG BASE/ML)
Approval Date
1986-09-16
Active Ingredient
METHOTREXATE SODIUM
Application Number
89342
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/8ML (EQ 25MG BASE/ML)
Approval Date
1986-09-16
Regulatory Status
RX
Drug Name
METHOTREXATE SODIUM PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2005-08-12
Active Ingredient
METHOTREXATE SODIUM
Application Number
40632
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2005-08-12
Regulatory Status
RX
Drug Name
METHOTREXATE SODIUM PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/2ML (EQ 25MG BASE/ML)
Approval Date
1986-09-16
Active Ingredient
METHOTREXATE SODIUM
Application Number
89340
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/2ML (EQ 25MG BASE/ML)
Approval Date
1986-09-16
Regulatory Status
RX
Drug Name
METHOTREXATE SODIUM PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/10ML (EQ 25MG BASE/ML)
Approval Date
1986-09-16
Active Ingredient
METHOTREXATE SODIUM
Application Number
89343
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/10ML (EQ 25MG BASE/ML)
Approval Date
1986-09-16
Regulatory Status
RX
Drug Name
METHYLENE BLUE
Product Number
1
Dosage Form
-
Strength
50MG/10ML (5MG/ML)
Approval Date
2024-12-17
Active Ingredient
METHYLENE BLUE
Application Number
216959
Product Number
1
Dosage Form
-
Strength
50MG/10ML (5MG/ML)
Approval Date
2024-12-17
Regulatory Status
RX
Drug Name
METHYLPREDNISOLONE ACETATE
Product Number
1
Dosage Form
-
Strength
80MG/ML
Approval Date
2025-04-16
Active Ingredient
METHYLPREDNISOLONE ACETATE
Application Number
219145
Product Number
1
Dosage Form
-
Strength
80MG/ML
Approval Date
2025-04-16
Regulatory Status
RX
Drug Name
METHYLPREDNISOLONE SODIUM SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2016-02-16
Active Ingredient
METHYLPREDNISOLONE SODIUM SUCCINATE
Application Number
202691
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2016-02-16
Regulatory Status
RX
Drug Name
METHYLPREDNISOLONE SODIUM SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2016-02-16
Active Ingredient
METHYLPREDNISOLONE SODIUM SUCCINATE
Application Number
202691
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2016-02-16
Regulatory Status
RX
Drug Name
METHYLPREDNISOLONE SODIUM SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/VIAL
Approval Date
2022-09-26
Active Ingredient
METHYLPREDNISOLONE SODIUM SUCCINATE
Application Number
203125
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/VIAL
Approval Date
2022-09-26
Regulatory Status
RX
Drug Name
METHYLPREDNISOLONE SODIUM SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 125MG BASE/VIAL
Approval Date
2022-09-26
Active Ingredient
METHYLPREDNISOLONE SODIUM SUCCINATE
Application Number
203125
Product Number
2
Dosage Form
-
Strength
EQ 125MG BASE/VIAL
Approval Date
2022-09-26
Regulatory Status
RX
Drug Name
METOPROLOL TARTRATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2003-07-07
Active Ingredient
METOPROLOL TARTRATE
Application Number
76495
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2003-07-07
Regulatory Status
RX
Drug Name
METOPROLOL TARTRATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2007-05-30
Active Ingredient
METOPROLOL TARTRATE
Application Number
77761
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2007-05-30
Regulatory Status
RX
Drug Name
METRONIDAZOLE
Product Number
1
Dosage Form
-
Strength
500MG/100ML
Approval Date
1984-03-30
Active Ingredient
METRONIDAZOLE
Application Number
18907
Product Number
1
Dosage Form
-
Strength
500MG/100ML
Approval Date
1984-03-30
Regulatory Status
Discontinued
Drug Name
MICAFUNGIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/VIAL
Approval Date
2021-07-09
Active Ingredient
MICAFUNGIN SODIUM
Application Number
213261
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE/VIAL
Approval Date
2021-07-09
Regulatory Status
RX
Drug Name
MICAFUNGIN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
2021-07-09
Active Ingredient
MICAFUNGIN SODIUM
Application Number
213261
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE/VIAL
Approval Date
2021-07-09
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2000-06-20
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75243
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2000-06-20
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-20
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75243
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-20
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-23
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75247
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-23
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2000-06-23
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75247
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2000-06-23
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2000-06-20
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75324
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2000-06-20
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-20
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75324
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-20
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-20
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75421
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-20
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2000-06-20
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75421
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2000-06-20
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2002-04-30
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75873
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2002-04-30
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2020-12-11
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
212847
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2020-12-11
Regulatory Status
RX
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2020-12-11
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
212847
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2020-12-11
Regulatory Status
RX
Drug Name
MIDAZOLAM IN 0.9% SODIUM CHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG/50ML (1MG/ML)
Approval Date
2023-04-17
Active Ingredient
MIDAZOLAM
Application Number
216159
Product Number
1
Dosage Form
-
Strength
50MG/50ML (1MG/ML)
Approval Date
2023-04-17
Regulatory Status
RX
Drug Name
MIDAZOLAM IN 0.9% SODIUM CHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG/100ML (1MG/ML)
Approval Date
2023-04-17
Active Ingredient
MIDAZOLAM
Application Number
216159
Product Number
2
Dosage Form
-
Strength
100MG/100ML (1MG/ML)
Approval Date
2023-04-17
Regulatory Status
RX
Drug Name
MILRINONE LACTATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2002-05-28
Active Ingredient
MILRINONE LACTATE
Application Number
75530
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2002-05-28
Regulatory Status
Discontinued
Drug Name
MILRINONE LACTATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2002-05-28
Active Ingredient
MILRINONE LACTATE
Application Number
75660
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2002-05-28
Regulatory Status
RX
Drug Name
MILRINONE LACTATE
Product Number
2
Dosage Form
-
Strength
EQ 20MG /20ML (1MG/ML)
Approval Date
-
Active Ingredient
MILRINONE LACTATE
Application Number
75660
Product Number
2
Dosage Form
-
Strength
EQ 20MG /20ML (1MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
MILRINONE LACTATE
Product Number
3
Dosage Form
-
Strength
EQ 50MG /50ML (1MG/ML)
Approval Date
-
Active Ingredient
MILRINONE LACTATE
Application Number
75660
Product Number
3
Dosage Form
-
Strength
EQ 50MG /50ML (1MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
MILRINONE LACTATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2002-05-28
Active Ingredient
MILRINONE LACTATE
Application Number
75852
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2002-05-28
Regulatory Status
Discontinued
Drug Name
MILRINONE LACTATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2010-12-03
Active Ingredient
MILRINONE LACTATE
Application Number
77966
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2010-12-03
Regulatory Status
RX
Drug Name
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Approval Date
2002-05-28
Active Ingredient
MILRINONE LACTATE
Application Number
75510
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Approval Date
2002-05-28
Regulatory Status
Discontinued
Drug Name
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Approval Date
2008-05-21
Active Ingredient
MILRINONE LACTATE
Application Number
78113
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Approval Date
2008-05-21
Regulatory Status
RX
Drug Name
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
Approval Date
2008-05-21
Active Ingredient
MILRINONE LACTATE
Application Number
78113
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
Approval Date
2008-05-21
Regulatory Status
RX
Drug Name
MILRINONE LACTATE IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Approval Date
2010-01-21
Active Ingredient
MILRINONE LACTATE
Application Number
90038
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Approval Date
2010-01-21
Regulatory Status
RX
Drug Name
MILRINONE LACTATE IN PLASTIC CONTAINER
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
Approval Date
2010-01-21
Active Ingredient
MILRINONE LACTATE
Application Number
90038
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
Approval Date
2010-01-21
Regulatory Status
RX
Drug Name
MINOXIDIL (FOR MEN)
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1996-12-24
Active Ingredient
MINOXIDIL
Application Number
74731
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1996-12-24
Regulatory Status
Discontinued
Drug Name
MINOXIDIL (FOR WOMEN)
Product Number
2
Dosage Form
-
Strength
2%
Approval Date
2005-05-11
Active Ingredient
MINOXIDIL
Application Number
74731
Product Number
2
Dosage Form
-
Strength
2%
Approval Date
2005-05-11
Regulatory Status
Discontinued
Drug Name
MITIGARE
Product Number
1
Dosage Form
-
Strength
0.6MG
Approval Date
2014-09-26
Active Ingredient
COLCHICINE
Application Number
204820
Product Number
1
Dosage Form
-
Strength
0.6MG
Approval Date
2014-09-26
Regulatory Status
RX
Drug Name
MITOMYCIN
Product Number
1
Dosage Form
-
Strength
5MG/VIAL
Approval Date
1995-04-19
Active Ingredient
MITOMYCIN
Application Number
64117
Product Number
1
Dosage Form
-
Strength
5MG/VIAL
Approval Date
1995-04-19
Regulatory Status
Discontinued
Drug Name
MITOMYCIN
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
1995-04-19
Active Ingredient
MITOMYCIN
Application Number
64117
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
1995-04-19
Regulatory Status
RX
Drug Name
MITOMYCIN
Product Number
3
Dosage Form
-
Strength
40MG/VIAL
Approval Date
1999-06-02
Active Ingredient
MITOMYCIN
Application Number
64117
Product Number
3
Dosage Form
-
Strength
40MG/VIAL
Approval Date
1999-06-02
Regulatory Status
RX
Drug Name
MITOMYCIN
Product Number
1
Dosage Form
-
Strength
5MG/VIAL
Approval Date
1999-12-23
Active Ingredient
MITOMYCIN
Application Number
64180
Product Number
1
Dosage Form
-
Strength
5MG/VIAL
Approval Date
1999-12-23
Regulatory Status
RX
Drug Name
MITOMYCIN
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
1999-12-23
Active Ingredient
MITOMYCIN
Application Number
64180
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
1999-12-23
Regulatory Status
RX
Drug Name
MITOXANTRONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Approval Date
2006-04-11
Active Ingredient
MITOXANTRONE HYDROCHLORIDE
Application Number
76611
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Approval Date
2006-04-11
Regulatory Status
RX
Drug Name
MITOXANTRONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML)
Approval Date
2006-04-11
Active Ingredient
MITOXANTRONE HYDROCHLORIDE
Application Number
76611
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML)
Approval Date
2006-04-11
Regulatory Status
RX
Drug Name
MITOXANTRONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
Approval Date
2006-04-11
Active Ingredient
MITOXANTRONE HYDROCHLORIDE
Application Number
76611
Product Number
3
Dosage Form
-
Strength
EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
Approval Date
2006-04-11
Regulatory Status
RX
Drug Name
MODAFINIL
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2012-09-26
Active Ingredient
MODAFINIL
Application Number
90543
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2012-09-26
Regulatory Status
Discontinued
Drug Name
MODAFINIL
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2012-09-26
Active Ingredient
MODAFINIL
Application Number
90543
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2012-09-26
Regulatory Status
Discontinued
Drug Name
MONTELUKAST SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-08-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
90655
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-08-03
Regulatory Status
Discontinued
Drug Name
MONTELUKAST SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2012-08-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
91128
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2012-08-03
Regulatory Status
Discontinued
Drug Name
MONTELUKAST SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-08-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
91128
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-08-03
Regulatory Status
Discontinued
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
10MG/5ML
Approval Date
2008-03-17
Active Ingredient
MORPHINE SULFATE
Application Number
22195
Product Number
1
Dosage Form
-
Strength
10MG/5ML
Approval Date
2008-03-17
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
2
Dosage Form
-
Strength
20MG/5ML
Approval Date
2008-03-17
Active Ingredient
MORPHINE SULFATE
Application Number
22195
Product Number
2
Dosage Form
-
Strength
20MG/5ML
Approval Date
2008-03-17
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
3
Dosage Form
-
Strength
100MG/5ML
Approval Date
2010-01-25
Active Ingredient
MORPHINE SULFATE
Application Number
22195
Product Number
3
Dosage Form
-
Strength
100MG/5ML
Approval Date
2010-01-25
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2008-03-17
Active Ingredient
MORPHINE SULFATE
Application Number
22207
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2008-03-17
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2008-03-17
Active Ingredient
MORPHINE SULFATE
Application Number
22207
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2008-03-17
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
4MG/ML
Approval Date
2015-05-21
Active Ingredient
MORPHINE SULFATE
Application Number
205758
Product Number
1
Dosage Form
-
Strength
4MG/ML
Approval Date
2015-05-21
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
2
Dosage Form
-
Strength
8MG/ML
Approval Date
2015-05-21
Active Ingredient
MORPHINE SULFATE
Application Number
205758
Product Number
2
Dosage Form
-
Strength
8MG/ML
Approval Date
2015-05-21
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
3
Dosage Form
-
Strength
10MG/ML
Approval Date
2015-05-21
Active Ingredient
MORPHINE SULFATE
Application Number
205758
Product Number
3
Dosage Form
-
Strength
10MG/ML
Approval Date
2015-05-21
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2017-07-06
Active Ingredient
MORPHINE SULFATE
Application Number
208809
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2017-07-06
Regulatory Status
Discontinued
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2023-01-12
Active Ingredient
MORPHINE SULFATE
Application Number
211452
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2023-01-12
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
2
Dosage Form
-
Strength
4MG/ML
Approval Date
2023-01-12
Active Ingredient
MORPHINE SULFATE
Application Number
211452
Product Number
2
Dosage Form
-
Strength
4MG/ML
Approval Date
2023-01-12
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
3
Dosage Form
-
Strength
8MG/ML
Approval Date
2023-01-12
Active Ingredient
MORPHINE SULFATE
Application Number
211452
Product Number
3
Dosage Form
-
Strength
8MG/ML
Approval Date
2023-01-12
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
4
Dosage Form
-
Strength
10MG/ML
Approval Date
2023-01-12
Active Ingredient
MORPHINE SULFATE
Application Number
211452
Product Number
4
Dosage Form
-
Strength
10MG/ML
Approval Date
2023-01-12
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
5
Dosage Form
-
Strength
15MG/ML
Approval Date
2023-01-12
Active Ingredient
MORPHINE SULFATE
Application Number
211452
Product Number
5
Dosage Form
-
Strength
15MG/ML
Approval Date
2023-01-12
Regulatory Status
RX
Drug Name
MYCOPHENOLATE MOFETIL
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2008-07-29
Active Ingredient
MYCOPHENOLATE MOFETIL
Application Number
65410
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2008-07-29
Regulatory Status
Discontinued
Drug Name
MYCOPHENOLATE MOFETIL
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2008-07-29
Active Ingredient
MYCOPHENOLATE MOFETIL
Application Number
65413
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2008-07-29
Regulatory Status
Discontinued
Drug Name
NALOXONE
Product Number
1
Dosage Form
-
Strength
0.4MG/ML
Approval Date
1986-09-24
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
70298
Product Number
1
Dosage Form
-
Strength
0.4MG/ML
Approval Date
1986-09-24
Regulatory Status
Discontinued
Drug Name
NALOXONE
Product Number
1
Dosage Form
-
Strength
0.4MG/ML
Approval Date
1986-09-24
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
70299
Product Number
1
Dosage Form
-
Strength
0.4MG/ML
Approval Date
1986-09-24
Regulatory Status
RX
Drug Name
NALOXONE
Product Number
1
Dosage Form
-
Strength
0.4MG/ML
Approval Date
1986-09-24
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
70496
Product Number
1
Dosage Form
-
Strength
0.4MG/ML
Approval Date
1986-09-24
Regulatory Status
Discontinued
Drug Name
NALOXONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.02MG/ML
Approval Date
1988-05-24
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
71272
Product Number
1
Dosage Form
-
Strength
0.02MG/ML
Approval Date
1988-05-24
Regulatory Status
Discontinued
Drug Name
NALOXONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1988-05-24
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
71273
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1988-05-24
Regulatory Status
Discontinued
Drug Name
NALOXONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1988-05-24
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
71274
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1988-05-24
Regulatory Status
Discontinued
Drug Name
NALOXONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1988-05-24
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
71287
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1988-05-24
Regulatory Status
Discontinued
Drug Name
NALOXONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2022-06-10
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
212300
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2022-06-10
Regulatory Status
RX
Drug Name
NALOXONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
0.4MG/ML
Approval Date
2024-03-07
Active Ingredient
NALOXONE HYDROCHLORIDE
Application Number
212300
Product Number
2
Dosage Form
-
Strength
0.4MG/ML
Approval Date
2024-03-07
Regulatory Status
RX
Drug Name
NAPROXEN
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1994-03-30
Active Ingredient
NAPROXEN
Application Number
74190
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1994-03-30
Regulatory Status
RX
Drug Name
NAPROXEN
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2004-01-14
Active Ingredient
NAPROXEN
Application Number
76494
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2004-01-14
Regulatory Status
Discontinued
Drug Name
NAPROXEN
Product Number
2
Dosage Form
-
Strength
375MG
Approval Date
2004-01-14
Active Ingredient
NAPROXEN
Application Number
76494
Product Number
2
Dosage Form
-
Strength
375MG
Approval Date
2004-01-14
Regulatory Status
Discontinued
Drug Name
NAPROXEN
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
2004-01-14
Active Ingredient
NAPROXEN
Application Number
76494
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
2004-01-14
Regulatory Status
Discontinued
Drug Name
NAPROXEN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
1996-05-14
Active Ingredient
NAPROXEN SODIUM
Application Number
74480
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
1996-05-14
Regulatory Status
Discontinued
Drug Name
NAPROXEN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
1998-02-18
Active Ingredient
NAPROXEN SODIUM
Application Number
74480
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
1998-02-18
Regulatory Status
Discontinued
Drug Name
NARATRIPTAN
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2010-07-07
Active Ingredient
NARATRIPTAN HYDROCHLORIDE
Application Number
90381
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2010-07-07
Regulatory Status
RX
Drug Name
NARATRIPTAN
Product Number
2
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2010-07-07
Active Ingredient
NARATRIPTAN HYDROCHLORIDE
Application Number
90381
Product Number
2
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2010-07-07
Regulatory Status
RX
Drug Name
NEOSTIGMINE METHYLSULFATE
Product Number
1
Dosage Form
-
Strength
5MG/10ML (0.5MG/ML)
Approval Date
2015-12-28
Active Ingredient
NEOSTIGMINE METHYLSULFATE
Application Number
207042
Product Number
1
Dosage Form
-
Strength
5MG/10ML (0.5MG/ML)
Approval Date
2015-12-28
Regulatory Status
RX
Drug Name
NEOSTIGMINE METHYLSULFATE
Product Number
2
Dosage Form
-
Strength
10MG/10ML (1MG/ML)
Approval Date
2015-12-28
Active Ingredient
NEOSTIGMINE METHYLSULFATE
Application Number
207042
Product Number
2
Dosage Form
-
Strength
10MG/10ML (1MG/ML)
Approval Date
2015-12-28
Regulatory Status
RX
Drug Name
NEOSTIGMINE METHYLSULFATE
Product Number
1
Dosage Form
-
Strength
3MG/3ML (1MG/ML)
Approval Date
2022-07-13
Active Ingredient
NEOSTIGMINE METHYLSULFATE
Application Number
216206
Product Number
1
Dosage Form
-
Strength
3MG/3ML (1MG/ML)
Approval Date
2022-07-13
Regulatory Status
Discontinued
Drug Name
NIACIN
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Active Ingredient
NIACIN
Application Number
83718
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
NICARDIPINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG/10ML (2.5MG/ML)
Approval Date
2008-07-24
Active Ingredient
NICARDIPINE HYDROCHLORIDE
Application Number
22276
Product Number
1
Dosage Form
-
Strength
25MG/10ML (2.5MG/ML)
Approval Date
2008-07-24
Regulatory Status
RX
Drug Name
NICARDIPINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG/10ML (2.5MG/ML)
Approval Date
2009-12-28
Active Ingredient
NICARDIPINE HYDROCHLORIDE
Application Number
78714
Product Number
1
Dosage Form
-
Strength
25MG/10ML (2.5MG/ML)
Approval Date
2009-12-28
Regulatory Status
Discontinued
Drug Name
NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Product Number
2
Dosage Form
-
Strength
20MG/200ML (0.1MG/ML)
Approval Date
2016-04-07
Active Ingredient
NICARDIPINE HYDROCHLORIDE
Application Number
22276
Product Number
2
Dosage Form
-
Strength
20MG/200ML (0.1MG/ML)
Approval Date
2016-04-07
Regulatory Status
RX
Drug Name
NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Product Number
3
Dosage Form
-
Strength
40MG/200ML (0.2MG/ML)
Approval Date
2016-04-07
Active Ingredient
NICARDIPINE HYDROCHLORIDE
Application Number
22276
Product Number
3
Dosage Form
-
Strength
40MG/200ML (0.2MG/ML)
Approval Date
2016-04-07
Regulatory Status
RX
Drug Name
NOREPINEPHRINE BITARTRATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2003-10-31
Active Ingredient
NOREPINEPHRINE BITARTRATE
Application Number
40462
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2003-10-31
Regulatory Status
RX
Drug Name
NOREPINEPHRINE BITARTRATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2018-11-07
Active Ingredient
NOREPINEPHRINE BITARTRATE
Application Number
203662
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2018-11-07
Regulatory Status
RX
Drug Name
OFLOXACIN
Product Number
1
Dosage Form
-
Strength
0.3%
Approval Date
2008-03-17
Active Ingredient
OFLOXACIN
Application Number
76616
Product Number
1
Dosage Form
-
Strength
0.3%
Approval Date
2008-03-17
Regulatory Status
Discontinued
Drug Name
OLANZAPINE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2017-06-16
Active Ingredient
OLANZAPINE
Application Number
204866
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2017-06-16
Regulatory Status
Discontinued
Drug Name
OLANZAPINE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2017-06-16
Active Ingredient
OLANZAPINE
Application Number
204866
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2017-06-16
Regulatory Status
Discontinued
Drug Name
OLANZAPINE
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2017-06-16
Active Ingredient
OLANZAPINE
Application Number
204866
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2017-06-16
Regulatory Status
Discontinued
Drug Name
OLANZAPINE
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2017-06-16
Active Ingredient
OLANZAPINE
Application Number
204866
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2017-06-16
Regulatory Status
Discontinued
Drug Name
OLANZAPINE
Product Number
5
Dosage Form
-
Strength
15MG
Approval Date
2017-06-16
Active Ingredient
OLANZAPINE
Application Number
204866
Product Number
5
Dosage Form
-
Strength
15MG
Approval Date
2017-06-16
Regulatory Status
Discontinued
Drug Name
OLANZAPINE
Product Number
6
Dosage Form
-
Strength
20MG
Approval Date
2017-06-16
Active Ingredient
OLANZAPINE
Application Number
204866
Product Number
6
Dosage Form
-
Strength
20MG
Approval Date
2017-06-16
Regulatory Status
Discontinued
Drug Name
OLOPATADINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.665MG/SPRAY
Approval Date
2020-08-19
Active Ingredient
OLOPATADINE HYDROCHLORIDE
Application Number
213757
Product Number
1
Dosage Form
-
Strength
0.665MG/SPRAY
Approval Date
2020-08-19
Regulatory Status
Discontinued
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
76781
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Regulatory Status
Discontinued
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/5ML
Approval Date
2006-12-26
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
76960
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/5ML
Approval Date
2006-12-26
Regulatory Status
RX
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
76967
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Regulatory Status
RX
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
77365
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Regulatory Status
RX
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2007-09-06
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
77545
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2007-09-06
Regulatory Status
Discontinued
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2007-09-06
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
77545
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2007-09-06
Regulatory Status
Discontinued
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 24MG BASE
Approval Date
2007-09-06
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
77545
Product Number
3
Dosage Form
-
Strength
EQ 24MG BASE
Approval Date
2007-09-06
Regulatory Status
Discontinued
Drug Name
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
76780
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Regulatory Status
Discontinued
Drug Name
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
77011
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Regulatory Status
RX
Drug Name
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
77541
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE/ML
Approval Date
2006-12-26
Regulatory Status
RX
Drug Name
ORPHENADRINE CITRATE
Product Number
1
Dosage Form
-
Strength
30MG/ML
Approval Date
2003-03-04
Active Ingredient
ORPHENADRINE CITRATE
Application Number
40463
Product Number
1
Dosage Form
-
Strength
30MG/ML
Approval Date
2003-03-04
Regulatory Status
RX
Drug Name
OXCARBAZEPINE
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2007-10-09
Active Ingredient
OXCARBAZEPINE
Application Number
77795
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2007-10-09
Regulatory Status
Discontinued
Drug Name
OXCARBAZEPINE
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2007-10-09
Active Ingredient
OXCARBAZEPINE
Application Number
77795
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2007-10-09
Regulatory Status
Discontinued
Drug Name
OXCARBAZEPINE
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
2007-10-09
Active Ingredient
OXCARBAZEPINE
Application Number
77795
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
2007-10-09
Regulatory Status
Discontinued
Drug Name
OXCARBAZEPINE
Product Number
1
Dosage Form
-
Strength
300MG/5ML
Approval Date
2012-10-03
Active Ingredient
OXCARBAZEPINE
Application Number
201193
Product Number
1
Dosage Form
-
Strength
300MG/5ML
Approval Date
2012-10-03
Regulatory Status
Discontinued
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2013-07-12
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
203208
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2013-07-12
Regulatory Status
Discontinued
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2013-07-15
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
204037
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2013-07-15
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2017-08-07
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
208795
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2017-08-07
Regulatory Status
Discontinued
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2017-08-10
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
208817
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2017-08-10
Regulatory Status
Discontinued
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2010-09-27
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
90964
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2010-09-27
Regulatory Status
RX
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2010-09-27
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
90964
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2010-09-27
Regulatory Status
RX
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2013-07-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
200822
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2013-07-15
Regulatory Status
Discontinued
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2013-07-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
200822
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2013-07-15
Regulatory Status
Discontinued
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2013-07-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
200822
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2013-07-15
Regulatory Status
Discontinued
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2013-07-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
200822
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2013-07-15
Regulatory Status
Discontinued
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
15MG
Approval Date
2013-07-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
200822
Product Number
5
Dosage Form
-
Strength
15MG
Approval Date
2013-07-15
Regulatory Status
Discontinued
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
20MG
Approval Date
2013-07-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
200822
Product Number
6
Dosage Form
-
Strength
20MG
Approval Date
2013-07-15
Regulatory Status
Discontinued
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
7
Dosage Form
-
Strength
30MG
Approval Date
2013-07-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
200822
Product Number
7
Dosage Form
-
Strength
30MG
Approval Date
2013-07-15
Regulatory Status
Discontinued
Drug Name
OXYTETRACYCLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
1982-01-01
Active Ingredient
OXYTETRACYCLINE HYDROCHLORIDE
Application Number
60770
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
OXYTOCIN
Product Number
1
Dosage Form
-
Strength
10USP UNITS/ML (10USP UNITS/ML)
Approval Date
1982-01-01
Active Ingredient
OXYTOCIN
Application Number
18243
Product Number
1
Dosage Form
-
Strength
10USP UNITS/ML (10USP UNITS/ML)
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
OXYTOCIN
Product Number
2
Dosage Form
-
Strength
100USP UNITS/10ML (10USP UNITS/ML)
Approval Date
2007-01-10
Active Ingredient
OXYTOCIN
Application Number
18243
Product Number
2
Dosage Form
-
Strength
100USP UNITS/10ML (10USP UNITS/ML)
Approval Date
2007-01-10
Regulatory Status
RX
Drug Name
OXYTOCIN
Product Number
1
Dosage Form
-
Strength
10USP UNITS/ML (10USP UNITS/ML)
Approval Date
2013-02-13
Active Ingredient
OXYTOCIN
Application Number
200219
Product Number
1
Dosage Form
-
Strength
10USP UNITS/ML (10USP UNITS/ML)
Approval Date
2013-02-13
Regulatory Status
RX
Drug Name
PACLITAXEL
Product Number
1
Dosage Form
-
Strength
6MG/ML
Approval Date
2002-01-28
Active Ingredient
PACLITAXEL
Application Number
75190
Product Number
1
Dosage Form
-
Strength
6MG/ML
Approval Date
2002-01-28
Regulatory Status
RX
Drug Name
PALONOSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE/2ML (EQ 0.125MG BASE/ML)
Approval Date
2016-08-22
Active Ingredient
PALONOSETRON HYDROCHLORIDE
Application Number
207963
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE/2ML (EQ 0.125MG BASE/ML)
Approval Date
2016-08-22
Regulatory Status
Discontinued
Drug Name
PAMIDRONATE DISODIUM
Product Number
1
Dosage Form
-
Strength
30MG/10ML (3MG/ML)
Approval Date
2002-03-04
Active Ingredient
PAMIDRONATE DISODIUM
Application Number
21113
Product Number
1
Dosage Form
-
Strength
30MG/10ML (3MG/ML)
Approval Date
2002-03-04
Regulatory Status
RX
Drug Name
PAMIDRONATE DISODIUM
Product Number
2
Dosage Form
-
Strength
90MG/10ML (9MG/ML)
Approval Date
2002-03-04
Active Ingredient
PAMIDRONATE DISODIUM
Application Number
21113
Product Number
2
Dosage Form
-
Strength
90MG/10ML (9MG/ML)
Approval Date
2002-03-04
Regulatory Status
RX
Drug Name
PAMIDRONATE DISODIUM
Product Number
1
Dosage Form
-
Strength
30MG/VIAL
Approval Date
2001-04-30
Active Ingredient
PAMIDRONATE DISODIUM
Application Number
75290
Product Number
1
Dosage Form
-
Strength
30MG/VIAL
Approval Date
2001-04-30
Regulatory Status
RX
Drug Name
PAMIDRONATE DISODIUM
Product Number
3
Dosage Form
-
Strength
90MG/VIAL
Approval Date
2001-04-30
Active Ingredient
PAMIDRONATE DISODIUM
Application Number
75290
Product Number
3
Dosage Form
-
Strength
90MG/VIAL
Approval Date
2001-04-30
Regulatory Status
RX
Drug Name
PANTOPRAZOLE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/VIAL
Approval Date
2017-06-30
Active Ingredient
PANTOPRAZOLE SODIUM
Application Number
209463
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/VIAL
Approval Date
2017-06-30
Regulatory Status
RX
Drug Name
PARICALCITOL
Product Number
1
Dosage Form
-
Strength
0.002MG/ML (0.002MG/ML)
Approval Date
2014-11-18
Active Ingredient
PARICALCITOL
Application Number
205917
Product Number
1
Dosage Form
-
Strength
0.002MG/ML (0.002MG/ML)
Approval Date
2014-11-18
Regulatory Status
Discontinued
Drug Name
PARICALCITOL
Product Number
2
Dosage Form
-
Strength
0.005MG/ML (0.005MG/ML)
Approval Date
2014-11-18
Active Ingredient
PARICALCITOL
Application Number
205917
Product Number
2
Dosage Form
-
Strength
0.005MG/ML (0.005MG/ML)
Approval Date
2014-11-18
Regulatory Status
Discontinued
Drug Name
PARICALCITOL
Product Number
3
Dosage Form
-
Strength
0.01MG/2ML (0.005MG/ML)
Approval Date
2014-11-18
Active Ingredient
PARICALCITOL
Application Number
205917
Product Number
3
Dosage Form
-
Strength
0.01MG/2ML (0.005MG/ML)
Approval Date
2014-11-18
Regulatory Status
Discontinued
Drug Name
PENICILLIN V POTASSIUM
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2013-10-11
Active Ingredient
PENICILLIN V POTASSIUM
Application Number
90549
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2013-10-11
Regulatory Status
RX
Drug Name
PENICILLIN V POTASSIUM
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2013-10-11
Active Ingredient
PENICILLIN V POTASSIUM
Application Number
90549
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2013-10-11
Regulatory Status
RX
Drug Name
PENTOBARBITAL SODIUM
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2017-11-13
Active Ingredient
PENTOBARBITAL SODIUM
Application Number
203619
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2017-11-13
Regulatory Status
RX
Drug Name
PERINDOPRIL ERBUMINE
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2009-11-10
Active Ingredient
PERINDOPRIL ERBUMINE
Application Number
90072
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2009-11-10
Regulatory Status
Discontinued
Drug Name
PERINDOPRIL ERBUMINE
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2009-11-10
Active Ingredient
PERINDOPRIL ERBUMINE
Application Number
90072
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2009-11-10
Regulatory Status
Discontinued
Drug Name
PERINDOPRIL ERBUMINE
Product Number
3
Dosage Form
-
Strength
8MG
Approval Date
2009-11-10
Active Ingredient
PERINDOPRIL ERBUMINE
Application Number
90072
Product Number
3
Dosage Form
-
Strength
8MG
Approval Date
2009-11-10
Regulatory Status
Discontinued
Drug Name
PHENOXYBENZAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2012-07-16
Active Ingredient
PHENOXYBENZAMINE HYDROCHLORIDE
Application Number
201050
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2012-07-16
Regulatory Status
Discontinued
Drug Name
PHENTOLAMINE MESYLATE
Product Number
1
Dosage Form
-
Strength
5MG/VIAL
Approval Date
1998-03-11
Active Ingredient
PHENTOLAMINE MESYLATE
Application Number
40235
Product Number
1
Dosage Form
-
Strength
5MG/VIAL
Approval Date
1998-03-11
Regulatory Status
RX
Drug Name
PHENYLEPHRINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG/ML (10MG/ML)
Approval Date
2012-12-20
Active Ingredient
PHENYLEPHRINE HYDROCHLORIDE
Application Number
203826
Product Number
1
Dosage Form
-
Strength
10MG/ML (10MG/ML)
Approval Date
2012-12-20
Regulatory Status
RX
Drug Name
PHENYLEPHRINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2019-06-19
Active Ingredient
PHENYLEPHRINE HYDROCHLORIDE
Application Number
203826
Product Number
2
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2019-06-19
Regulatory Status
RX
Drug Name
PHENYLEPHRINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
100MG/10ML (10MG/ML)
Approval Date
2019-06-19
Active Ingredient
PHENYLEPHRINE HYDROCHLORIDE
Application Number
203826
Product Number
3
Dosage Form
-
Strength
100MG/10ML (10MG/ML)
Approval Date
2019-06-19
Regulatory Status
RX
Drug Name
PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML;6.25MG/5ML
Approval Date
2014-12-23
Active Ingredient
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
Application Number
40675
Product Number
1
Dosage Form
-
Strength
5MG/5ML;6.25MG/5ML
Approval Date
2014-12-23
Regulatory Status
Discontinued
Drug Name
PHENYTOIN SODIUM
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Active Ingredient
PHENYTOIN SODIUM
Application Number
84307
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PHYTONADIONE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2024-12-19
Active Ingredient
PHYTONADIONE
Application Number
212112
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2024-12-19
Regulatory Status
Discontinued
Drug Name
PIROXICAM
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2017-08-11
Active Ingredient
PIROXICAM
Application Number
209256
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2017-08-11
Regulatory Status
Discontinued
Drug Name
PIROXICAM
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2017-08-11
Active Ingredient
PIROXICAM
Application Number
209256
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2017-08-11
Regulatory Status
Discontinued
Drug Name
POLYMYXIN B SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 500,000 UNITS BASE/VIAL
Approval Date
1982-01-01
Active Ingredient
POLYMYXIN B SULFATE
Application Number
60716
Product Number
1
Dosage Form
-
Strength
EQ 500,000 UNITS BASE/VIAL
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
POSACONAZOLE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2020-05-15
Active Ingredient
POSACONAZOLE
Application Number
208773
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2020-05-15
Regulatory Status
RX
Drug Name
PREDNISOLONE
Product Number
1
Dosage Form
-
Strength
15MG/5ML
Approval Date
2003-02-27
Active Ingredient
PREDNISOLONE
Application Number
40401
Product Number
1
Dosage Form
-
Strength
15MG/5ML
Approval Date
2003-02-27
Regulatory Status
Discontinued
Drug Name
PREDNISOLONE SODIUM PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/5ML
Approval Date
2003-03-26
Active Ingredient
PREDNISOLONE SODIUM PHOSPHATE
Application Number
75183
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/5ML
Approval Date
2003-03-26
Regulatory Status
Discontinued
Drug Name
PREDNISONE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2004-01-08
Active Ingredient
PREDNISONE
Application Number
40538
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2004-01-08
Regulatory Status
Discontinued
Drug Name
PREDNISONE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2010-11-01
Active Ingredient
PREDNISONE
Application Number
40890
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2010-11-01
Regulatory Status
Discontinued
Drug Name
PREDNISONE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1982-01-01
Active Ingredient
PREDNISONE
Application Number
80352
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PREDNISONE
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1982-04-22
Active Ingredient
PREDNISONE
Application Number
80352
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1982-04-22
Regulatory Status
RX
Drug Name
PREDNISONE
Product Number
3
Dosage Form
-
Strength
2.5MG
Approval Date
1982-04-22
Active Ingredient
PREDNISONE
Application Number
80352
Product Number
3
Dosage Form
-
Strength
2.5MG
Approval Date
1982-04-22
Regulatory Status
RX
Drug Name
PREDNISONE
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
1982-01-01
Active Ingredient
PREDNISONE
Application Number
80352
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PREDNISONE
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
1982-01-01
Active Ingredient
PREDNISONE
Application Number
80352
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PREDNISONE
Product Number
6
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Active Ingredient
PREDNISONE
Application Number
80352
Product Number
6
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PREDNISONE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1984-06-01
Active Ingredient
PREDNISONE
Application Number
88465
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1984-06-01
Regulatory Status
Discontinued
Drug Name
PREDNISONE
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
1984-11-08
Active Ingredient
PREDNISONE
Application Number
88703
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
1984-11-08
Regulatory Status
RX
Drug Name
PREDNISONE INTENSOL
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1985-02-20
Active Ingredient
PREDNISONE
Application Number
88810
Product Number
1
Dosage Form
-
Strength
5MG/ML
Approval Date
1985-02-20
Regulatory Status
RX
Drug Name
PRIMIDONE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2006-07-27
Active Ingredient
PRIMIDONE
Application Number
40667
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2006-07-27
Regulatory Status
Discontinued
Drug Name
PRIMIDONE
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2006-07-27
Active Ingredient
PRIMIDONE
Application Number
40667
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2006-07-27
Regulatory Status
Discontinued
Drug Name
PROCAINAMIDE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1986-04-17
Active Ingredient
PROCAINAMIDE HYDROCHLORIDE
Application Number
89029
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1986-04-17
Regulatory Status
Discontinued
Drug Name
PROCHLORPERAZINE EDISYLATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1988-05-03
Active Ingredient
PROCHLORPERAZINE EDISYLATE
Application Number
89523
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1988-05-03
Regulatory Status
Discontinued
Drug Name
PROCHLORPERAZINE EDISYLATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1989-08-29
Active Ingredient
PROCHLORPERAZINE EDISYLATE
Application Number
89903
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1989-08-29
Regulatory Status
RX
Drug Name
PROCHLORPERAZINE EDISYLATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2022-11-22
Active Ingredient
PROCHLORPERAZINE EDISYLATE
Application Number
213630
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2022-11-22
Regulatory Status
Discontinued
Drug Name
PROGESTERONE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2010-10-28
Active Ingredient
PROGESTERONE
Application Number
91033
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2010-10-28
Regulatory Status
RX
Drug Name
PROMETHAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Active Ingredient
PROMETHAZINE HYDROCHLORIDE
Application Number
83312
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PROMETHAZINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Active Ingredient
PROMETHAZINE HYDROCHLORIDE
Application Number
83312
Product Number
2
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
Product Number
1
Dosage Form
-
Strength
10MG/5ML;6.25MG/5ML
Approval Date
1997-08-26
Active Ingredient
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
Application Number
40151
Product Number
1
Dosage Form
-
Strength
10MG/5ML;6.25MG/5ML
Approval Date
1997-08-26
Regulatory Status
Discontinued
Drug Name
PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Product Number
1
Dosage Form
-
Strength
15MG/5ML;6.25MG/5ML
Approval Date
1996-07-31
Active Ingredient
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
Application Number
40027
Product Number
1
Dosage Form
-
Strength
15MG/5ML;6.25MG/5ML
Approval Date
1996-07-31
Regulatory Status
Discontinued
Drug Name
PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE
Product Number
1
Dosage Form
-
Strength
10MG/5ML;5MG/5ML;6.25MG/5ML
Approval Date
2014-12-23
Active Ingredient
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
Application Number
40674
Product Number
1
Dosage Form
-
Strength
10MG/5ML;5MG/5ML;6.25MG/5ML
Approval Date
2014-12-23
Regulatory Status
Discontinued
Drug Name
PROPANTHELINE BROMIDE
Product Number
1
Dosage Form
-
Strength
7.5MG
Approval Date
1982-01-01
Active Ingredient
PROPANTHELINE BROMIDE
Application Number
80927
Product Number
1
Dosage Form
-
Strength
7.5MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PROPANTHELINE BROMIDE
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
1982-01-01
Active Ingredient
PROPANTHELINE BROMIDE
Application Number
80927
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PROPOFOL
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2005-04-19
Active Ingredient
PROPOFOL
Application Number
74848
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2005-04-19
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG/5ML
Approval Date
1987-05-15
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
70690
Product Number
1
Dosage Form
-
Strength
40MG/5ML
Approval Date
1987-05-15
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
20MG/5ML
Approval Date
1987-05-15
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
70690
Product Number
2
Dosage Form
-
Strength
20MG/5ML
Approval Date
1987-05-15
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2008-01-31
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
77760
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2008-01-31
Regulatory Status
RX
Drug Name
PROTAMINE SULFATE
Product Number
1
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
1986-11-05
Active Ingredient
PROTAMINE SULFATE
Application Number
89474
Product Number
1
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
1986-11-05
Regulatory Status
Discontinued
Drug Name
PROTAMINE SULFATE
Product Number
1
Dosage Form
-
Strength
250MG/25ML (10MG/ML)
Approval Date
1986-11-05
Active Ingredient
PROTAMINE SULFATE
Application Number
89475
Product Number
1
Dosage Form
-
Strength
250MG/25ML (10MG/ML)
Approval Date
1986-11-05
Regulatory Status
Discontinued
Drug Name
PROTAMINE SULFATE
Product Number
2
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
1988-06-07
Active Ingredient
PROTAMINE SULFATE
Application Number
89475
Product Number
2
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
1988-06-07
Regulatory Status
Discontinued
Drug Name
PROTRIPTYLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2008-09-16
Active Ingredient
PROTRIPTYLINE HYDROCHLORIDE
Application Number
78913
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2008-09-16
Regulatory Status
Discontinued
Drug Name
PROTRIPTYLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2008-09-16
Active Ingredient
PROTRIPTYLINE HYDROCHLORIDE
Application Number
78913
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2008-09-16
Regulatory Status
Discontinued
Drug Name
PRUCALOPRIDE SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2025-06-24
Active Ingredient
PRUCALOPRIDE SUCCINATE
Application Number
217662
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2025-06-24
Regulatory Status
RX
Drug Name
PRUCALOPRIDE SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2025-06-24
Active Ingredient
PRUCALOPRIDE SUCCINATE
Application Number
217662
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2025-06-24
Regulatory Status
RX
Drug Name
PYRAZINAMIDE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1992-06-30
Active Ingredient
PYRAZINAMIDE
Application Number
81319
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1992-06-30
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
90120
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
90749
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
90749
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
3
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
90749
Product Number
3
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
4
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
90749
Product Number
4
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
5
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
90749
Product Number
5
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUINIDINE SULFATE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1982-01-01
Active Ingredient
QUINIDINE SULFATE
Application Number
83862
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
RAMIPRIL
Product Number
1
Dosage Form
-
Strength
1.25MG
Approval Date
2008-06-18
Active Ingredient
RAMIPRIL
Application Number
77900
Product Number
1
Dosage Form
-
Strength
1.25MG
Approval Date
2008-06-18
Regulatory Status
RX
Drug Name
RAMIPRIL
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
2008-06-18
Active Ingredient
RAMIPRIL
Application Number
77900
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
2008-06-18
Regulatory Status
RX
Drug Name
RAMIPRIL
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2008-06-18
Active Ingredient
RAMIPRIL
Application Number
77900
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2008-06-18
Regulatory Status
RX
Drug Name
RAMIPRIL
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2008-06-18
Active Ingredient
RAMIPRIL
Application Number
77900
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2008-06-18
Regulatory Status
RX
Drug Name
RANITIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE/ML
Approval Date
2005-03-02
Active Ingredient
RANITIDINE HYDROCHLORIDE
Application Number
74777
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE/ML
Approval Date
2005-03-02
Regulatory Status
Discontinued
Drug Name
RANITIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE/ML
Approval Date
2006-02-16
Active Ingredient
RANITIDINE HYDROCHLORIDE
Application Number
77458
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE/ML
Approval Date
2006-02-16
Regulatory Status
Discontinued
Drug Name
REGADENOSON
Product Number
1
Dosage Form
-
Strength
0.4MG/5ML (0.08MG/ML)
Approval Date
2023-02-02
Active Ingredient
REGADENOSON
Application Number
215827
Product Number
1
Dosage Form
-
Strength
0.4MG/5ML (0.08MG/ML)
Approval Date
2023-02-02
Regulatory Status
RX
Drug Name
REGLAN
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
METOCLOPRAMIDE HYDROCHLORIDE
Application Number
17862
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
REGLAN
Product Number
4
Dosage Form
-
Strength
EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1987-05-28
Active Ingredient
METOCLOPRAMIDE HYDROCHLORIDE
Application Number
17862
Product Number
4
Dosage Form
-
Strength
EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1987-05-28
Regulatory Status
Discontinued
Drug Name
REMIFENTANIL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/VIAL
Approval Date
2020-10-13
Active Ingredient
REMIFENTANIL HYDROCHLORIDE
Application Number
210594
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/VIAL
Approval Date
2020-10-13
Regulatory Status
RX
Drug Name
REMIFENTANIL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE/VIAL
Approval Date
2020-10-13
Active Ingredient
REMIFENTANIL HYDROCHLORIDE
Application Number
210594
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE/VIAL
Approval Date
2020-10-13
Regulatory Status
RX
Drug Name
REMIFENTANIL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 5MG BASE/VIAL
Approval Date
2020-10-13
Active Ingredient
REMIFENTANIL HYDROCHLORIDE
Application Number
210594
Product Number
3
Dosage Form
-
Strength
EQ 5MG BASE/VIAL
Approval Date
2020-10-13
Regulatory Status
RX
Drug Name
RESERPINE
Product Number
1
Dosage Form
-
Strength
0.1MG
Approval Date
1982-01-01
Active Ingredient
RESERPINE
Application Number
80975
Product Number
1
Dosage Form
-
Strength
0.1MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
RESERPINE
Product Number
2
Dosage Form
-
Strength
0.25MG
Approval Date
1982-01-01
Active Ingredient
RESERPINE
Application Number
80975
Product Number
2
Dosage Form
-
Strength
0.25MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
RESERPINE
Product Number
3
Dosage Form
-
Strength
1MG
Approval Date
1982-01-01
Active Ingredient
RESERPINE
Application Number
80975
Product Number
3
Dosage Form
-
Strength
1MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
REVEX
Product Number
1
Dosage Form
-
Strength
EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1995-04-17
Active Ingredient
NALMEFENE HYDROCHLORIDE
Application Number
20459
Product Number
1
Dosage Form
-
Strength
EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1995-04-17
Regulatory Status
Discontinued
Drug Name
REVEX
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE/2ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1995-04-17
Active Ingredient
NALMEFENE HYDROCHLORIDE
Application Number
20459
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE/2ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1995-04-17
Regulatory Status
Discontinued
Drug Name
RIFAMPIN
Product Number
1
Dosage Form
-
Strength
600MG/VIAL
Approval Date
1999-10-29
Active Ingredient
RIFAMPIN
Application Number
64217
Product Number
1
Dosage Form
-
Strength
600MG/VIAL
Approval Date
1999-10-29
Regulatory Status
RX
Drug Name
RIFAMPIN
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2001-03-14
Active Ingredient
RIFAMPIN
Application Number
65028
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2001-03-14
Regulatory Status
Discontinued
Drug Name
RIFAMPIN
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2001-03-14
Active Ingredient
RIFAMPIN
Application Number
65028
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2001-03-14
Regulatory Status
Discontinued
Drug Name
RIFAMPIN
Product Number
1
Dosage Form
-
Strength
600MG/VIAL
Approval Date
2016-03-03
Active Ingredient
RIFAMPIN
Application Number
205039
Product Number
1
Dosage Form
-
Strength
600MG/VIAL
Approval Date
2016-03-03
Regulatory Status
RX
Drug Name
RIFAMPIN AND ISONIAZID
Product Number
1
Dosage Form
-
Strength
150MG;300MG
Approval Date
2005-07-29
Active Ingredient
ISONIAZID; RIFAMPIN
Application Number
65221
Product Number
1
Dosage Form
-
Strength
150MG;300MG
Approval Date
2005-07-29
Regulatory Status
Discontinued
Drug Name
RISPERIDONE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2009-07-29
Active Ingredient
RISPERIDONE
Application Number
76904
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2009-07-29
Regulatory Status
Discontinued
Drug Name
RITONAVIR
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2020-12-03
Active Ingredient
RITONAVIR
Application Number
205801
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2020-12-03
Regulatory Status
Discontinued
Drug Name
ROBAXIN
Product Number
1
Dosage Form
-
Strength
1GM/10ML (100MG/ML)
Approval Date
1982-01-01
Active Ingredient
METHOCARBAMOL
Application Number
11790
Product Number
1
Dosage Form
-
Strength
1GM/10ML (100MG/ML)
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
ROBINUL
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
1982-01-01
Active Ingredient
GLYCOPYRROLATE
Application Number
17558
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
ROCURONIUM BROMIDE
Product Number
1
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2023-05-24
Active Ingredient
ROCURONIUM BROMIDE
Application Number
217034
Product Number
1
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2023-05-24
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE
Approval Date
2008-05-05
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
77852
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE
Approval Date
2008-05-05
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2008-05-05
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
77852
Product Number
2
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2008-05-05
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2008-05-05
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
77852
Product Number
3
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2008-05-05
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2008-05-05
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
77852
Product Number
4
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2008-05-05
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
EQ 3MG BASE
Approval Date
2008-05-05
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
77852
Product Number
5
Dosage Form
-
Strength
EQ 3MG BASE
Approval Date
2008-05-05
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2008-05-05
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
77852
Product Number
6
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2008-05-05
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
7
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2008-05-19
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
77852
Product Number
7
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2008-05-19
Regulatory Status
Discontinued
Drug Name
ROPIVACAINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2024-08-15
Active Ingredient
ROPIVACAINE HYDROCHLORIDE
Application Number
211907
Product Number
1
Dosage Form
-
Strength
200MG/100ML (2MG/ML)
Approval Date
2024-08-15
Regulatory Status
RX
Drug Name
ROPIVACAINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2024-08-15
Active Ingredient
ROPIVACAINE HYDROCHLORIDE
Application Number
211907
Product Number
2
Dosage Form
-
Strength
400MG/200ML (2MG/ML)
Approval Date
2024-08-15
Regulatory Status
RX
Drug Name
ROPIVACAINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
500MG/100ML (5MG/ML)
Approval Date
2024-08-15
Active Ingredient
ROPIVACAINE HYDROCHLORIDE
Application Number
211907
Product Number
3
Dosage Form
-
Strength
500MG/100ML (5MG/ML)
Approval Date
2024-08-15
Regulatory Status
RX
Drug Name
ROPIVACAINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG/20ML (2MG/ML)
Approval Date
2020-07-20
Active Ingredient
ROPIVACAINE HYDROCHLORIDE
Application Number
214074
Product Number
1
Dosage Form
-
Strength
40MG/20ML (2MG/ML)
Approval Date
2020-07-20
Regulatory Status
RX
Drug Name
ROPIVACAINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
150MG/30ML (5MG/ML)
Approval Date
2020-07-20
Active Ingredient
ROPIVACAINE HYDROCHLORIDE
Application Number
214074
Product Number
2
Dosage Form
-
Strength
150MG/30ML (5MG/ML)
Approval Date
2020-07-20
Regulatory Status
RX
Drug Name
ROPIVACAINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
150MG/20ML (7.5MG/ML)
Approval Date
2020-07-20
Active Ingredient
ROPIVACAINE HYDROCHLORIDE
Application Number
214074
Product Number
3
Dosage Form
-
Strength
150MG/20ML (7.5MG/ML)
Approval Date
2020-07-20
Regulatory Status
RX
Drug Name
ROPIVACAINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
200MG/20ML (10MG/ML)
Approval Date
2020-07-20
Active Ingredient
ROPIVACAINE HYDROCHLORIDE
Application Number
214074
Product Number
4
Dosage Form
-
Strength
200MG/20ML (10MG/ML)
Approval Date
2020-07-20
Regulatory Status
RX
Drug Name
ROSIGLITAZONE MALEATE
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
-
Active Ingredient
ROSIGLITAZONE MALEATE
Application Number
78658
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ROSIGLITAZONE MALEATE
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
-
Active Ingredient
ROSIGLITAZONE MALEATE
Application Number
78658
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ROSIGLITAZONE MALEATE
Product Number
3
Dosage Form
-
Strength
8MG
Approval Date
-
Active Ingredient
ROSIGLITAZONE MALEATE
Application Number
78658
Product Number
3
Dosage Form
-
Strength
8MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ROXICET
Product Number
1
Dosage Form
-
Strength
325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Application Number
87003
Product Number
1
Dosage Form
-
Strength
325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
ROXICET
Product Number
1
Dosage Form
-
Strength
325MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1986-12-03
Active Ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Application Number
89351
Product Number
1
Dosage Form
-
Strength
325MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1986-12-03
Regulatory Status
Discontinued
Drug Name
RUFINAMIDE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2016-05-16
Active Ingredient
RUFINAMIDE
Application Number
204988
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2016-05-16
Regulatory Status
RX
Drug Name
RUFINAMIDE
Product Number
2
Dosage Form
-
Strength
400MG
Approval Date
2016-05-16
Active Ingredient
RUFINAMIDE
Application Number
204988
Product Number
2
Dosage Form
-
Strength
400MG
Approval Date
2016-05-16
Regulatory Status
RX
Drug Name
RUFINAMIDE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2019-04-23
Active Ingredient
RUFINAMIDE
Application Number
207363
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2019-04-23
Regulatory Status
RX
Drug Name
SAPROPTERIN DIHYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2025-06-11
Active Ingredient
SAPROPTERIN DIHYDROCHLORIDE
Application Number
218797
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2025-06-11
Regulatory Status
RX
Drug Name
SERTRALINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2009-08-10
Active Ingredient
SERTRALINE HYDROCHLORIDE
Application Number
77864
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2009-08-10
Regulatory Status
Discontinued
Drug Name
SERTRALINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2009-08-10
Active Ingredient
SERTRALINE HYDROCHLORIDE
Application Number
77864
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2009-08-10
Regulatory Status
Discontinued
Drug Name
SERTRALINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2009-08-10
Active Ingredient
SERTRALINE HYDROCHLORIDE
Application Number
77864
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2009-08-10
Regulatory Status
Discontinued
Drug Name
SODIUM ACETATE
Product Number
1
Dosage Form
-
Strength
40MEQ/20ML (2MEQ/ML)
Approval Date
2024-03-15
Active Ingredient
SODIUM ACETATE
Application Number
216920
Product Number
1
Dosage Form
-
Strength
40MEQ/20ML (2MEQ/ML)
Approval Date
2024-03-15
Regulatory Status
RX
Drug Name
SODIUM ACETATE
Product Number
2
Dosage Form
-
Strength
100MEQ/50ML (2MEQ/ML)
Approval Date
2024-03-15
Active Ingredient
SODIUM ACETATE
Application Number
216920
Product Number
2
Dosage Form
-
Strength
100MEQ/50ML (2MEQ/ML)
Approval Date
2024-03-15
Regulatory Status
RX
Drug Name
SODIUM ACETATE
Product Number
3
Dosage Form
-
Strength
200MEQ/100ML (2MEQ/ML)
Approval Date
2024-03-15
Active Ingredient
SODIUM ACETATE
Application Number
216920
Product Number
3
Dosage Form
-
Strength
200MEQ/100ML (2MEQ/ML)
Approval Date
2024-03-15
Regulatory Status
RX
Drug Name
SODIUM BUTABARBITAL
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
1982-01-01
Active Ingredient
BUTABARBITAL SODIUM
Application Number
85418
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
SODIUM BUTABARBITAL
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
1982-01-01
Active Ingredient
BUTABARBITAL SODIUM
Application Number
85432
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
SODIUM CHLORIDE 0.9%
Product Number
1
Dosage Form
-
Strength
18MG/2ML (9MG/ML)
Approval Date
2013-09-24
Active Ingredient
SODIUM CHLORIDE
Application Number
201833
Product Number
1
Dosage Form
-
Strength
18MG/2ML (9MG/ML)
Approval Date
2013-09-24
Regulatory Status
RX
Drug Name
SODIUM CHLORIDE 0.9%
Product Number
2
Dosage Form
-
Strength
90MG/10ML (9MG/ML)
Approval Date
2015-01-07
Active Ingredient
SODIUM CHLORIDE
Application Number
201833
Product Number
2
Dosage Form
-
Strength
90MG/10ML (9MG/ML)
Approval Date
2015-01-07
Regulatory Status
RX
Drug Name
SODIUM CHLORIDE 0.9%
Product Number
1
Dosage Form
-
Strength
90MG/10ML (9MG/ML)
Approval Date
2012-01-20
Active Ingredient
SODIUM CHLORIDE
Application Number
201850
Product Number
1
Dosage Form
-
Strength
90MG/10ML (9MG/ML)
Approval Date
2012-01-20
Regulatory Status
Discontinued
Drug Name
SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE
Product Number
1
Dosage Form
-
Strength
EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML)
Approval Date
2011-03-31
Active Ingredient
SODIUM FERRIC GLUCONATE COMPLEX
Application Number
78215
Product Number
1
Dosage Form
-
Strength
EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML)
Approval Date
2011-03-31
Regulatory Status
RX
Drug Name
SODIUM OXYBATE
Product Number
1
Dosage Form
-
Strength
0.5GM/ML
Approval Date
2017-01-17
Active Ingredient
SODIUM OXYBATE
Application Number
202090
Product Number
1
Dosage Form
-
Strength
0.5GM/ML
Approval Date
2017-01-17
Regulatory Status
Discontinued
Drug Name
SODIUM POLYSTYRENE SULFONATE
Product Number
1
Dosage Form
-
Strength
15GM/60ML
Approval Date
1986-11-17
Active Ingredient
SODIUM POLYSTYRENE SULFONATE
Application Number
89049
Product Number
1
Dosage Form
-
Strength
15GM/60ML
Approval Date
1986-11-17
Regulatory Status
Discontinued
Drug Name
SODIUM TETRADECYL SULFATE
Product Number
1
Dosage Form
-
Strength
60MG/2ML (30MG/ML)
Approval Date
2019-12-09
Active Ingredient
SODIUM TETRADECYL SULFATE
Application Number
209937
Product Number
1
Dosage Form
-
Strength
60MG/2ML (30MG/ML)
Approval Date
2019-12-09
Regulatory Status
RX
Drug Name
SOLRIAMFETOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2026-06-17
Active Ingredient
SOLRIAMFETOL HYDROCHLORIDE
Application Number
218016
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2026-06-17
Regulatory Status
RX
Drug Name
SOLRIAMFETOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2026-06-17
Active Ingredient
SOLRIAMFETOL HYDROCHLORIDE
Application Number
218016
Product Number
2
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2026-06-17
Regulatory Status
RX
Drug Name
SPARINE
Product Number
6
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Active Ingredient
PROMAZINE HYDROCHLORIDE
Application Number
10349
Product Number
6
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
SPARINE
Product Number
8
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Active Ingredient
PROMAZINE HYDROCHLORIDE
Application Number
10349
Product Number
8
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
STERILE WATER FOR INJECTION
Product Number
1
Dosage Form
-
Strength
100% (10ML)
Approval Date
2015-09-02
Active Ingredient
STERILE WATER FOR INJECTION
Application Number
206369
Product Number
1
Dosage Form
-
Strength
100% (10ML)
Approval Date
2015-09-02
Regulatory Status
RX
Drug Name
STERILE WATER FOR INJECTION
Product Number
2
Dosage Form
-
Strength
100% (20ML)
Approval Date
2015-09-02
Active Ingredient
STERILE WATER FOR INJECTION
Application Number
206369
Product Number
2
Dosage Form
-
Strength
100% (20ML)
Approval Date
2015-09-02
Regulatory Status
Discontinued
Drug Name
STERILE WATER FOR INJECTION
Product Number
1
Dosage Form
-
Strength
100%
Approval Date
2023-01-31
Active Ingredient
STERILE WATER FOR INJECTION
Application Number
212735
Product Number
1
Dosage Form
-
Strength
100%
Approval Date
2023-01-31
Regulatory Status
RX
Drug Name
SUCCINYLCHOLINE CHLORIDE
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2020-06-12
Active Ingredient
SUCCINYLCHOLINE CHLORIDE
Application Number
213229
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2020-06-12
Regulatory Status
RX
Drug Name
SUCCINYLCHOLINE CHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG/5ML (20MG/ML)
Approval Date
2021-08-20
Active Ingredient
SUCCINYLCHOLINE CHLORIDE
Application Number
215143
Product Number
1
Dosage Form
-
Strength
100MG/5ML (20MG/ML)
Approval Date
2021-08-20
Regulatory Status
Discontinued
Drug Name
SUCRALFATE
Product Number
1
Dosage Form
-
Strength
1GM/10ML
Approval Date
2024-07-23
Active Ingredient
SUCRALFATE
Application Number
212769
Product Number
1
Dosage Form
-
Strength
1GM/10ML
Approval Date
2024-07-23
Regulatory Status
Discontinued
Drug Name
SUFENTANIL CITRATE
Product Number
1
Dosage Form
-
Strength
EQ 0.05MG BASE/ML
Approval Date
1995-12-15
Active Ingredient
SUFENTANIL CITRATE
Application Number
74413
Product Number
1
Dosage Form
-
Strength
EQ 0.05MG BASE/ML
Approval Date
1995-12-15
Regulatory Status
Discontinued
Drug Name
SUGAMMADEX SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Active Ingredient
SUGAMMADEX SODIUM
Application Number
218727
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Regulatory Status
RX
Drug Name
SUGAMMADEX SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Active Ingredient
SUGAMMADEX SODIUM
Application Number
218728
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Regulatory Status
RX
Drug Name
SUGAMMADEX SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Active Ingredient
SUGAMMADEX SODIUM
Application Number
218728
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Regulatory Status
RX
Drug Name
SULFAMETHOXAZOLE AND TRIMETHOPRIM
Product Number
1
Dosage Form
-
Strength
80MG/ML;16MG/ML
Approval Date
1987-12-29
Active Ingredient
SULFAMETHOXAZOLE; TRIMETHOPRIM
Application Number
70627
Product Number
1
Dosage Form
-
Strength
80MG/ML;16MG/ML
Approval Date
1987-12-29
Regulatory Status
Discontinued
Drug Name
SULFAMETHOXAZOLE AND TRIMETHOPRIM
Product Number
1
Dosage Form
-
Strength
80MG/ML;16MG/ML
Approval Date
1987-12-29
Active Ingredient
SULFAMETHOXAZOLE; TRIMETHOPRIM
Application Number
70628
Product Number
1
Dosage Form
-
Strength
80MG/ML;16MG/ML
Approval Date
1987-12-29
Regulatory Status
Discontinued
Drug Name
SULFAMETHOXAZOLE AND TRIMETHOPRIM
Product Number
1
Dosage Form
-
Strength
200MG/5ML;40MG/5ML
Approval Date
1997-12-29
Active Ingredient
SULFAMETHOXAZOLE; TRIMETHOPRIM
Application Number
74650
Product Number
1
Dosage Form
-
Strength
200MG/5ML;40MG/5ML
Approval Date
1997-12-29
Regulatory Status
Discontinued
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2013-05-21
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
78298
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2013-05-21
Regulatory Status
Discontinued
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2013-05-21
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
78298
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2013-05-21
Regulatory Status
Discontinued
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2013-05-21
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
78298
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2013-05-21
Regulatory Status
Discontinued
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Approval Date
2009-02-06
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
79123
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Approval Date
2009-02-06
Regulatory Status
RX
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Approval Date
2013-09-16
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
200183
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Approval Date
2013-09-16
Regulatory Status
RX
Drug Name
TAPENTADOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2026-02-10
Active Ingredient
TAPENTADOL HYDROCHLORIDE
Application Number
205057
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2026-02-10
Regulatory Status
Discontinued
Drug Name
TAPENTADOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2026-02-10
Active Ingredient
TAPENTADOL HYDROCHLORIDE
Application Number
205057
Product Number
2
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2026-02-10
Regulatory Status
Discontinued
Drug Name
TAPENTADOL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2026-02-10
Active Ingredient
TAPENTADOL HYDROCHLORIDE
Application Number
205057
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2026-02-10
Regulatory Status
Discontinued
Drug Name
TERAZOSIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2001-04-12
Active Ingredient
TERAZOSIN HYDROCHLORIDE
Application Number
75498
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2001-04-12
Regulatory Status
Discontinued
Drug Name
TERAZOSIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2001-04-12
Active Ingredient
TERAZOSIN HYDROCHLORIDE
Application Number
75498
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2001-04-12
Regulatory Status
Discontinued
Drug Name
TERAZOSIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2001-04-12
Active Ingredient
TERAZOSIN HYDROCHLORIDE
Application Number
75498
Product Number
3
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2001-04-12
Regulatory Status
Discontinued
Drug Name
TERAZOSIN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2001-04-12
Active Ingredient
TERAZOSIN HYDROCHLORIDE
Application Number
75498
Product Number
4
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2001-04-12
Regulatory Status
Discontinued
Drug Name
TERBUTALINE SULFATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2009-05-20
Active Ingredient
TERBUTALINE SULFATE
Application Number
78630
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2009-05-20
Regulatory Status
RX
Drug Name
TESTOSTERONE CYPIONATE
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2010-07-15
Active Ingredient
TESTOSTERONE CYPIONATE
Application Number
90387
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2010-07-15
Regulatory Status
RX
Drug Name
TESTOSTERONE CYPIONATE
Product Number
2
Dosage Form
-
Strength
200MG/ML
Approval Date
2010-07-15
Active Ingredient
TESTOSTERONE CYPIONATE
Application Number
90387
Product Number
2
Dosage Form
-
Strength
200MG/ML
Approval Date
2010-07-15
Regulatory Status
RX
Drug Name
TESTOSTERONE CYPIONATE
Product Number
1
Dosage Form
-
Strength
200MG/ML
Approval Date
2012-05-01
Active Ingredient
TESTOSTERONE CYPIONATE
Application Number
91244
Product Number
1
Dosage Form
-
Strength
200MG/ML
Approval Date
2012-05-01
Regulatory Status
RX
Drug Name
TESTOSTERONE ENANTHATE
Product Number
1
Dosage Form
-
Strength
200MG/ML
Approval Date
2012-09-18
Active Ingredient
TESTOSTERONE ENANTHATE
Application Number
91120
Product Number
1
Dosage Form
-
Strength
200MG/ML
Approval Date
2012-09-18
Regulatory Status
RX
Drug Name
TESTOSTERONE UNDECANOATE
Product Number
1
Dosage Form
-
Strength
750MG/3ML (250MG/ML)
Approval Date
-
Active Ingredient
TESTOSTERONE UNDECANOATE
Application Number
207583
Product Number
1
Dosage Form
-
Strength
750MG/3ML (250MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
TETRABENAZINE
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
2019-04-08
Active Ingredient
TETRABENAZINE
Application Number
209739
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
2019-04-08
Regulatory Status
Discontinued
Drug Name
TETRABENAZINE
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2019-04-08
Active Ingredient
TETRABENAZINE
Application Number
209739
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2019-04-08
Regulatory Status
Discontinued
Drug Name
TETRACYCLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1982-01-01
Active Ingredient
TETRACYCLINE HYDROCHLORIDE
Application Number
60768
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
TETRACYCLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Active Ingredient
TETRACYCLINE HYDROCHLORIDE
Application Number
60768
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
THIOTEPA
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
2023-09-05
Active Ingredient
THIOTEPA
Application Number
211755
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
2023-09-05
Regulatory Status
RX
Drug Name
THIOTHIXENE HYDROCHLORIDE INTENSOL
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1992-06-30
Active Ingredient
THIOTHIXENE HYDROCHLORIDE
Application Number
73494
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1992-06-30
Regulatory Status
Discontinued
Drug Name
TIMOLOL MALEATE
Product Number
1
Dosage Form
-
Strength
EQ 0.5% BASE
Approval Date
2002-09-10
Active Ingredient
TIMOLOL MALEATE
Application Number
75163
Product Number
1
Dosage Form
-
Strength
EQ 0.5% BASE
Approval Date
2002-09-10
Regulatory Status
Discontinued
Drug Name
TINIDAZOLE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2012-04-30
Active Ingredient
TINIDAZOLE
Application Number
201172
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2012-04-30
Regulatory Status
Discontinued
Drug Name
TINIDAZOLE
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2012-04-30
Active Ingredient
TINIDAZOLE
Application Number
201172
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2012-04-30
Regulatory Status
Discontinued
Drug Name
TOBRAMYCIN
Product Number
1
Dosage Form
-
Strength
300MG/5ML
Approval Date
2014-05-28
Active Ingredient
TOBRAMYCIN
Application Number
201422
Product Number
1
Dosage Form
-
Strength
300MG/5ML
Approval Date
2014-05-28
Regulatory Status
RX
Drug Name
TOBRAMYCIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
1991-04-26
Active Ingredient
TOBRAMYCIN SULFATE
Application Number
63113
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
1991-04-26
Regulatory Status
Discontinued
Drug Name
TOBRAMYCIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
1991-04-26
Active Ingredient
TOBRAMYCIN SULFATE
Application Number
63117
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
1991-04-26
Regulatory Status
RX
Drug Name
TOBRAMYCIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
1991-07-29
Active Ingredient
TOBRAMYCIN SULFATE
Application Number
63118
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
1991-07-29
Regulatory Status
Discontinued
Drug Name
TOBRAMYCIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
1991-11-27
Active Ingredient
TOBRAMYCIN SULFATE
Application Number
63127
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
1991-11-27
Regulatory Status
Discontinued
Drug Name
TOBRAMYCIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
1991-11-27
Active Ingredient
TOBRAMYCIN SULFATE
Application Number
63128
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
1991-11-27
Regulatory Status
Discontinued
Drug Name
TOFACITINIB CITRATE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2023-09-25
Active Ingredient
TOFACITINIB CITRATE
Application Number
216878
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE/ML
Approval Date
2023-09-25
Regulatory Status
RX
Drug Name
TOPIRAMATE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2013-11-25
Active Ingredient
TOPIRAMATE
Application Number
91185
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2013-11-25
Regulatory Status
Discontinued
Drug Name
TOPIRAMATE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2013-11-25
Active Ingredient
TOPIRAMATE
Application Number
91185
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2013-11-25
Regulatory Status
Discontinued
Drug Name
TOPIRAMATE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2013-11-25
Active Ingredient
TOPIRAMATE
Application Number
91185
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2013-11-25
Regulatory Status
Discontinued
Drug Name
TOPIRAMATE
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2013-11-25
Active Ingredient
TOPIRAMATE
Application Number
91185
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2013-11-25
Regulatory Status
Discontinued
Drug Name
TORSEMIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2005-03-01
Active Ingredient
TORSEMIDE
Application Number
76943
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2005-03-01
Regulatory Status
Discontinued
Drug Name
TORSEMIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2005-03-01
Active Ingredient
TORSEMIDE
Application Number
76943
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2005-03-01
Regulatory Status
Discontinued
Drug Name
TORSEMIDE
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
2005-03-01
Active Ingredient
TORSEMIDE
Application Number
76943
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
2005-03-01
Regulatory Status
RX
Drug Name
TORSEMIDE
Product Number
1
Dosage Form
-
Strength
20MG/2ML (10MG/ML)
Approval Date
2008-06-11
Active Ingredient
TORSEMIDE
Application Number
78007
Product Number
1
Dosage Form
-
Strength
20MG/2ML (10MG/ML)
Approval Date
2008-06-11
Regulatory Status
Discontinued
Drug Name
TORSEMIDE
Product Number
2
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2008-06-11
Active Ingredient
TORSEMIDE
Application Number
78007
Product Number
2
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2008-06-11
Regulatory Status
Discontinued
Drug Name
TRAMETINIB DIMETHYL SULFOXIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.5MG
Approval Date
2024-08-06
Active Ingredient
TRAMETINIB DIMETHYL SULFOXIDE
Application Number
219002
Product Number
1
Dosage Form
-
Strength
EQ 0.5MG
Approval Date
2024-08-06
Regulatory Status
Discontinued
Drug Name
TRAMETINIB DIMETHYL SULFOXIDE
Product Number
2
Dosage Form
-
Strength
EQ 2MG
Approval Date
2024-08-06
Active Ingredient
TRAMETINIB DIMETHYL SULFOXIDE
Application Number
219002
Product Number
2
Dosage Form
-
Strength
EQ 2MG
Approval Date
2024-08-06
Regulatory Status
Discontinued
Drug Name
TRIAMCINOLONE ACETONIDE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2024-12-09
Active Ingredient
TRIAMCINOLONE ACETONIDE
Application Number
215254
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2024-12-09
Regulatory Status
RX
Drug Name
TRIAZOLAM
Product Number
1
Dosage Form
-
Strength
0.125MG
Approval Date
1994-06-01
Active Ingredient
TRIAZOLAM
Application Number
74224
Product Number
1
Dosage Form
-
Strength
0.125MG
Approval Date
1994-06-01
Regulatory Status
Discontinued
Drug Name
TRIAZOLAM
Product Number
2
Dosage Form
-
Strength
0.25MG
Approval Date
1994-06-01
Active Ingredient
TRIAZOLAM
Application Number
74224
Product Number
2
Dosage Form
-
Strength
0.25MG
Approval Date
1994-06-01
Regulatory Status
Discontinued
Drug Name
TRIFLURIDINE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2017-07-28
Active Ingredient
TRIFLURIDINE
Application Number
205438
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2017-07-28
Regulatory Status
Discontinued
Drug Name
TRIHEXYPHENIDYL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2000-02-16
Active Ingredient
TRIHEXYPHENIDYL HYDROCHLORIDE
Application Number
40337
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2000-02-16
Regulatory Status
Discontinued
Drug Name
TRIHEXYPHENIDYL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2000-02-16
Active Ingredient
TRIHEXYPHENIDYL HYDROCHLORIDE
Application Number
40337
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2000-02-16
Regulatory Status
Discontinued
Drug Name
TYZAVAN
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/100ML (EQ 5MG BASE/ML)
Approval Date
2019-02-15
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
211962
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/100ML (EQ 5MG BASE/ML)
Approval Date
2019-02-15
Regulatory Status
RX
Drug Name
TYZAVAN
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/200ML (EQ 5MG BASE/ML)
Approval Date
2019-02-15
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
211962
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/200ML (EQ 5MG BASE/ML)
Approval Date
2019-02-15
Regulatory Status
RX
Drug Name
TYZAVAN
Product Number
3
Dosage Form
-
Strength
EQ 1.5GM BASE/300ML (EQ 5MG BASE/ML)
Approval Date
2019-02-15
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
211962
Product Number
3
Dosage Form
-
Strength
EQ 1.5GM BASE/300ML (EQ 5MG BASE/ML)
Approval Date
2019-02-15
Regulatory Status
RX
Drug Name
TYZAVAN
Product Number
4
Dosage Form
-
Strength
EQ 2GM BASE/400ML (EQ 5MG BASE/ML)
Approval Date
2019-02-15
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
211962
Product Number
4
Dosage Form
-
Strength
EQ 2GM BASE/400ML (EQ 5MG BASE/ML)
Approval Date
2019-02-15
Regulatory Status
RX
Drug Name
TYZAVAN
Product Number
5
Dosage Form
-
Strength
EQ 750MG BASE/150ML (EQ 5MG BASE/ML)
Approval Date
2020-05-13
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
211962
Product Number
5
Dosage Form
-
Strength
EQ 750MG BASE/150ML (EQ 5MG BASE/ML)
Approval Date
2020-05-13
Regulatory Status
RX
Drug Name
TYZAVAN
Product Number
6
Dosage Form
-
Strength
EQ 1.25GM BASE/250ML (EQ 5MG BASE/ML)
Approval Date
2020-05-13
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
211962
Product Number
6
Dosage Form
-
Strength
EQ 1.25GM BASE/250ML (EQ 5MG BASE/ML)
Approval Date
2020-05-13
Regulatory Status
RX
Drug Name
TYZAVAN
Product Number
7
Dosage Form
-
Strength
EQ 1.75GM BASE/350ML (EQ 5MG BASE/ML)
Approval Date
2020-05-13
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
211962
Product Number
7
Dosage Form
-
Strength
EQ 1.75GM BASE/350ML (EQ 5MG BASE/ML)
Approval Date
2020-05-13
Regulatory Status
RX
Drug Name
VALACYCLOVIR HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2010-05-24
Active Ingredient
VALACYCLOVIR HYDROCHLORIDE
Application Number
78656
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2010-05-24
Regulatory Status
Discontinued
Drug Name
VALACYCLOVIR HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
2010-05-24
Active Ingredient
VALACYCLOVIR HYDROCHLORIDE
Application Number
78656
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
2010-05-24
Regulatory Status
Discontinued
Drug Name
VALPROATE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/ML
Approval Date
2010-02-17
Active Ingredient
VALPROATE SODIUM
Application Number
78523
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/ML
Approval Date
2010-02-17
Regulatory Status
RX
Drug Name
VALPROIC ACID
Product Number
1
Dosage Form
-
Strength
250MG/5ML
Approval Date
1995-01-13
Active Ingredient
VALPROIC ACID
Application Number
74060
Product Number
1
Dosage Form
-
Strength
250MG/5ML
Approval Date
1995-01-13
Regulatory Status
Discontinued
Drug Name
VALRUBICIN
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2019-04-19
Active Ingredient
VALRUBICIN
Application Number
206430
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2019-04-19
Regulatory Status
RX
Drug Name
VANCOLED
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1986-07-22
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
62682
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1986-07-22
Regulatory Status
Discontinued
Drug Name
VANCOLED
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-03-30
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
62682
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-03-30
Regulatory Status
Discontinued
Drug Name
VANCOLED
Product Number
3
Dosage Form
-
Strength
EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-05-11
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
62682
Product Number
3
Dosage Form
-
Strength
EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-05-11
Regulatory Status
Discontinued
Drug Name
VANCOLED
Product Number
4
Dosage Form
-
Strength
EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-05-11
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
62682
Product Number
4
Dosage Form
-
Strength
EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-05-11
Regulatory Status
Discontinued
Drug Name
VANCOLED
Product Number
5
Dosage Form
-
Strength
EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-05-11
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
62682
Product Number
5
Dosage Form
-
Strength
EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-05-11
Regulatory Status
Discontinued
Drug Name
VANCOMYCIN
Product Number
1
Dosage Form
-
Strength
5GM/100ML (50MG/ML)
Approval Date
2021-08-26
Active Ingredient
VANCOMYCIN
Application Number
213895
Product Number
1
Dosage Form
-
Strength
5GM/100ML (50MG/ML)
Approval Date
2021-08-26
Regulatory Status
Discontinued
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1988-08-02
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
62879
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
1988-08-02
Regulatory Status
Discontinued
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1988-08-02
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
62879
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
1988-08-02
Regulatory Status
Discontinued
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2020-08-11
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
203300
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2020-08-11
Regulatory Status
Discontinued
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2020-08-11
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
203300
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2020-08-11
Regulatory Status
RX
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2015-12-28
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
204107
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2015-12-28
Regulatory Status
RX
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2015-12-28
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
204107
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2015-12-28
Regulatory Status
RX
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 5GM BASE/VIAL
Approval Date
2018-10-15
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
204360
Product Number
1
Dosage Form
-
Strength
EQ 5GM BASE/VIAL
Approval Date
2018-10-15
Regulatory Status
RX
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2018-10-15
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
204360
Product Number
2
Dosage Form
-
Strength
EQ 10GM BASE/VIAL
Approval Date
2018-10-15
Regulatory Status
RX
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 750MG BASE/VIAL
Approval Date
2018-10-03
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
206616
Product Number
1
Dosage Form
-
Strength
EQ 750MG BASE/VIAL
Approval Date
2018-10-03
Regulatory Status
RX
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1.25GM BASE/VIAL
Approval Date
2023-06-29
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
217489
Product Number
1
Dosage Form
-
Strength
EQ 1.25GM BASE/VIAL
Approval Date
2023-06-29
Regulatory Status
RX
Drug Name
VANCOMYCIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1.5GM BASE/VIAL
Approval Date
2023-06-29
Active Ingredient
VANCOMYCIN HYDROCHLORIDE
Application Number
217489
Product Number
2
Dosage Form
-
Strength
EQ 1.5GM BASE/VIAL
Approval Date
2023-06-29
Regulatory Status
RX
Drug Name
VECURONIUM BROMIDE
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
1999-08-23
Active Ingredient
VECURONIUM BROMIDE
Application Number
75218
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
1999-08-23
Regulatory Status
Discontinued
Drug Name
VECURONIUM BROMIDE
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
1999-08-23
Active Ingredient
VECURONIUM BROMIDE
Application Number
75218
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
1999-08-23
Regulatory Status
Discontinued
Drug Name
VECURONIUM BROMIDE
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
2000-06-13
Active Ingredient
VECURONIUM BROMIDE
Application Number
75549
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
2000-06-13
Regulatory Status
RX
Drug Name
VECURONIUM BROMIDE
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
2000-06-13
Active Ingredient
VECURONIUM BROMIDE
Application Number
75549
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
2000-06-13
Regulatory Status
RX
Drug Name
VECURONIUM BROMIDE
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
2019-07-30
Active Ingredient
VECURONIUM BROMIDE
Application Number
203725
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
2019-07-30
Regulatory Status
RX
Drug Name
VECURONIUM BROMIDE
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
2019-07-30
Active Ingredient
VECURONIUM BROMIDE
Application Number
203725
Product Number
2
Dosage Form
-
Strength
20MG/VIAL
Approval Date
2019-07-30
Regulatory Status
RX
Drug Name
VIGABATRIN
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2022-08-29
Active Ingredient
VIGABATRIN
Application Number
213104
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2022-08-29
Regulatory Status
RX
Drug Name
VINBLASTINE SULFATE
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
1987-04-09
Active Ingredient
VINBLASTINE SULFATE
Application Number
89395
Product Number
1
Dosage Form
-
Strength
10MG/VIAL
Approval Date
1987-04-09
Regulatory Status
RX
Drug Name
VINORELBINE TARTRATE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2003-06-10
Active Ingredient
VINORELBINE TARTRATE
Application Number
75992
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2003-06-10
Regulatory Status
RX
Drug Name
VINORELBINE TARTRATE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2003-12-11
Active Ingredient
VINORELBINE TARTRATE
Application Number
76461
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2003-12-11
Regulatory Status
RX
Drug Name
VORICONAZOLE
Product Number
1
Dosage Form
-
Strength
200MG/VIAL
Approval Date
2017-03-09
Active Ingredient
VORICONAZOLE
Application Number
208562
Product Number
1
Dosage Form
-
Strength
200MG/VIAL
Approval Date
2017-03-09
Regulatory Status
RX
Drug Name
VORICONAZOLE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
VORICONAZOLE
Application Number
208562
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VOSOL
Product Number
1
Dosage Form
-
Strength
2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
ACETIC ACID, GLACIAL
Application Number
12179
Product Number
1
Dosage Form
-
Strength
2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
XOPENEX
Product Number
1
Dosage Form
-
Strength
EQ 0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-03-25
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
20837
Product Number
1
Dosage Form
-
Strength
EQ 0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-03-25
Regulatory Status
Discontinued
Drug Name
XOPENEX
Product Number
2
Dosage Form
-
Strength
EQ 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-03-25
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
20837
Product Number
2
Dosage Form
-
Strength
EQ 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1999-03-25
Regulatory Status
Discontinued
Drug Name
XOPENEX
Product Number
3
Dosage Form
-
Strength
EQ 0.0103% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2002-01-30
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
20837
Product Number
3
Dosage Form
-
Strength
EQ 0.0103% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2002-01-30
Regulatory Status
Discontinued
Drug Name
XOPENEX
Product Number
4
Dosage Form
-
Strength
EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2003-07-18
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
20837
Product Number
4
Dosage Form
-
Strength
EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2003-07-18
Regulatory Status
Discontinued
Drug Name
XTRENBO
Product Number
2
Dosage Form
-
Strength
120MG/1.7ML(70MG/ML)
Approval Date
-
Active Ingredient
DENOSUMAB-QBDE
Application Number
761439
Product Number
2
Dosage Form
-
Strength
120MG/1.7ML(70MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZALEPLON
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2008-06-06
Active Ingredient
ZALEPLON
Application Number
77237
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2008-06-06
Regulatory Status
RX
Drug Name
ZALEPLON
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2008-06-06
Active Ingredient
ZALEPLON
Application Number
77237
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2008-06-06
Regulatory Status
RX
Drug Name
ZALEPLON
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2008-11-25
Active Ingredient
ZALEPLON
Application Number
78147
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2008-11-25
Regulatory Status
Discontinued
Drug Name
ZALEPLON
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2008-11-25
Active Ingredient
ZALEPLON
Application Number
78147
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2008-11-25
Regulatory Status
Discontinued
Drug Name
ZIDOVUDINE
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2005-09-19
Active Ingredient
ZIDOVUDINE
Application Number
76844
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2005-09-19
Regulatory Status
Discontinued
Drug Name
ZOLEDRONIC ACID
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/5ML
Approval Date
2013-06-03
Active Ingredient
ZOLEDRONIC ACID
Application Number
202182
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/5ML
Approval Date
2013-06-03
Regulatory Status
RX
Drug Name
ZOLPIDEM TARTRATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2008-04-30
Active Ingredient
ZOLPIDEM TARTRATE
Application Number
78129
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2008-04-30
Regulatory Status
Discontinued
Drug Name
ZOLPIDEM TARTRATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2008-04-30
Active Ingredient
ZOLPIDEM TARTRATE
Application Number
78129
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2008-04-30
Regulatory Status
Discontinued
Drug Status Breakdown
1144 total- RX
- Discontinued
- Unclassified
- OTC
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ABIRATERONE ACETATE
Application Number
208339
Product Number
1
Active Ingredient
ABIRATERONE ACETATE
Dosage Form
-
Strength
250MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.